1	Function	function	NN	_	0	ROOT
2	,	,	,	_	1	P
3	expression	expression	NN	_	1	CONJ
4	and	and	CC	_	3	COORD
5	localization	localization	NN	_	4	CONJ
6	of	of	IN	_	1	NMOD
7	annexin	annexin	NN	_	8	NMOD
8	A7	a0	NN	_	6	PMOD
9	in	in	IN	_	1	LOC
10	platelets	platelet	NNS	_	9	PMOD
11	and	and	CC	_	10	COORD
12	red	red	JJ	_	14	NMOD
13	blood	blood	NN	_	14	NMOD
14	cells	cell	NNS	_	11	CONJ
15	:	:	:	_	1	P
16	Insights	insight	NNS	_	1	DEP
17	derived	derive	VBN	_	16	NMOD
18	from	from	IN	_	17	ADV
19	an	an	DT	_	23	NMOD
20	annexin	annexin	NN	_	21	NMOD
21	A7	a0	NN	_	23	NMOD
22	mutant	mutant	JJ	_	23	NMOD
23	mouse	mouse	NN	_	18	PMOD

1	Abstract	abstract	NN	_	0	ROOT

1	Background	background	NN	_	0	ROOT

1	Annexin	annexin	NN	_	2	NMOD
2	A7	a0	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	a	a	DT	_	11	NMOD
5	Ca2+	ca0+	NN	_	10	AMOD
6	-	-	HYPH	_	5	P
7	and	and	CC	_	5	COORD
8	phospholipid	phospholipid	NN	_	7	CONJ
9	-	-	HYPH	_	5	P
10	binding	bind	VBG	_	11	NMOD
11	protein	protein	NN	_	3	PRD
12	expressed	express	VBN	_	11	NMOD
13	as	as	IN	_	12	MNR
14	a	a	DT	_	19	NMOD
15	47	0	CD	_	18	NMOD
16	and	and	CC	_	15	COORD
17	51	0	CD	_	16	CONJ
18	kDa	kda	NN	_	19	NMOD
19	isoform	isoform	NN	_	13	PMOD
20	,	,	,	_	19	P
21	which	which	WDT	_	22	SBJ
22	is	be	VBZ	_	19	NMOD
23	thought	think	VBN	_	22	VC
24	to	to	TO	_	23	OPRD
25	be	be	VB	_	24	IM
26	involved	involve	VBN	_	25	VC
27	in	in	IN	_	26	ADV
28	membrane	membrane	NN	_	29	NMOD
29	fusion	fusion	NN	_	30	NMOD
30	processes	process	NNS	_	27	PMOD
31	.	.	.	_	3	P

1	Recently	recently	RB	_	6	TMP
2	the	the	DT	_	5	NMOD
3	47	0	CD	_	4	NMOD
4	kDa	kda	NN	_	5	NMOD
5	isoform	isoform	NN	_	6	SBJ
6	has	have	VBZ	_	0	ROOT
7	been	be	VBN	_	6	VC
8	identified	identify	VBN	_	7	VC
9	in	in	IN	_	8	LOC
10	erythrocytes	erythrocyte	NNS	_	9	PMOD
11	where	where	WRB	_	16	LOC
12	it	it	PRP	_	13	SBJ
13	was	be	VBD	_	10	NMOD
14	proposed	propose	VBN	_	13	VC
15	to	to	TO	_	14	OPRD
16	be	be	VB	_	15	IM
17	a	a	DT	_	19	NMOD
18	key	key	JJ	_	19	NMOD
19	component	component	NN	_	16	PRD
20	in	in	IN	_	19	NMOD
21	the	the	DT	_	22	NMOD
22	process	process	NN	_	20	PMOD
23	of	of	IN	_	22	NMOD
24	the	the	DT	_	29	NMOD
25	Ca2+	ca0+	NN	_	27	AMOD
26	-	-	HYPH	_	25	P
27	dependent	dependent	JJ	_	29	NMOD
28	vesicle	vesicle	NN	_	29	NMOD
29	release	release	NN	_	23	PMOD
30	,	,	,	_	22	P
31	a	a	DT	_	32	NMOD
32	process	process	NN	_	22	APPO
33	with	with	IN	_	39	ADV
34	which	which	WDT	_	33	PMOD
35	red	red	JJ	_	37	NMOD
36	blood	blood	NN	_	37	NMOD
37	cells	cell	NNS	_	38	SBJ
38	might	might	MD	_	32	NMOD
39	protect	protect	VB	_	38	VC
40	themselves	themselves	PRP	_	39	OBJ
41	against	against	IN	_	39	ADV
42	an	an	DT	_	43	NMOD
43	attack	attack	NN	_	41	PMOD
44	by	by	IN	_	43	NMOD
45	for	for	IN	_	48	NMOD
46	example	example	NN	_	45	PMOD
47	complement	complement	NN	_	48	NMOD
48	components	component	NNS	_	44	PMOD
49	.	.	.	_	6	P

1	Results	result	NNS	_	0	ROOT

1	The	the	DT	_	2	NMOD
2	role	role	NN	_	10	SBJ
3	of	of	IN	_	2	NMOD
4	annexin	annexin	NN	_	5	NMOD
5	A7	a0	NN	_	3	PMOD
6	in	in	IN	_	2	LOC
7	red	red	JJ	_	9	NMOD
8	blood	blood	NN	_	9	NMOD
9	cells	cell	NNS	_	6	PMOD
10	was	be	VBD	_	0	ROOT
11	addressed	address	VBN	_	10	VC
12	in	in	IN	_	11	LOC
13	erythrocytes	erythrocyte	NNS	_	12	PMOD
14	from	from	IN	_	13	NMOD
15	anxA7	anxa0	JJ	_	19	NMOD
16	-	-	SYM	_	15	P
17	/	/	HYPH	_	15	P
18	-	-	SYM	_	15	P
19	mice	mouse	NNS	_	14	PMOD
20	.	.	.	_	10	P

1	Interestingly	interestingly	RB	_	9	ADV
2	,	,	,	_	9	P
3	the	the	DT	_	8	NMOD
4	Ca2+	ca0+	NN	_	6	AMOD
5	-	-	HYPH	_	4	P
6	mediated	mediate	VBN	_	8	NMOD
7	vesiculation	vesiculation	NN	_	8	NMOD
8	process	process	NN	_	9	SBJ
9	was	be	VBD	_	0	ROOT
10	not	not	RB	_	9	ADV
11	impaired	impair	VBN	_	9	VC
12	.	.	.	_	9	P

1	Also	also	RB	_	6	ADV
2	,	,	,	_	6	P
3	the	the	DT	_	5	NMOD
4	membrane	membrane	NN	_	5	NMOD
5	organization	organization	NN	_	6	SBJ
6	appeared	appear	VBD	_	0	ROOT
7	not	not	RB	_	8	ADV
8	to	to	TO	_	6	OPRD
9	be	be	VB	_	8	IM
10	disturbed	disturb	VBN	_	9	VC
11	as	as	IN	_	10	ADV
12	assessed	assess	VBN	_	11	SUB
13	using	use	VBG	_	12	MNR
14	gradient	gradient	NN	_	15	NMOD
15	fractionation	fractionation	NN	_	16	NMOD
16	studies	study	NNS	_	13	OBJ
17	.	.	.	_	6	P

1	Instead	instead	RB	_	7	ADV
2	,	,	,	_	7	P
3	lack	lack	NN	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	annexin	annexin	NN	_	6	NMOD
6	A7	a0	NN	_	4	PMOD
7	led	lead	VBD	_	0	ROOT
8	to	to	IN	_	7	ADV
9	an	an	DT	_	12	NMOD
10	altered	altered	JJ	_	12	NMOD
11	cell	cell	NN	_	12	NMOD
12	shape	shape	NN	_	8	PMOD
13	and	and	CC	_	12	COORD
14	increased	increase	VBN	_	16	NMOD
15	osmotic	osmotic	JJ	_	16	NMOD
16	resistance	resistance	NN	_	13	CONJ
17	of	of	IN	_	12	NMOD
18	red	red	JJ	_	20	NMOD
19	blood	blood	NN	_	20	NMOD
20	cells	cell	NNS	_	17	PMOD
21	.	.	.	_	7	P

1	Annexin	annexin	NN	_	2	NMOD
2	A7	a0	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	also	also	RB	_	3	ADV
5	identified	identify	VBN	_	3	VC
6	in	in	IN	_	5	LOC
7	platelets	platelet	NNS	_	6	PMOD
8	.	.	.	_	3	P

1	In	in	IN	_	6	LOC
2	these	these	DT	_	3	NMOD
3	cells	cell	NNS	_	1	PMOD
4	its	its	PRP$	_	5	NMOD
5	loss	loss	NN	_	6	SBJ
6	led	lead	VBD	_	0	ROOT
7	to	to	IN	_	6	ADV
8	a	a	DT	_	12	NMOD
9	slightly	slightly	RB	_	10	AMOD
10	slower	slow	JJR	_	12	NMOD
11	aggregation	aggregation	NN	_	12	NMOD
12	velocity	velocity	NN	_	7	PMOD
13	which	which	WDT	_	14	SBJ
14	seems	seem	VBZ	_	12	NMOD
15	to	to	TO	_	14	OPRD
16	be	be	VB	_	15	IM
17	compensated	compensate	VBN	_	16	VC
18	by	by	IN	_	17	MNR
19	an	an	DT	_	21	NMOD
20	increased	increase	VBN	_	21	NMOD
21	number	number	NN	_	18	PMOD
22	of	of	IN	_	21	NMOD
23	platelets	platelet	NNS	_	22	PMOD
24	.	.	.	_	6	P

1	The	the	DT	_	2	NMOD
2	results	result	NNS	_	3	SBJ
3	appear	appear	VBP	_	0	ROOT
4	to	to	TO	_	3	OPRD
5	rule	rule	VB	_	4	IM
6	out	out	RP	_	5	PRT
7	an	an	DT	_	9	NMOD
8	important	important	JJ	_	9	NMOD
9	role	role	NN	_	5	OBJ
10	of	of	IN	_	9	NMOD
11	annexin	annexin	NN	_	12	NMOD
12	A7	a0	NN	_	10	PMOD
13	in	in	IN	_	9	NMOD
14	membrane	membrane	NN	_	15	NMOD
15	fusion	fusion	NN	_	16	NMOD
16	processes	process	NNS	_	13	PMOD
17	occurring	occur	VBG	_	16	NMOD
18	in	in	IN	_	17	LOC
19	red	red	JJ	_	21	NMOD
20	blood	blood	NN	_	21	NMOD
21	cells	cell	NNS	_	18	PMOD
22	.	.	.	_	3	P

1	Instead	instead	RB	_	4	ADV
2	the	the	DT	_	3	NMOD
3	protein	protein	NN	_	4	SBJ
4	might	might	MD	_	0	ROOT
5	be	be	VB	_	4	VC
6	involved	involve	VBN	_	5	VC
7	in	in	IN	_	6	ADV
8	the	the	DT	_	9	NMOD
9	organization	organization	NN	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	13	NMOD
12	membrane	membrane	NN	_	13	NMOD
13	cytoskeleton	cytoskeleton	NN	_	10	PMOD
14	.	.	.	_	4	P

1	Red	red	JJ	_	3	NMOD
2	blood	blood	NN	_	3	NMOD
3	cells	cell	NNS	_	4	SBJ
4	may	may	MD	_	0	ROOT
5	represent	represent	VB	_	4	VC
6	an	an	DT	_	8	NMOD
7	appropriate	appropriate	JJ	_	8	NMOD
8	model	model	NN	_	5	OBJ
9	to	to	TO	_	8	NMOD
10	study	study	VB	_	9	IM
11	the	the	DT	_	12	NMOD
12	role	role	NN	_	10	OBJ
13	of	of	IN	_	12	NMOD
14	annexin	annexin	NN	_	15	NMOD
15	A7	a0	NN	_	13	PMOD
16	in	in	IN	_	12	NMOD
17	cellular	cellular	JJ	_	18	NMOD
18	processes	process	NNS	_	16	PMOD
19	.	.	.	_	4	P

1	Conclusion	conclusion	NN	_	0	ROOT

1	We	we	PRP	_	2	SBJ
2	have	have	VBP	_	0	ROOT
3	demonstrated	demonstrate	VBN	_	2	VC
4	the	the	DT	_	5	NMOD
5	presence	presence	NN	_	3	OBJ
6	of	of	IN	_	5	NMOD
7	both	both	CC	_	10	COORD
8	annexin	annexin	NN	_	9	NMOD
9	A7	a0	NN	_	10	NMOD
10	isoforms	isoforms	NNS	_	6	PMOD
11	in	in	IN	_	5	LOC
12	red	red	JJ	_	14	NMOD
13	blood	blood	NN	_	14	NMOD
14	cells	cell	NNS	_	11	PMOD
15	and	and	CC	_	5	COORD
16	the	the	DT	_	17	NMOD
17	presence	presence	NN	_	15	CONJ
18	of	of	IN	_	17	NMOD
19	the	the	DT	_	21	NMOD
20	small	small	JJ	_	21	NMOD
21	isoform	isoform	NN	_	18	PMOD
22	in	in	IN	_	17	LOC
23	platelets	platelet	NNS	_	22	PMOD
24	.	.	.	_	2	P

1	In	in	IN	_	10	LOC
2	both	both	DT	_	4	NMOD
3	cell	cell	NN	_	4	NMOD
4	types	type	NNS	_	1	PMOD
5	the	the	DT	_	6	NMOD
6	loss	loss	NN	_	10	SBJ
7	of	of	IN	_	6	NMOD
8	annexin	annexin	NN	_	9	NMOD
9	A7	a0	NN	_	7	PMOD
10	impairs	impair	VBZ	_	0	ROOT
11	cellular	cellular	JJ	_	12	NMOD
12	functions	function	NNS	_	10	OBJ
13	.	.	.	_	10	P

1	The	the	DT	_	2	NMOD
2	defects	defect	NNS	_	4	SBJ
3	observed	observe	VBN	_	2	NMOD
4	are	be	VBP	_	0	ROOT
5	however	however	RB	_	4	ADV
6	not	not	RB	_	4	ADV
7	compatible	compatible	JJ	_	4	PRD
8	with	with	IN	_	7	AMOD
9	a	a	DT	_	11	NMOD
10	crucial	crucial	JJ	_	11	NMOD
11	role	role	NN	_	8	PMOD
12	for	for	IN	_	11	NMOD
13	annexin	annexin	NN	_	14	NMOD
14	A7	a0	NN	_	12	PMOD
15	in	in	IN	_	11	NMOD
16	membrane	membrane	NN	_	17	NMOD
17	fusion	fusion	NN	_	18	NMOD
18	processes	process	NNS	_	15	PMOD
19	in	in	IN	_	11	LOC
20	these	these	DT	_	22	NMOD
21	cell	cell	NN	_	22	NMOD
22	types	type	NNS	_	19	PMOD
23	.	.	.	_	4	P

1	Background	background	NN	_	0	ROOT

1	Annexin	annexin	NN	_	2	NMOD
2	A7	a0	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	a	a	DT	_	11	NMOD
5	Ca2+	ca0+	NN	_	10	AMOD
6	-	-	HYPH	_	5	P
7	and	and	CC	_	5	COORD
8	phospholipid	phospholipid	NN	_	7	CONJ
9	-	-	HYPH	_	5	P
10	binding	bind	VBG	_	11	NMOD
11	protein	protein	NN	_	3	PRD
12	,	,	,	_	11	P
13	which	which	WDT	_	14	SBJ
14	was	be	VBD	_	11	NMOD
15	isolated	isolate	VBN	_	14	VC
16	as	as	IN	_	15	ADV
17	the	the	DT	_	18	NMOD
18	agent	agent	NN	_	16	PMOD
19	that	that	WDT	_	20	SBJ
20	mediated	mediate	VBD	_	18	NMOD
21	aggregation	aggregation	NN	_	20	OBJ
22	of	of	IN	_	21	NMOD
23	chromaffin	chromaffin	NN	_	24	NMOD
24	granules	granule	NNS	_	22	PMOD
25	and	and	CC	_	21	COORD
26	fusion	fusion	NN	_	25	CONJ
27	of	of	IN	_	26	NMOD
28	phospholipid	phospholipid	NN	_	29	NMOD
29	membranes	membrane	NNS	_	27	PMOD
30	in	in	IN	_	21	NMOD
31	the	the	DT	_	32	NMOD
32	presence	presence	NN	_	30	PMOD
33	of	of	IN	_	32	NMOD
34	Ca2+	ca0+	NN	_	33	PMOD
35	.	.	.	_	3	P

1	This	this	DT	_	2	NMOD
2	activity	activity	NN	_	3	SBJ
3	led	lead	VBD	_	0	ROOT
4	to	to	IN	_	3	ADV
5	the	the	DT	_	6	NMOD
6	proposal	proposal	NN	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	annexin	annexin	NN	_	9	NMOD
9	A7	a0	NN	_	11	NMOD
10	's	's	POS	_	9	NMOD
11	involvement	involvement	NN	_	7	PMOD
12	in	in	IN	_	11	NMOD
13	the	the	DT	_	15	NMOD
14	exocytotic	exocytotic	JJ	_	15	NMOD
15	secretion	secretion	NN	_	12	PMOD
16	of	of	IN	_	15	NMOD
17	catecholamines	catecholamine	NNS	_	16	PMOD
18	[	[	-LRB-	_	19	P
19	1	0	CD	_	3	PRN
20	]	]	-RRB-	_	19	P
21	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	protein	protein	NN	_	3	SBJ
3	belongs	belong	VBZ	_	0	ROOT
4	to	to	IN	_	3	ADV
5	a	a	DT	_	6	NMOD
6	family	family	NN	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	evolutionarily	evolutionarily	RB	_	9	AMOD
9	conserved	conserve	VBN	_	10	NMOD
10	proteins	protein	NNS	_	7	PMOD
11	of	of	IN	_	10	NMOD
12	a	a	DT	_	14	NMOD
13	bipartite	bipartite	JJ	_	14	NMOD
14	structure	structure	NN	_	11	PMOD
15	with	with	IN	_	10	NMOD
16	a	a	DT	_	17	NMOD
17	variable	variable	JJ	_	15	PMOD
18	N	n	NN	_	20	AMOD
19	-	-	HYPH	_	18	P
20	terminal	terminal	JJ	_	17	NMOD
21	and	and	CC	_	17	COORD
22	a	a	DT	_	23	NMOD
23	conserved	conserve	VBN	_	21	CONJ
24	C	c	NN	_	26	AMOD
25	-	-	HYPH	_	24	P
26	terminal	terminal	JJ	_	23	NMOD
27	domain	domain	NN	_	23	NMOD
28	.	.	.	_	3	P

1	The	the	DT	_	5	NMOD
2	C	c	NN	_	4	AMOD
3	-	-	HYPH	_	2	P
4	terminal	terminal	JJ	_	5	NMOD
5	domain	domain	NN	_	6	SBJ
6	is	be	VBZ	_	22	DEP
7	responsible	responsible	JJ	_	6	PRD
8	for	for	IN	_	7	AMOD
9	the	the	DT	_	10	NMOD
10	Ca2+	ca0+	NN	_	8	PMOD
11	-	-	HYPH	_	10	P
12	and	and	CC	_	10	COORD
13	phospholipid	phospholipid	NN	_	12	CONJ
14	-	-	HYPH	_	10	P
15	binding	bind	VBG	_	10	NMOD
16	,	,	,	_	22	P
17	the	the	DT	_	21	NMOD
18	N	n	NN	_	20	AMOD
19	-	-	HYPH	_	18	P
20	terminal	terminal	JJ	_	21	NMOD
21	domain	domain	NN	_	22	SBJ
22	appears	appear	VBZ	_	0	ROOT
23	to	to	TO	_	22	OPRD
24	confer	confer	VB	_	23	IM
25	functional	functional	JJ	_	26	NMOD
26	diversity	diversity	NN	_	24	OBJ
27	[	[	-LRB-	_	28	P
28	2	0	CD	_	22	PRN
29	-	-	SYM	_	30	P
30	4	0	CD	_	28	NMOD
31	]	]	-RRB-	_	28	P
32	.	.	.	_	22	P

1	The	the	DT	_	2	NMOD
2	binding	binding	NN	_	7	SBJ
3	to	to	IN	_	2	NMOD
4	negatively	negatively	RB	_	5	AMOD
5	charged	charged	JJ	_	6	NMOD
6	phospholipids	phospholipid	NNS	_	3	PMOD
7	is	be	VBZ	_	0	ROOT
8	thought	think	VBN	_	7	VC
9	to	to	TO	_	8	OPRD
10	be	be	VB	_	9	IM
11	mediated	mediate	VBN	_	10	VC
12	by	by	IN	_	11	LGS
13	Ca2+	ca0+	NN	_	14	NMOD
14	ions	ion	NNS	_	12	PMOD
15	.	.	.	_	7	P

1	Annexin	annexin	NN	_	2	NMOD
2	A7	a0	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	unique	unique	JJ	_	3	PRD
5	in	in	IN	_	6	SUB
6	that	that	IN	_	3	PRP
7	it	it	PRP	_	8	SBJ
8	carries	carry	VBZ	_	6	SUB
9	an	an	DT	_	15	NMOD
10	extraordinarily	extraordinarily	RB	_	11	AMOD
11	long	long	JJ	_	15	NMOD
12	and	and	CC	_	11	COORD
13	hydrophobic	hydrophobic	JJ	_	12	CONJ
14	amino	amino	NN	_	15	NMOD
15	terminus	terminus	NN	_	8	OBJ
16	with	with	IN	_	15	NMOD
17	more	more	JJR	_	21	NMOD
18	than	than	IN	_	17	QMOD
19	100	0	CD	_	17	QMOD
20	amino	amino	NN	_	21	NMOD
21	acids	acid	NNS	_	16	PMOD
22	.	.	.	_	3	P

1	Alternative	alternative	JJ	_	2	NMOD
2	splicing	splicing	NN	_	3	SBJ
3	gives	give	VBZ	_	0	ROOT
4	rise	rise	NN	_	3	OBJ
5	to	to	IN	_	3	ADV
6	two	two	CD	_	7	NMOD
7	isoforms	isoforms	NNS	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	47	0	CD	_	12	NMOD
10	and	and	CC	_	9	COORD
11	51	0	CD	_	10	CONJ
12	kDa	kda	NN	_	8	PMOD
13	.	.	.	_	3	P

1	Both	both	DT	_	2	NMOD
2	isoforms	isoforms	NNS	_	3	SBJ
3	differ	differ	VBP	_	0	ROOT
4	by	by	IN	_	3	ADV
5	an	an	DT	_	8	NMOD
6	additional	additional	JJ	_	8	NMOD
7	cassette	cassette	NN	_	8	NMOD
8	exon	exon	NN	_	4	PMOD
9	located	located	JJ	_	8	NMOD
10	in	in	IN	_	9	LOC
11	the	the	DT	_	13	NMOD
12	first	$#ORD#$	JJ	_	13	NMOD
13	third	$#ORD#$	NN	_	10	PMOD
14	of	of	IN	_	13	NMOD
15	the	the	DT	_	19	NMOD
16	N	n	NN	_	18	AMOD
17	-	-	HYPH	_	16	P
18	terminal	terminal	JJ	_	19	NMOD
19	domain	domain	NN	_	14	PMOD
20	.	.	.	_	3	P

1	Most	most	JJS	_	2	NMOD
2	tissues	tissue	NNS	_	3	SBJ
3	harbor	harbor	VBP	_	12	DEP
4	only	only	RB	_	8	NMOD
5	the	the	DT	_	8	NMOD
6	47	0	CD	_	7	NMOD
7	kDa	kda	NN	_	8	NMOD
8	isoform	isoform	NN	_	3	OBJ
9	,	,	,	_	12	P
10	both	both	DT	_	11	NMOD
11	forms	form	NNS	_	12	SBJ
12	are	be	VBP	_	0	ROOT
13	found	find	VBN	_	12	VC
14	in	in	IN	_	13	LOC
15	brain	brain	NN	_	14	PMOD
16	and	and	CC	_	15	COORD
17	heart	heart	NN	_	16	CONJ
18	,	,	,	_	13	P
19	while	while	IN	_	25	ADV
20	the	the	DT	_	22	NMOD
21	large	large	JJ	_	22	NMOD
22	isoform	isoform	NN	_	23	SBJ
23	is	be	VBZ	_	13	ADV
24	exclusively	exclusively	RB	_	23	ADV
25	expressed	express	VBN	_	23	VC
26	in	in	IN	_	25	LOC
27	mature	mature	JJ	_	29	NMOD
28	skeletal	skeletal	JJ	_	29	NMOD
29	muscle	muscle	NN	_	26	PMOD
30	.	.	.	_	12	P

1	At	at	IN	_	7	ADV
2	the	the	DT	_	4	NMOD
3	cellular	cellular	JJ	_	4	NMOD
4	level	level	NN	_	1	PMOD
5	annexin	annexin	NN	_	6	NMOD
6	A7	a0	NN	_	7	SBJ
7	can	can	MD	_	0	ROOT
8	be	be	VB	_	7	VC
9	detected	detect	VBN	_	8	VC
10	in	in	IN	_	9	LOC
11	the	the	DT	_	12	NMOD
12	cytosol	cytosol	NN	_	10	PMOD
13	,	,	,	_	10	P
14	at	at	IN	_	10	CONJ
15	the	the	DT	_	17	NMOD
16	plasma	plasma	NN	_	17	NMOD
17	membrane	membrane	NN	_	14	PMOD
18	,	,	,	_	14	P
19	around	around	IN	_	14	CONJ
20	the	the	DT	_	21	NMOD
21	nucleus	nucleus	NN	_	19	PMOD
22	,	,	,	_	19	P
23	at	at	IN	_	19	CONJ
24	vesicular	vesicular	JJ	_	25	NMOD
25	structures	structure	NNS	_	23	PMOD
26	including	include	VBG	_	25	NMOD
27	adrenal	adrenal	JJ	_	29	NMOD
28	chromaffin	chromaffin	NN	_	29	NMOD
29	granules	granule	NNS	_	26	PMOD
30	,	,	,	_	23	P
31	and	and	CC	_	23	COORD
32	at	at	IN	_	31	CONJ
33	the	the	DT	_	37	NMOD
34	t	t	NN	_	36	NMOD
35	-	-	HYPH	_	34	P
36	tubule	tubule	NN	_	37	NMOD
37	system	system	NN	_	32	PMOD
38	[	[	-LRB-	_	41	P
39	5	0	CD	_	41	NMOD
40	,	,	,	_	41	P
41	6	0	CD	_	9	PRN
42	]	]	-RRB-	_	41	P
43	.	.	.	_	7	P

1	Annexin	annexin	NN	_	2	NMOD
2	A7	a0	NN	_	3	SBJ
3	translocates	translocate	VBZ	_	0	ROOT
4	to	to	IN	_	3	ADV
5	membranes	membrane	NNS	_	4	PMOD
6	in	in	IN	_	3	MNR
7	a	a	DT	_	11	NMOD
8	Ca2+	ca0+	NN	_	10	AMOD
9	-	-	HYPH	_	8	P
10	dependent	dependent	JJ	_	11	NMOD
11	fashion	fashion	NN	_	6	PMOD
12	and	and	CC	_	3	COORD
13	,	,	,	_	21	P
14	when	when	WRB	_	18	TMP
15	intracellular	intracellular	JJ	_	17	NMOD
16	Ca2+	ca0+	NN	_	17	NMOD
17	levels	level	NNS	_	18	SBJ
18	rise	rise	VBP	_	21	TMP
19	,	,	,	_	21	P
20	sequentially	sequentially	RB	_	21	TMP
21	redistributes	redistribute	VBZ	_	12	CONJ
22	to	to	IN	_	21	ADV
23	the	the	DT	_	24	NMOD
24	plasma	plasma	NN	_	22	PMOD
25	and	and	CC	_	24	COORD
26	the	the	DT	_	28	NMOD
27	nuclear	nuclear	JJ	_	28	NMOD
28	membrane	membrane	NN	_	25	CONJ
29	as	as	RB	_	31	ADV
30	well	well	RB	_	31	ADV
31	as	as	IN	_	22	COORD
32	to	to	IN	_	31	CONJ
33	intracellular	intracellular	JJ	_	34	NMOD
34	vesicles	vesicle	NNS	_	32	PMOD
35	.	.	.	_	3	P

1	Furthermore	furthermore	RB	_	5	ADV
2	,	,	,	_	5	P
3	annexin	annexin	NN	_	4	NMOD
4	A7	a0	NN	_	5	SBJ
5	associates	associate	VBZ	_	0	ROOT
6	with	with	IN	_	5	ADV
7	lipid	lipid	NN	_	8	NMOD
8	rafts	raft	NNS	_	6	PMOD
9	[	[	-LRB-	_	10	P
10	7	0	CD	_	5	PRN
11	]	]	-RRB-	_	10	P
12	.	.	.	_	5	P

1	Lipid	lipid	NN	_	2	NMOD
2	rafts	raft	NNS	_	3	SBJ
3	play	play	VBP	_	0	ROOT
4	a	a	DT	_	6	NMOD
5	key	key	JJ	_	6	NMOD
6	role	role	NN	_	3	OBJ
7	in	in	IN	_	3	ADV
8	membrane	membrane	NN	_	9	NMOD
9	budding	budding	NN	_	7	PMOD
10	and	and	CC	_	7	COORD
11	in	in	IN	_	10	CONJ
12	vesiculation	vesiculation	NN	_	13	NMOD
13	processes	process	NNS	_	11	PMOD
14	such	such	JJ	_	15	PMOD
15	as	as	IN	_	13	NMOD
16	endo	endo	AFX	_	15	PMOD
17	-	-	HYPH	_	16	P
18	and	and	CC	_	16	COORD
19	exocytosis	exocytosis	NN	_	18	CONJ
20	[	[	-LRB-	_	21	P
21	8	0	CD	_	3	PRN
22	-	-	SYM	_	23	P
23	10	0	CD	_	21	NMOD
24	]	]	-RRB-	_	21	P
25	.	.	.	_	3	P

1	Two	two	CD	_	3	NMOD
2	binding	bind	VBG	_	3	NMOD
3	partners	partner	NNS	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	annexin	annexin	NN	_	6	NMOD
6	A7	a0	NN	_	4	PMOD
7	have	have	VBP	_	0	ROOT
8	been	be	VBN	_	7	VC
9	identified	identify	VBN	_	8	VC
10	,	,	,	_	9	P
11	sorcin	sorcin	NN	_	3	NMOD
12	and	and	CC	_	11	COORD
13	galectin	galectin	NN	_	12	CONJ
14	-	-	HYPH	_	13	P
15	3	0	CD	_	13	NMOD
16	[	[	-LRB-	_	17	P
17	11	0	CD	_	9	PRN
18	-	-	SYM	_	19	P
19	13	0	CD	_	17	NMOD
20	]	]	-RRB-	_	17	P
21	.	.	.	_	7	P

1	Sorcin	sorcin	NN	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	a	a	DT	_	7	NMOD
4	Ca2+	ca0+	NN	_	6	AMOD
5	-	-	HYPH	_	4	P
6	binding	bind	VBG	_	7	NMOD
7	protein	protein	NN	_	2	PRD
8	and	and	CC	_	2	COORD
9	belongs	belong	VBZ	_	8	CONJ
10	to	to	IN	_	9	ADV
11	the	the	DT	_	17	NMOD
12	penta	penta	NN	_	16	NMOD
13	EF	ef	NN	_	15	NMOD
14	-	-	HYPH	_	13	P
15	hand	hand	NN	_	16	NMOD
16	protein	protein	NN	_	17	NMOD
17	family	family	NN	_	10	PMOD
18	[	[	-LRB-	_	19	P
19	14	0	CD	_	2	PRN
20	]	]	-RRB-	_	19	P
21	.	.	.	_	2	P

1	Like	like	IN	_	5	ADV
2	annexin	annexin	NN	_	3	NMOD
3	A7	a0	NN	_	1	PMOD
4	it	it	PRP	_	5	SBJ
5	binds	bind	VBZ	_	0	ROOT
6	to	to	IN	_	5	ADV
7	membranes	membrane	NNS	_	6	PMOD
8	in	in	IN	_	5	MNR
9	a	a	DT	_	13	NMOD
10	Ca2+	ca0+	NN	_	12	AMOD
11	-	-	HYPH	_	10	P
12	dependent	dependent	JJ	_	13	NMOD
13	manner	manner	NN	_	8	PMOD
14	.	.	.	_	5	P

1	Sorcin	sorcin	NN	_	3	SBJ
2	also	also	RB	_	3	ADV
3	has	have	VBZ	_	0	ROOT
4	been	be	VBN	_	3	VC
5	described	describe	VBN	_	4	VC
6	as	as	IN	_	5	ADV
7	interaction	interaction	NN	_	8	NMOD
8	partner	partner	NN	_	6	PMOD
9	of	of	IN	_	8	NMOD
10	the	the	DT	_	12	NMOD
11	ryanodine	ryanodine	NN	_	12	NMOD
12	receptor	receptor	NN	_	9	PMOD
13	,	,	,	_	3	P
14	and	and	CC	_	3	COORD
15	appears	appear	VBZ	_	14	CONJ
16	to	to	TO	_	15	OPRD
17	modulate	modulate	VB	_	16	IM
18	its	its	PRP$	_	19	NMOD
19	function	function	NN	_	17	OBJ
20	[	[	-LRB-	_	21	P
21	15	0	CD	_	3	PRN
22	]	]	-RRB-	_	21	P
23	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	influence	influence	NN	_	14	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	9	NMOD
5	sorcin	sorcin	NN	_	7	NMOD
6	/	/	HYPH	_	5	P
7	annexin	annexin	NN	_	8	NMOD
8	A7	a0	NN	_	9	NMOD
9	interaction	interaction	NN	_	3	PMOD
10	on	on	IN	_	2	NMOD
11	the	the	DT	_	13	NMOD
12	ryanodine	ryanodine	NN	_	13	NMOD
13	receptor	receptor	NN	_	10	PMOD
14	is	be	VBZ	_	0	ROOT
15	unknown	unknown	JJ	_	14	PRD
16	.	.	.	_	14	P

1	Sorcin	sorcin	NN	_	5	SBJ
2	and	and	CC	_	1	COORD
3	annexin	annexin	NN	_	4	NMOD
4	A7	a0	NN	_	2	CONJ
5	are	be	VBP	_	0	ROOT
6	coexpressed	coexpressed	VBN	_	5	VC
7	in	in	IN	_	6	LOC
8	all	all	DT	_	9	NMOD
9	tissues	tissue	NNS	_	7	PMOD
10	examined	examine	VBN	_	9	NMOD
11	so	so	RB	_	12	AMOD
12	far	far	RB	_	10	TMP
13	[	[	-LRB-	_	14	P
14	11	0	CD	_	6	PRN
15	]	]	-RRB-	_	14	P
16	.	.	.	_	5	P

1	The	the	DT	_	2	NMOD
2	binding	binding	NN	_	8	SBJ
3	of	of	IN	_	2	NMOD
4	annexin	annexin	NN	_	5	NMOD
5	A7	a0	NN	_	3	PMOD
6	and	and	CC	_	5	COORD
7	sorcin	sorcin	NN	_	6	CONJ
8	is	be	VBZ	_	0	ROOT
9	Ca2+	ca0+	NN	_	11	AMOD
10	-	-	HYPH	_	9	P
11	dependent	dependent	JJ	_	8	PRD
12	and	and	CC	_	8	COORD
13	occurs	occur	VBZ	_	12	CONJ
14	at	at	IN	_	13	ADV
15	micromolar	micromolar	JJ	_	16	NMOD
16	Ca2+	ca0+	NN	_	17	NMOD
17	concentrations	concentration	NNS	_	14	PMOD
18	.	.	.	_	8	P

1	The	the	DT	_	3	NMOD
2	binding	bind	VBG	_	3	NMOD
3	sites	site	NNS	_	4	SBJ
4	have	have	VBP	_	0	ROOT
5	been	be	VBN	_	4	VC
6	localised	localise	VBN	_	5	VC
7	to	to	IN	_	6	ADV
8	the	the	DT	_	14	NMOD
9	amino	amino	NN	_	10	AMOD
10	terminal	terminal	JJ	_	14	NMOD
11	GGYY	ggyy	NN	_	14	NMOD
12	and	and	CC	_	11	COORD
13	GYGG	gygg	NN	_	12	CONJ
14	motifs	motif	NNS	_	7	PMOD
15	in	in	IN	_	14	LOC
16	sorcin	sorcin	NN	_	15	PMOD
17	and	and	CC	_	7	COORD
18	to	to	IN	_	17	CONJ
19	the	the	DT	_	21	NMOD
20	GYPP	gypp	NN	_	21	NMOD
21	motif	motif	NN	_	18	PMOD
22	in	in	IN	_	21	LOC
23	the	the	DT	_	25	NMOD
24	amino	amino	NN	_	25	NMOD
25	terminus	terminus	NN	_	22	PMOD
26	of	of	IN	_	25	NMOD
27	annexin	annexin	NN	_	28	NMOD
28	A7	a0	NN	_	26	PMOD
29	.	.	.	_	4	P

1	The	the	DT	_	2	NMOD
2	proteins	protein	NNS	_	3	SBJ
3	bind	bind	VBP	_	0	ROOT
4	to	to	IN	_	3	ADV
5	each	each	DT	_	6	NMOD
6	other	other	JJ	_	4	PMOD
7	with	with	IN	_	3	ADV
8	a	a	DT	_	9	NMOD
9	stoichiometry	stoichiometry	NN	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	two	two	CD	_	13	NMOD
12	sorcin	sorcin	NN	_	13	NMOD
13	molecules	molecule	NNS	_	10	PMOD
14	per	per	IN	_	13	NMOD
15	annexin	annexin	NN	_	16	NMOD
16	A7	a0	NN	_	17	NMOD
17	molecule	molecule	NN	_	14	PMOD
18	[	[	-LRB-	_	19	P
19	12	0	CD	_	3	PRN
20	]	]	-RRB-	_	19	P
21	.	.	.	_	3	P

1	Galectin	galectin	NN	_	4	SBJ
2	-	-	HYPH	_	1	P
3	3	0	CD	_	1	NMOD
4	is	be	VBZ	_	0	ROOT
5	a	a	DT	_	8	NMOD
6	multifunctional	multifunctional	JJ	_	8	NMOD
7	oncogenic	oncogenic	JJ	_	8	NMOD
8	protein	protein	NN	_	4	PRD
9	with	with	IN	_	8	NMOD
10	an	an	DT	_	12	NMOD
11	anti-apoptotic	anti-apoptotic	JJ	_	12	NMOD
12	activity	activity	NN	_	9	PMOD
13	found	find	VBN	_	8	NMOD
14	in	in	IN	_	13	LOC
15	the	the	DT	_	17	NMOD
16	extracellular	extracellular	JJ	_	17	NMOD
17	space	space	NN	_	14	PMOD
18	,	,	,	_	17	P
19	in	in	IN	_	17	LOC
20	the	the	DT	_	21	NMOD
21	nucleus	nucleus	NN	_	19	PMOD
22	and	and	CC	_	21	COORD
23	cytoplasm	cytoplasm	NN	_	22	CONJ
24	and	and	CC	_	14	COORD
25	in	in	IN	_	24	CONJ
26	mitochondria	mitochondrion	NNS	_	25	PMOD
27	.	.	.	_	4	P

1	Cytoplasmic	cytoplasmic	JJ	_	2	NMOD
2	galectin	galectin	NN	_	5	SBJ
3	-	-	HYPH	_	2	P
4	3	0	CD	_	2	NMOD
5	correlates	correlate	VBZ	_	0	ROOT
6	with	with	IN	_	5	ADV
7	tumor	tumor	NN	_	8	NMOD
8	progression	progression	NN	_	6	PMOD
9	and	and	CC	_	5	COORD
10	protects	protect	VBZ	_	9	CONJ
11	mitochondrial	mitochondrial	JJ	_	12	NMOD
12	integrity	integrity	NN	_	10	OBJ
13	.	.	.	_	5	P

1	Down	down	NN	_	2	NMOD
2	regulation	regulation	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	annexin	annexin	NN	_	5	NMOD
5	A7	a0	NN	_	3	PMOD
6	prevents	prevent	VBZ	_	0	ROOT
7	galectin	galectin	NN	_	9	NMOD
8	-	-	HYPH	_	7	P
9	3	0	NN	_	10	NMOD
10	translocation	translocation	NN	_	6	OBJ
11	to	to	IN	_	10	NMOD
12	the	the	DT	_	14	NMOD
13	perinuclear	perinuclear	JJ	_	14	NMOD
14	membrane	membrane	NN	_	11	PMOD
15	and	and	CC	_	6	COORD
16	increases	increase	VBZ	_	15	CONJ
17	galectin	galectin	NN	_	19	NMOD
18	-	-	HYPH	_	17	P
19	3	0	NN	_	20	NMOD
20	secretion	secretion	NN	_	16	OBJ
21	.	.	.	_	6	P

1	For	for	IN	_	18	ADV
2	annexin	annexin	NN	_	3	NMOD
3	A7	a0	NN	_	1	PMOD
4	a	a	DT	_	5	NMOD
5	role	role	NN	_	18	SBJ
6	for	for	IN	_	5	NMOD
7	galectin	galectin	NN	_	9	NMOD
8	-	-	HYPH	_	7	P
9	3	0	NN	_	10	NMOD
10	trafficking	trafficking	NN	_	6	PMOD
11	,	,	,	_	10	P
12	apoptosis	apoptosis	NN	_	13	NMOD
13	regulation	regulation	NN	_	10	CONJ
14	,	,	,	_	13	P
15	and	and	CC	_	13	COORD
16	mitochondrial	mitochondrial	JJ	_	17	NMOD
17	integrity	integrity	NN	_	15	CONJ
18	was	be	VBD	_	0	ROOT
19	proposed	propose	VBN	_	18	VC
20	[	[	-LRB-	_	21	P
21	13	0	CD	_	19	PRN
22	]	]	-RRB-	_	21	P
23	.	.	.	_	18	P

1	The	the	DT	_	3	NMOD
2	cellular	cellular	JJ	_	3	NMOD
3	role	role	NN	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	annexin	annexin	NN	_	6	NMOD
6	A7	a0	NN	_	4	PMOD
7	is	be	VBZ	_	0	ROOT
8	not	not	RB	_	7	ADV
9	well	well	RB	_	7	ADV
10	understood	understand	VBN	_	7	VC
11	.	.	.	_	7	P

1	It	it	PRP	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	thought	think	VBN	_	2	VC
4	to	to	TO	_	3	OPRD
5	regulate	regulate	VB	_	4	IM
6	and	and	CC	_	5	COORD
7	stabilize	stabilize	VB	_	6	CONJ
8	membrane	membrane	NN	_	9	NMOD
9	domains	domain	NNS	_	5	OBJ
10	and	and	CC	_	4	COORD
11	to	to	TO	_	10	CONJ
12	have	have	VB	_	11	IM
13	a	a	DT	_	14	NMOD
14	role	role	NN	_	12	OBJ
15	in	in	IN	_	12	ADV
16	Ca2+	ca0+	NN	_	17	NMOD
17	homeostasis	homeostasis	NN	_	15	PMOD
18	and	and	CC	_	17	COORD
19	Ca2+	ca0+	NN	_	21	AMOD
20	-	-	HYPH	_	19	P
21	dependent	dependent	JJ	_	23	NMOD
22	signaling	signaling	NN	_	23	NMOD
23	pathways	pathway	NNS	_	18	CONJ
24	.	.	.	_	2	P

1	These	these	DT	_	2	NMOD
2	proposals	proposal	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	supported	support	VBN	_	3	VC
5	by	by	IN	_	4	LGS
6	data	datum	NNS	_	5	PMOD
7	obtained	obtain	VBN	_	6	NMOD
8	from	from	IN	_	7	ADV
9	analysis	analysis	NN	_	8	PMOD
10	of	of	IN	_	9	NMOD
11	annexin	annexin	NN	_	12	NMOD
12	A7	a0	NN	_	13	AMOD
13	deficient	deficient	JJ	_	15	NMOD
14	mouse	mouse	NN	_	15	NMOD
15	mutants	mutant	NNS	_	10	PMOD
16	.	.	.	_	3	P

1	Two	two	CD	_	7	NMOD
2	annexin	annexin	NN	_	3	NMOD
3	A7	a0	NN	_	7	NMOD
4	129Sv	0sv	NN	_	7	NMOD
5	null	null	JJ	_	7	NMOD
6	mice	mouse	NNS	_	7	NMOD
7	strains	strain	NNS	_	8	SBJ
8	were	be	VBD	_	0	ROOT
9	generated	generate	VBN	_	8	VC
10	independently	independently	RB	_	9	ADV
11	using	use	VBG	_	9	ADV
12	a	a	DT	_	14	NMOD
13	different	different	JJ	_	14	NMOD
14	strategy	strategy	NN	_	11	OBJ
15	.	.	.	_	8	P

1	The	the	DT	_	2	NMOD
2	one	one	CD	_	10	SBJ
3	of	of	IN	_	2	NMOD
4	Srivastava	srivastava	NNP	_	3	PMOD
5	et	et	FW	_	6	AMOD
6	al.	al.	FW	_	4	NMOD
7	[	[	-LRB-	_	8	P
8	16	0	CD	_	4	PRN
9	]	]	-RRB-	_	8	P
10	is	be	VBZ	_	0	ROOT
11	lethal	lethal	JJ	_	10	PRD
12	.	.	.	_	10	P

1	Heterozygous	heterozygous	JJ	_	2	NMOD
2	mice	mouse	NNS	_	3	SBJ
3	exhibit	exhibit	VBP	_	0	ROOT
4	an	an	DT	_	7	NMOD
5	insulin	insulin	NN	_	6	NMOD
6	secretion	secretion	NN	_	7	NMOD
7	defect	defect	NN	_	3	OBJ
8	and	and	CC	_	7	COORD
9	tumor	tumor	NN	_	10	NMOD
10	phenotypes	phenotype	NNS	_	8	CONJ
11	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	null	null	JJ	_	3	NMOD
3	strain	strain	NN	_	12	SBJ
4	reported	report	VBN	_	3	NMOD
5	by	by	IN	_	4	LGS
6	Herr	herr	NNP	_	5	PMOD
7	et	et	FW	_	8	AMOD
8	al.	al.	FW	_	6	NMOD
9	[	[	-LRB-	_	10	P
10	17	0	CD	_	4	PRN
11	]	]	-RRB-	_	10	P
12	is	be	VBZ	_	0	ROOT
13	viable	viable	JJ	_	15	AMOD
14	,	,	,	_	15	P
15	healthy	healthy	JJ	_	12	PRD
16	,	,	,	_	12	P
17	and	and	CC	_	12	COORD
18	shows	show	VBZ	_	17	CONJ
19	no	no	DT	_	22	NMOD
20	insulin	insulin	NN	_	21	NMOD
21	secretion	secretion	NN	_	22	NMOD
22	defect	defect	NN	_	18	OBJ
23	or	or	CC	_	22	COORD
24	other	other	JJ	_	26	NMOD
25	obvious	obvious	JJ	_	26	NMOD
26	defects	defect	NNS	_	23	CONJ
27	.	.	.	_	12	P

1	However	however	RB	_	11	ADV
2	,	,	,	_	11	P
3	in	in	IN	_	11	LOC
4	isolated	isolate	VBN	_	5	NMOD
5	cardiomyocytes	cardiomyocytes	NNS	_	3	PMOD
6	the	the	DT	_	10	NMOD
7	frequency	frequency	NN	_	9	AMOD
8	-	-	HYPH	_	7	P
9	induced	induce	VBN	_	10	NMOD
10	shortening	shortening	NN	_	11	SBJ
11	is	be	VBZ	_	0	ROOT
12	disturbed	disturb	VBN	_	11	VC
13	.	.	.	_	11	P

1	Here	here	RB	_	3	ADV
2	we	we	PRP	_	3	SBJ
3	have	have	VBP	_	0	ROOT
4	focused	focus	VBN	_	3	VC
5	on	on	IN	_	4	ADV
6	the	the	DT	_	7	NMOD
7	analysis	analysis	NN	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	red	red	JJ	_	11	NMOD
10	blood	blood	NN	_	11	NMOD
11	cells	cell	NNS	_	8	PMOD
12	and	and	CC	_	11	COORD
13	platelets	platelet	NNS	_	12	CONJ
14	of	of	IN	_	11	NMOD
15	the	the	DT	_	20	NMOD
16	anxA7	anxa0	JJ	_	20	NMOD
17	-	-	SYM	_	16	P
18	/	/	HYPH	_	16	P
19	-	-	SYM	_	16	P
20	mutant	mutant	NN	_	14	PMOD
21	.	.	.	_	3	P

1	Generally	generally	RB	_	8	ADV
2	,	,	,	_	8	P
3	red	red	JJ	_	5	NMOD
4	blood	blood	NN	_	5	NMOD
5	cells	cell	NNS	_	8	SBJ
6	and	and	CC	_	5	COORD
7	platelets	platelet	NNS	_	6	CONJ
8	were	be	VBD	_	0	ROOT
9	thought	think	VBN	_	8	VC
10	not	not	RB	_	9	ADV
11	to	to	TO	_	9	OPRD
12	contain	contain	VB	_	11	IM
13	annexin	annexin	NN	_	14	NMOD
14	A7	a0	NN	_	12	OBJ
15	and	and	CC	_	8	COORD
16	only	only	RB	_	17	AMOD
17	recently	recently	RB	_	22	TMP
18	the	the	DT	_	21	NMOD
19	47	0	CD	_	20	NMOD
20	kDa	kda	NN	_	21	NMOD
21	isoform	isoform	NN	_	22	SBJ
22	has	have	VBZ	_	15	CONJ
23	been	be	VBN	_	22	VC
24	reported	report	VBN	_	23	VC
25	as	as	IN	_	24	ADV
26	component	component	NN	_	25	PMOD
27	of	of	IN	_	26	NMOD
28	red	red	JJ	_	30	NMOD
29	blood	blood	NN	_	30	NMOD
30	cells	cell	NNS	_	27	PMOD
31	[	[	-LRB-	_	32	P
32	7	0	CD	_	24	PRN
33	]	]	-RRB-	_	32	P
34	.	.	.	_	8	P

1	Red	red	JJ	_	3	NMOD
2	blood	blood	NN	_	3	NMOD
3	cells	cell	NNS	_	4	SBJ
4	undergo	undergo	VBP	_	0	ROOT
5	various	various	JJ	_	9	NMOD
6	biochemical	biochemical	JJ	_	9	NMOD
7	or	or	CC	_	6	COORD
8	morphological	morphological	JJ	_	7	CONJ
9	changes	change	NNS	_	4	OBJ
10	that	that	WDT	_	11	SBJ
11	appear	appear	VBP	_	9	NMOD
12	to	to	TO	_	11	OPRD
13	be	be	VB	_	12	IM
14	Ca2+	ca0+	NN	_	16	AMOD
15	-	-	HYPH	_	14	P
16	dependent	dependent	JJ	_	17	NMOD
17	processes	process	NNS	_	13	PRD
18	[	[	-LRB-	_	21	P
19	18	0	CD	_	21	NMOD
20	,	,	,	_	21	P
21	19	0	CD	_	4	PRN
22	]	]	-RRB-	_	21	P
23	.	.	.	_	4	P

1	One	one	CD	_	4	SBJ
2	of	of	IN	_	1	NMOD
3	them	them	PRP	_	2	PMOD
4	is	be	VBZ	_	0	ROOT
5	the	the	DT	_	6	NMOD
6	release	release	NN	_	4	PRD
7	of	of	IN	_	6	NMOD
8	hemoglobin	hemoglobin	NN	_	10	AMOD
9	-	-	HYPH	_	8	P
10	containing	contain	VBG	_	11	NMOD
11	exovesicles	exovesicles	NNS	_	7	PMOD
12	occurring	occur	VBG	_	6	NMOD
13	in	in	FW	_	14	AMOD
14	vivo	vivo	FW	_	12	LOC
15	as	as	RB	_	17	ADV
16	well	well	RB	_	17	ADV
17	as	as	IN	_	14	COORD
18	in	in	FW	_	19	AMOD
19	vitro	vitro	FW	_	17	CONJ
20	[	[	-LRB-	_	23	P
21	7	0	CD	_	23	NMOD
22	,	,	,	_	23	P
23	20	0	CD	_	4	PRN
24	]	]	-RRB-	_	23	P
25	.	.	.	_	4	P

1	This	this	DT	_	2	NMOD
2	process	process	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	thought	think	VBN	_	3	VC
5	to	to	TO	_	4	OPRD
6	represent	represent	VB	_	5	IM
7	a	a	DT	_	9	NMOD
8	protective	protective	JJ	_	9	NMOD
9	method	method	NN	_	6	OBJ
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	14	NMOD
12	red	red	JJ	_	14	NMOD
13	blood	blood	NN	_	14	NMOD
14	cell	cell	NN	_	10	PMOD
15	against	against	IN	_	9	NMOD
16	an	an	DT	_	17	NMOD
17	attack	attack	NN	_	15	PMOD
18	by	by	IN	_	17	NMOD
19	for	for	IN	_	22	NMOD
20	example	example	NN	_	19	PMOD
21	complement	complement	NN	_	22	NMOD
22	components	component	NNS	_	18	PMOD
23	.	.	.	_	3	P

1	Red	red	JJ	_	3	NMOD
2	blood	blood	NN	_	3	NMOD
3	cells	cell	NNS	_	10	SBJ
4	which	which	WDT	_	5	SBJ
5	lack	lack	VBP	_	3	NMOD
6	the	the	DT	_	7	NMOD
7	ability	ability	NN	_	5	OBJ
8	to	to	TO	_	7	NMOD
9	vesiculate	vesiculate	VB	_	8	IM
10	cause	cause	VB	_	0	ROOT
11	a	a	DT	_	12	NMOD
12	disease	disease	NN	_	10	OBJ
13	with	with	IN	_	10	ADV
14	red	red	JJ	_	16	NMOD
15	blood	blood	NN	_	16	NMOD
16	cell	cell	NN	_	17	NMOD
17	destruction	destruction	NN	_	13	PMOD
18	and	and	CC	_	17	COORD
19	haemoglobinuria	haemoglobinuria	NN	_	18	CONJ
20	[	[	-LRB-	_	21	P
21	21	0	CD	_	10	PRN
22	]	]	-RRB-	_	21	P
23	.	.	.	_	10	P

1	There	there	EX	_	2	SBJ
2	exist	exist	VBP	_	0	ROOT
3	two	two	CD	_	4	NMOD
4	types	type	NNS	_	2	OBJ
5	of	of	IN	_	4	NMOD
6	vesicles	vesicle	NNS	_	5	PMOD
7	,	,	,	_	4	P
8	micro	micro	AFX	_	4	APPO
9	-	-	HYPH	_	8	P
10	and	and	CC	_	8	COORD
11	nanovesicles	nanovesicles	NNS	_	10	CONJ
12	with	with	IN	_	4	NMOD
13	a	a	DT	_	14	NMOD
14	size	size	NN	_	12	PMOD
15	of	of	IN	_	14	NMOD
16	180	0	CD	_	17	NMOD
17	nm	nm	NN	_	15	PMOD
18	and	and	CC	_	17	COORD
19	60	0	CD	_	20	NMOD
20	nm	nm	NN	_	18	CONJ
21	,	,	,	_	2	P
22	respectively	respectively	RB	_	2	ADV
23	.	.	.	_	2	P

1	They	they	PRP	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	enriched	enrich	VBN	_	2	VC
4	in	in	IN	_	3	ADV
5	cholesterol	cholesterol	NN	_	8	AMOD
6	and	and	CC	_	5	COORD
7	sphingolipid	sphingolipid	NN	_	6	CONJ
8	rich	rich	JJ	_	11	NMOD
9	lipid	lipid	NN	_	10	NMOD
10	raft	raft	NN	_	11	NMOD
11	domains	domain	NNS	_	4	PMOD
12	that	that	WDT	_	13	SBJ
13	are	be	VBP	_	11	NMOD
14	associated	associate	VBN	_	13	VC
15	with	with	IN	_	14	ADV
16	proteins	protein	NNS	_	15	PMOD
17	like	like	IN	_	16	NMOD
18	acetylcholinesterase	acetylcholinesterase	NN	_	17	PMOD
19	,	,	,	_	18	P
20	cell	cell	NN	_	22	NMOD
21	surface	surface	NN	_	22	NMOD
22	proteins	protein	NNS	_	18	CONJ
23	including	include	VBG	_	22	NMOD
24	a	a	DT	_	26	NMOD
25	complement	complement	NN	_	26	NMOD
26	receptor	receptor	NN	_	23	PMOD
27	,	,	,	_	22	P
28	and	and	CC	_	22	COORD
29	the	the	DT	_	32	NMOD
30	lipid	lipid	NN	_	31	NMOD
31	raft	raft	NN	_	32	NMOD
32	proteins	protein	NNS	_	33	NMOD
33	stomatin	stomatin	NN	_	28	CONJ
34	and	and	CC	_	33	COORD
35	flotillin	flotillin	NN	_	34	CONJ
36	,	,	,	_	2	P
37	but	but	CC	_	2	COORD
38	they	they	PRP	_	39	SBJ
39	lack	lack	VBP	_	37	CONJ
40	any	any	DT	_	42	NMOD
41	cytoskeletal	cytoskeletal	JJ	_	42	NMOD
42	protein	protein	NN	_	39	OBJ
43	[	[	-LRB-	_	44	P
44	7	0	CD	_	39	PRN
45	]	]	-RRB-	_	44	P
46	.	.	.	_	2	P

1	Furthermore	furthermore	RB	_	4	ADV
2	,	,	,	_	4	P
3	they	they	PRP	_	4	SBJ
4	contain	contain	VBP	_	0	ROOT
5	sorcin	sorcin	NN	_	4	OBJ
6	and	and	CC	_	5	COORD
7	annexin	annexin	NN	_	8	NMOD
8	A7	a0	NN	_	6	CONJ
9	attached	attach	VBN	_	5	NMOD
10	to	to	IN	_	9	ADV
11	the	the	DT	_	13	NMOD
12	lipid	lipid	NN	_	13	NMOD
13	rafts	raft	NNS	_	10	PMOD
14	.	.	.	_	4	P

1	Both	both	DT	_	2	NMOD
2	proteins	protein	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	more	more	RBR	_	5	AMOD
5	abundant	abundant	JJ	_	3	PRD
6	in	in	IN	_	3	LOC
7	nanovesicles	nanovesicles	NNS	_	6	PMOD
8	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	vesicle	vesicle	NN	_	3	NMOD
3	formation	formation	NN	_	4	SBJ
4	goes	go	VBZ	_	0	ROOT
5	along	along	RP	_	4	PRT
6	with	with	IN	_	4	ADV
7	several	several	JJ	_	9	NMOD
8	other	other	JJ	_	9	NMOD
9	changes	change	NNS	_	6	PMOD
10	in	in	IN	_	9	LOC
11	the	the	DT	_	14	NMOD
12	red	red	JJ	_	14	NMOD
13	blood	blood	NN	_	14	NMOD
14	cell	cell	NN	_	10	PMOD
15	like	like	IN	_	9	NMOD
16	cytoskeletal	cytoskeletal	JJ	_	17	NMOD
17	rearrangements	rearrangement	NNS	_	15	PMOD
18	and	and	CC	_	17	COORD
19	changes	change	NNS	_	18	CONJ
20	in	in	IN	_	19	NMOD
21	the	the	DT	_	23	NMOD
22	phospholipid	phospholipid	NN	_	23	NMOD
23	orientation	orientation	NN	_	20	PMOD
24	in	in	IN	_	19	LOC
25	the	the	DT	_	27	NMOD
26	cellular	cellular	JJ	_	27	NMOD
27	membrane	membrane	NN	_	24	PMOD
28	.	.	.	_	4	P

1	Results	result	NNS	_	0	ROOT

1	Annexin	annexin	NN	_	2	NMOD
2	A7	a0	NN	_	3	NMOD
3	expression	expression	NN	_	0	ROOT
4	in	in	IN	_	3	LOC
5	red	red	JJ	_	7	NMOD
6	blood	blood	NN	_	7	NMOD
7	cells	cell	NNS	_	4	PMOD
8	,	,	,	_	7	P
9	red	red	JJ	_	11	NMOD
10	blood	blood	NN	_	11	NMOD
11	cell	cell	NN	_	12	AMOD
12	derived	derive	VBN	_	13	NMOD
13	exovesicles	exovesicles	NNS	_	7	APPO
14	and	and	CC	_	4	COORD
15	in	in	IN	_	14	CONJ
16	platelets	platelet	NNS	_	15	PMOD

1	Salzer	salzer	NNP	_	5	SBJ
2	et	et	FW	_	3	AMOD
3	al.	al.	FW	_	1	NMOD
4	recently	recently	RB	_	5	TMP
5	reported	report	VBD	_	0	ROOT
6	the	the	DT	_	7	NMOD
7	presence	presence	NN	_	5	OBJ
8	of	of	IN	_	7	NMOD
9	the	the	DT	_	12	NMOD
10	47	0	CD	_	11	NMOD
11	kDa	kda	NN	_	12	NMOD
12	isoform	isoform	NN	_	8	PMOD
13	of	of	IN	_	12	NMOD
14	annexin	annexin	NN	_	15	NMOD
15	A7	a0	NN	_	13	PMOD
16	and	and	CC	_	15	COORD
17	its	its	PRP$	_	18	NMOD
18	partner	partner	NN	_	19	NMOD
19	sorcin	sorcin	NN	_	16	CONJ
20	in	in	IN	_	12	LOC
21	micro	micro	NN	_	20	PMOD
22	-	-	HYPH	_	21	P
23	and	and	CC	_	21	COORD
24	nanovesicles	nanovesicles	NNS	_	23	CONJ
25	derived	derive	VBN	_	21	NMOD
26	from	from	IN	_	25	ADV
27	red	red	JJ	_	29	NMOD
28	blood	blood	NN	_	29	NMOD
29	cells	cell	NNS	_	26	PMOD
30	where	where	WRB	_	32	LOC
31	they	they	PRP	_	32	SBJ
32	are	be	VBP	_	29	NMOD
33	located	locate	VBN	_	32	VC
34	in	in	IN	_	33	LOC
35	the	the	DT	_	36	NMOD
36	lumen	lumen	NN	_	34	PMOD
37	and	and	CC	_	32	COORD
38	are	be	VBP	_	37	CONJ
39	also	also	RB	_	38	ADV
40	enriched	enrich	VBN	_	38	VC
41	in	in	IN	_	40	LOC
42	membrane	membrane	NN	_	43	NMOD
43	rafts	raft	NNS	_	41	PMOD
44	[	[	-LRB-	_	45	P
45	7	0	CD	_	5	PRN
46	]	]	-RRB-	_	45	P
47	.	.	.	_	5	P

1	We	we	PRP	_	2	SBJ
2	have	have	VBP	_	0	ROOT
3	now	now	RB	_	2	TMP
4	extended	extend	VBN	_	2	VC
5	these	these	DT	_	6	NMOD
6	findings	finding	NNS	_	4	OBJ
7	and	and	CC	_	2	COORD
8	show	show	VBP	_	7	CONJ
9	here	here	RB	_	8	ADV
10	that	that	IN	_	8	OBJ
11	the	the	DT	_	14	NMOD
12	51	0	CD	_	13	NMOD
13	kDa	kda	NN	_	14	NMOD
14	isoform	isoform	NN	_	15	SBJ
15	is	be	VBZ	_	10	SUB
16	present	present	JJ	_	15	PRD
17	as	as	RB	_	18	AMOD
18	well	well	RB	_	15	ADV
19	.	.	.	_	2	P

1	In	in	IN	_	15	LOC
2	western	western	JJ	_	3	NMOD
3	blots	blot	NNS	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	human	human	JJ	_	8	NMOD
6	red	red	JJ	_	8	NMOD
7	blood	blood	NN	_	8	NMOD
8	cells	cell	NNS	_	4	PMOD
9	the	the	DT	_	14	NMOD
10	47	0	CD	_	13	NMOD
11	and	and	CC	_	10	COORD
12	51	0	CD	_	11	CONJ
13	kDa	kda	NN	_	14	NMOD
14	isoforms	isoforms	NNS	_	15	SBJ
15	were	be	VBD	_	0	ROOT
16	detected	detect	VBN	_	15	VC
17	using	use	VBG	_	16	ADV
18	mAb	mab	NN	_	17	OBJ
19	203–217	0–0	CD	_	18	NMOD
20	(	(	-LRB-	_	21	P
21	Fig.	fig.	NN	_	16	PRN
22	1	0	CD	_	21	NMOD
23	)	)	-RRB-	_	21	P
24	.	.	.	_	15	P

1	The	the	DT	_	4	NMOD
2	47	0	CD	_	3	NMOD
3	kDa	kda	NN	_	4	NMOD
4	isoform	isoform	NN	_	5	SBJ
5	was	be	VBD	_	0	ROOT
6	detected	detect	VBN	_	5	VC
7	in	in	IN	_	6	LOC
8	silver	silver	NN	_	9	AMOD
9	stained	stain	VBN	_	10	NMOD
10	gels	gel	NNS	_	7	PMOD
11	and	and	CC	_	5	COORD
12	its	its	PRP$	_	13	NMOD
13	identity	identity	NN	_	17	SBJ
14	with	with	IN	_	13	NMOD
15	annexin	annexin	NN	_	16	NMOD
16	A7	a0	NN	_	14	PMOD
17	confirmed	confirm	VBN	_	11	GAP
18	by	by	IN	_	17	MNR
19	peptide	peptide	NN	_	21	NMOD
20	mass	mass	NN	_	21	NMOD
21	fingerprinting	fingerprinting	NN	_	18	PMOD
22	(	(	-LRB-	_	25	P
23	data	datum	NNS	_	25	SBJ
24	not	not	RB	_	25	ADV
25	shown	show	VBN	_	17	PRN
26	)	)	-RRB-	_	25	P
27	.	.	.	_	5	P

1	The	the	DT	_	4	NMOD
2	51	0	CD	_	3	NMOD
3	kDa	kda	NN	_	4	NMOD
4	isoform	isoform	NN	_	5	SBJ
5	was	be	VBD	_	0	ROOT
6	only	only	RB	_	5	ADV
7	detected	detect	VBN	_	5	VC
8	in	in	IN	_	7	LOC
9	western	western	JJ	_	10	NMOD
10	blots	blot	NNS	_	8	PMOD
11	.	.	.	_	5	P

1	Figure	figure	NN	_	0	ROOT
2	1	0	CD	_	1	NMOD

1	Expression	expression	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	annexin	annexin	NN	_	4	NMOD
4	A7	a0	NN	_	2	PMOD
5	in	in	IN	_	1	LOC
6	human	human	JJ	_	9	NMOD
7	red	red	JJ	_	9	NMOD
8	blood	blood	NN	_	9	NMOD
9	cells	cell	NNS	_	5	PMOD
10	(	(	-LRB-	_	11	P
11	1	0	CD	_	9	PRN
12	)	)	-RRB-	_	11	P
13	and	and	CC	_	9	COORD
14	human	human	JJ	_	15	NMOD
15	platelets	platelet	NNS	_	13	CONJ
16	(	(	-LRB-	_	17	P
17	2	0	CD	_	15	PRN
18	)	)	-RRB-	_	17	P
19	.	.	.	_	1	P

1	Protein	protein	NN	_	2	NMOD
2	homogenates	homogenate	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	separated	separate	VBN	_	3	VC
5	by	by	IN	_	4	MNR
6	SDS	sd	NN	_	8	NMOD
7	-	-	HYPH	_	6	P
8	PAGE	page	NN	_	5	PMOD
9	(	(	-LRB-	_	12	P
10	12	0	CD	_	11	NMOD
11	%	%	NN	_	12	NMOD
12	acrylamide	acrylamide	NN	_	4	PRN
13	)	)	-RRB-	_	12	P
14	.	.	.	_	3	P

1	The	the	DT	_	4	NMOD
2	resulting	result	VBG	_	4	NMOD
3	western	western	JJ	_	4	NMOD
4	blot	blot	NN	_	5	SBJ
5	was	be	VBD	_	12	DEP
6	probed	probe	VBN	_	5	VC
7	with	with	IN	_	6	MNR
8	mAb	mab	NN	_	7	PMOD
9	203–217	0–0	CD	_	8	NMOD
10	,	,	,	_	12	P
11	visualization	visualization	NN	_	12	SBJ
12	was	be	VBD	_	0	ROOT
13	by	by	IN	_	12	PRD
14	a	a	DT	_	18	NMOD
15	secondary	secondary	JJ	_	18	NMOD
16	peroxidase	peroxidase	NN	_	17	AMOD
17	coupled	couple	VBN	_	18	NMOD
18	antibody	antibody	NN	_	13	PMOD
19	followed	follow	VBN	_	18	NMOD
20	by	by	IN	_	19	LGS
21	ECL	ecl	NN	_	20	PMOD
22	.	.	.	_	12	P

1	Both	both	DT	_	2	NMOD
2	isoforms	isoforms	NNS	_	3	SBJ
3	are	be	VBP	_	16	DEP
4	detected	detect	VBN	_	3	VC
5	in	in	IN	_	4	LOC
6	red	red	JJ	_	8	NMOD
7	blood	blood	NN	_	8	NMOD
8	cells	cell	NNS	_	5	PMOD
9	,	,	,	_	16	P
10	in	in	IN	_	16	LOC
11	platelets	platelet	NNS	_	10	PMOD
12	only	only	RB	_	15	NMOD
13	the	the	DT	_	15	NMOD
14	small	small	JJ	_	15	NMOD
15	isoform	isoform	NN	_	16	SBJ
16	is	be	VBZ	_	0	ROOT
17	present	present	JJ	_	16	PRD
18	.	.	.	_	16	P

1	Its	its	PRP$	_	2	NMOD
2	presence	presence	NN	_	5	SBJ
3	in	in	IN	_	2	LOC
4	vesicles	vesicle	NNS	_	3	PMOD
5	led	lead	VBD	_	0	ROOT
6	to	to	IN	_	5	ADV
7	the	the	DT	_	8	NMOD
8	suggestion	suggestion	NN	_	6	PMOD
9	,	,	,	_	8	P
10	that	that	IN	_	8	NMOD
11	,	,	,	_	10	P
12	along	along	IN	_	19	ADV
13	with	with	IN	_	12	PMOD
14	raft	raft	NN	_	15	NMOD
15	domains	domain	NNS	_	13	PMOD
16	,	,	,	_	19	P
17	annexin	annexin	NN	_	18	NMOD
18	A7	a0	NN	_	19	SBJ
19	plays	play	VBZ	_	10	SUB
20	a	a	DT	_	21	NMOD
21	role	role	NN	_	19	OBJ
22	in	in	IN	_	19	ADV
23	membrane	membrane	NN	_	24	NMOD
24	organization	organization	NN	_	22	PMOD
25	and	and	CC	_	24	COORD
26	the	the	DT	_	28	NMOD
27	vesiculation	vesiculation	NN	_	28	NMOD
28	process	process	NN	_	25	CONJ
29	.	.	.	_	5	P

1	To	to	TO	_	6	PRP
2	examine	examine	VB	_	1	IM
3	this	this	DT	_	2	OBJ
4	,	,	,	_	6	P
5	we	we	PRP	_	6	SBJ
6	analysed	analyse	VBD	_	0	ROOT
7	the	the	DT	_	8	NMOD
8	ability	ability	NN	_	6	OBJ
9	of	of	IN	_	8	NMOD
10	red	red	JJ	_	12	NMOD
11	blood	blood	NN	_	12	NMOD
12	cells	cell	NNS	_	9	PMOD
13	derived	derive	VBN	_	12	NMOD
14	from	from	IN	_	13	ADV
15	the	the	DT	_	20	NMOD
16	annexin	annexin	NN	_	17	NMOD
17	A7	a0	NN	_	20	NMOD
18	knock	knock	NN	_	19	NMOD
19	out	out	NN	_	20	NMOD
20	mice	mouse	NNS	_	14	PMOD
21	(	(	-LRB-	_	22	P
22	anxA7	anxa0	NN	_	20	PRN
23	-	-	SYM	_	22	P
24	/	/	HYPH	_	22	P
25	-	-	SYM	_	22	P
26	)	)	-RRB-	_	22	P
27	to	to	TO	_	8	NMOD
28	form	form	VB	_	27	IM
29	exovesicles	exovesicles	NNS	_	28	OBJ
30	.	.	.	_	6	P

1	Because	because	IN	_	16	PRP
2	of	of	IN	_	1	PMOD
3	better	good	JJR	_	4	NMOD
4	accessibility	accessibility	NN	_	1	PMOD
5	and	and	CC	_	4	COORD
6	larger	large	JJR	_	8	NMOD
7	available	available	JJ	_	8	NMOD
8	amounts	amount	NNS	_	5	CONJ
9	that	that	WDT	_	10	SBJ
10	led	lead	VBD	_	4	NMOD
11	to	to	IN	_	10	ADV
12	clear	clear	JJ	_	13	NMOD
13	results	result	NNS	_	11	PMOD
14	,	,	,	_	16	P
15	we	we	PRP	_	16	SBJ
16	included	include	VBD	_	0	ROOT
17	our	our	PRP$	_	18	NMOD
18	data	datum	NNS	_	16	OBJ
19	obtained	obtain	VBN	_	18	NMOD
20	with	with	IN	_	19	MNR
21	human	human	JJ	_	22	NMOD
22	blood	blood	NN	_	20	PMOD
23	.	.	.	_	16	P

1	Independent	independent	JJ	_	18	ADV
2	of	of	IN	_	1	AMOD
3	the	the	DT	_	4	NMOD
4	presence	presence	NN	_	2	PMOD
5	of	of	IN	_	4	NMOD
6	annexin	annexin	NN	_	7	NMOD
7	A7	a0	NN	_	5	PMOD
8	both	both	DT	_	9	NMOD
9	types	type	NNS	_	18	SBJ
10	of	of	IN	_	9	NMOD
11	exovesicles	exovesicles	NNS	_	10	PMOD
12	,	,	,	_	9	P
13	micro	micro	AFX	_	9	APPO
14	-	-	HYPH	_	13	P
15	and	and	CC	_	13	COORD
16	nanovesicles	nanovesicles	NNS	_	15	CONJ
17	,	,	,	_	18	P
18	were	be	VBD	_	0	ROOT
19	released	release	VBN	_	18	VC
20	after	after	IN	_	19	TMP
21	Ca2+	ca0+	NN	_	23	NMOD
22	/	/	HYPH	_	21	P
23	ionophore	ionophore	NN	_	24	NMOD
24	treatment	treatment	NN	_	20	PMOD
25	as	as	IN	_	19	ADV
26	determined	determine	VBN	_	25	SUB
27	by	by	IN	_	26	LGS
28	acetylcholine	acetylcholine	NN	_	29	NMOD
29	esterase	esterase	NN	_	30	NMOD
30	activity	activity	NN	_	27	PMOD
31	and	and	CC	_	30	COORD
32	microscopic	microscopic	JJ	_	33	NMOD
33	examination	examination	NN	_	31	CONJ
34	.	.	.	_	18	P

1	Annexin	annexin	NN	_	2	NMOD
2	A7	a0	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	present	present	JJ	_	3	PRD
5	in	in	IN	_	3	LOC
6	both	both	CC	_	8	COORD
7	vesicle	vesicle	NN	_	8	NMOD
8	types	type	NNS	_	5	PMOD
9	where	where	WRB	_	11	LOC
10	it	it	PRP	_	11	SBJ
11	is	be	VBZ	_	8	LOC
12	more	more	RBR	_	13	AMOD
13	enriched	enriched	JJ	_	11	PRD
14	in	in	IN	_	11	LOC
15	nanovesicles	nanovesicles	NNS	_	14	PMOD
16	(	(	-LRB-	_	17	P
17	Fig.	fig.	NN	_	3	PRN
18	2	0	CD	_	17	NMOD
19	)	)	-RRB-	_	17	P
20	.	.	.	_	3	P

1	The	the	DT	_	4	NMOD
2	51	0	CD	_	3	NMOD
3	kDa	kda	NN	_	4	NMOD
4	isoform	isoform	NN	_	5	SBJ
5	is	be	VBZ	_	0	ROOT
6	only	only	RB	_	5	ADV
7	detectable	detectable	JJ	_	5	PRD
8	in	in	IN	_	5	LOC
9	nanovesicles	nanovesicles	NNS	_	8	PMOD
10	.	.	.	_	5	P

1	The	the	DT	_	2	NMOD
2	quantity	quantity	NN	_	7	SBJ
3	of	of	IN	_	2	NMOD
4	both	both	DT	_	6	NMOD
5	vesicle	vesicle	NN	_	6	NMOD
6	types	type	NNS	_	3	PMOD
7	did	do	VBD	_	0	ROOT
8	not	not	RB	_	7	ADV
9	differ	differ	VB	_	7	VC
10	between	between	IN	_	9	ADV
11	wild	wild	JJ	_	12	NMOD
12	type	type	NN	_	19	NMOD
13	and	and	CC	_	12	COORD
14	knock	knock	NN	_	15	NMOD
15	out	out	NN	_	13	CONJ
16	red	red	JJ	_	18	NMOD
17	blood	blood	NN	_	18	NMOD
18	cell	cell	NN	_	19	NMOD
19	vesicles	vesicle	NNS	_	10	PMOD
20	as	as	IN	_	9	ADV
21	determined	determine	VBN	_	20	SUB
22	by	by	IN	_	21	LGS
23	the	the	DT	_	26	NMOD
24	AChE	ache	NN	_	26	NMOD
25	-	-	HYPH	_	24	P
26	values	value	NNS	_	22	PMOD
27	(	(	-LRB-	_	40	P
28	A405	a0	NN	_	29	NMOD
29	nanovesicles	nanovesicles	NNS	_	40	DEP
30	:	:	:	_	29	P
31	~	~	SYM	_	32	P
32	0.18	0	CD	_	29	DEP
33	;	;	:	_	40	P
34	A405	a0	NN	_	35	NMOD
35	microvesicles	microvesicles	NNS	_	40	DEP
36	:	:	:	_	35	P
37	~	~	SYM	_	38	P
38	0.9	0	CD	_	35	DEP
39	;	;	:	_	40	P
40	both	both	DT	_	26	PRN
41	,	,	,	_	40	P
42	for	for	IN	_	40	NMOD
43	wt	wt	NN	_	42	PMOD
44	and	and	CC	_	43	COORD
45	ko	ko	NN	_	44	CONJ
46	)	)	-RRB-	_	40	P
47	.	.	.	_	7	P

1	It	it	PRP	_	2	SBJ
2	appears	appear	VBZ	_	0	ROOT
3	that	that	IN	_	2	OBJ
4	annexin	annexin	NN	_	5	NMOD
5	A7	a0	NN	_	16	SBJ
6	,	,	,	_	16	P
7	although	although	IN	_	16	ADV
8	it	it	PRP	_	9	SBJ
9	has	have	VBZ	_	7	SUB
10	been	be	VBN	_	9	VC
11	described	describe	VBN	_	10	VC
12	to	to	TO	_	11	OPRD
13	fuse	fuse	VB	_	12	IM
14	membranes	membrane	NNS	_	13	OBJ
15	,	,	,	_	16	P
16	is	be	VBZ	_	3	SUB
17	not	not	RB	_	16	ADV
18	a	a	DT	_	20	NMOD
19	key	key	JJ	_	20	NMOD
20	component	component	NN	_	16	PRD
21	in	in	IN	_	20	NMOD
22	the	the	DT	_	23	NMOD
23	process	process	NN	_	21	PMOD
24	of	of	IN	_	23	NMOD
25	the	the	DT	_	26	NMOD
26	formation	formation	NN	_	24	PMOD
27	of	of	IN	_	26	NMOD
28	red	red	JJ	_	30	NMOD
29	blood	blood	NN	_	30	NMOD
30	cell	cell	NN	_	31	NMOD
31	exovesicles	exovesicles	NNS	_	27	PMOD
32	.	.	.	_	2	P

1	When	when	WRB	_	3	TMP
2	we	we	PRP	_	3	SBJ
3	probed	probe	VBD	_	16	TMP
4	for	for	IN	_	3	PRP
5	the	the	DT	_	6	NMOD
6	presence	presence	NN	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	sorcin	sorcin	NN	_	7	PMOD
9	in	in	IN	_	3	LOC
10	wild	wild	JJ	_	11	NMOD
11	type	type	NN	_	14	NMOD
12	and	and	CC	_	11	COORD
13	mutant	mutant	JJ	_	12	CONJ
14	vesicles	vesicle	NNS	_	9	PMOD
15	we	we	PRP	_	16	SBJ
16	found	find	VBD	_	0	ROOT
17	that	that	IN	_	16	OBJ
18	the	the	DT	_	20	NMOD
19	sorcin	sorcin	NN	_	20	NMOD
20	levels	level	NNS	_	21	SBJ
21	were	be	VBD	_	17	SUB
22	reduced	reduce	VBN	_	21	VC
23	in	in	IN	_	22	LOC
24	the	the	DT	_	26	NMOD
25	mutant	mutant	JJ	_	26	NMOD
26	nanovesicles	nanovesicles	NNS	_	23	PMOD
27	(	(	-LRB-	_	28	P
28	Fig.	fig.	NN	_	16	PRN
29	2	0	CD	_	28	NMOD
30	)	)	-RRB-	_	28	P
31	.	.	.	_	16	P

1	Figure	figure	NN	_	0	ROOT
2	2	0	CD	_	1	NMOD

1	Enrichment	enrichment	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	annexin	annexin	NN	_	4	NMOD
4	A7	a0	NN	_	2	PMOD
5	and	and	CC	_	4	COORD
6	sorcin	sorcin	NN	_	5	CONJ
7	in	in	IN	_	1	LOC
8	exovesicles	exovesicles	NNS	_	7	PMOD
9	derived	derive	VBN	_	8	NMOD
10	from	from	IN	_	9	ADV
11	red	red	JJ	_	13	NMOD
12	blood	blood	NN	_	13	NMOD
13	cells	cell	NNS	_	10	PMOD
14	.	.	.	_	1	P

1	Vesicles	vesicle	NNS	_	17	SBJ
2	from	from	IN	_	1	NMOD
3	wild	wild	JJ	_	4	NMOD
4	type	type	NN	_	6	NMOD
5	(	(	-LRB-	_	6	P
6	wt	wt	NN	_	2	PMOD
7	)	)	-RRB-	_	6	P
8	and	and	CC	_	6	COORD
9	anxA7	anxa0	JJ	_	13	NMOD
10	-	-	SYM	_	9	P
11	/	/	HYPH	_	9	P
12	-	-	SYM	_	9	P
13	mutant	mutant	NN	_	15	NMOD
14	(	(	-LRB-	_	15	P
15	ko	ko	NN	_	8	CONJ
16	)	)	-RRB-	_	17	P
17	were	be	VBD	_	0	ROOT
18	generated	generate	VBN	_	17	VC
19	with	with	IN	_	18	MNR
20	Ca2+	ca0+	NN	_	22	NMOD
21	/	/	HYPH	_	20	P
22	ionophore	ionophore	NN	_	23	NMOD
23	treatment	treatment	NN	_	19	PMOD
24	,	,	,	_	18	P
25	isolated	isolate	VBN	_	18	CONJ
26	by	by	IN	_	25	MNR
27	differential	differential	JJ	_	28	NMOD
28	centrifugation	centrifugation	NN	_	26	PMOD
29	and	and	CC	_	25	COORD
30	analysed	analyse	VBN	_	29	CONJ
31	by	by	IN	_	30	MNR
32	immunoblotting	immunoblotting	VBG	_	31	PMOD
33	with	with	IN	_	30	MNR
34	mAb	mab	NN	_	35	NMOD
35	203	0	CD	_	33	PMOD
36	–	–	SYM	_	37	P
37	217	0	CD	_	35	NMOD
38	and	and	CC	_	35	COORD
39	a	a	DT	_	42	NMOD
40	sorcin	sorcin	NN	_	42	NMOD
41	polyclonal	polyclonal	JJ	_	42	NMOD
42	antibody	antibody	NN	_	38	CONJ
43	.	.	.	_	17	P

1	In	in	IN	_	8	ADV
2	general	general	JJ	_	1	PMOD
3	,	,	,	_	8	P
4	annexin	annexin	NN	_	5	NMOD
5	A7	a0	NN	_	8	SBJ
6	and	and	CC	_	5	COORD
7	sorcin	sorcin	NN	_	6	CONJ
8	are	be	VBP	_	0	ROOT
9	more	more	RBR	_	10	AMOD
10	abundant	abundant	JJ	_	8	PRD
11	in	in	IN	_	8	LOC
12	nanovesicles	nanovesicles	NNS	_	11	PMOD
13	.	.	.	_	8	P

1	The	the	DT	_	4	NMOD
2	51	0	CD	_	3	NMOD
3	kDa	kda	NN	_	4	NMOD
4	isoform	isoform	NN	_	11	SBJ
5	of	of	IN	_	4	NMOD
6	annexin	annexin	NN	_	7	NMOD
7	A7	a0	NN	_	5	PMOD
8	(	(	-LRB-	_	9	P
9	arrows	arrow	NNS	_	4	PRN
10	)	)	-RRB-	_	9	P
11	is	be	VBZ	_	0	ROOT
12	only	only	RB	_	11	ADV
13	observed	observe	VBN	_	11	VC
14	in	in	IN	_	13	LOC
15	nanovesicles	nanovesicles	NNS	_	14	PMOD
16	.	.	.	_	11	P

1	Samples	sample	NNS	_	6	SBJ
2	of	of	IN	_	1	NMOD
3	both	both	DT	_	5	NMOD
4	vesicles	vesicle	NNS	_	5	NMOD
5	types	type	NNS	_	2	PMOD
6	were	be	VBD	_	0	ROOT
7	normalized	normalize	VBN	_	6	VC
8	according	accord	VBG	_	7	ADV
9	to	to	IN	_	8	PMOD
10	their	their	PRP$	_	13	NMOD
11	acetylcholine	acetylcholine	NN	_	12	NMOD
12	esterase	esterase	NN	_	13	NMOD
13	activity	activity	NN	_	9	PMOD
14	.	.	.	_	6	P

1	Human	human	JJ	_	4	NMOD
2	red	red	JJ	_	4	NMOD
3	blood	blood	NN	_	4	NMOD
4	cells	cell	NNS	_	8	SBJ
5	(	(	-LRB-	_	6	P
6	co	co	NN	_	4	PRN
7	)	)	-RRB-	_	6	P
8	were	be	VBD	_	0	ROOT
9	used	use	VBN	_	8	VC
10	for	for	IN	_	9	PRP
11	control	control	NN	_	10	PMOD
12	and	and	CC	_	9	COORD
13	normalized	normalize	VBD	_	12	CONJ
14	independently	independently	RB	_	13	MNR
15	.	.	.	_	8	P

1	To	to	TO	_	13	PRP
2	study	study	VB	_	1	IM
3	the	the	DT	_	4	NMOD
4	distribution	distribution	NN	_	2	OBJ
5	of	of	IN	_	4	NMOD
6	annexin	annexin	NN	_	7	NMOD
7	A7	a0	NN	_	5	PMOD
8	in	in	IN	_	2	LOC
9	red	red	JJ	_	11	NMOD
10	blood	blood	NN	_	11	NMOD
11	cells	cell	NNS	_	8	PMOD
12	we	we	PRP	_	13	SBJ
13	used	use	VBD	_	0	ROOT
14	self	self	NN	_	15	AMOD
15	forming	form	VBG	_	18	NMOD
16	iodixanol	iodixanol	NN	_	18	NMOD
17	density	density	NN	_	18	NMOD
18	gradients	gradient	NNS	_	13	OBJ
19	.	.	.	_	13	P

1	Both	both	DT	_	2	NMOD
2	isoforms	isoforms	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	present	present	JJ	_	3	PRD
5	in	in	IN	_	3	LOC
6	the	the	DT	_	8	NMOD
7	soluble	soluble	JJ	_	8	NMOD
8	fraction	fraction	NN	_	5	PMOD
9	as	as	RB	_	11	ADV
10	well	well	RB	_	11	ADV
11	as	as	IN	_	5	COORD
12	in	in	IN	_	11	CONJ
13	the	the	DT	_	15	NMOD
14	gradient	gradient	NN	_	15	NMOD
15	fractions	fraction	NNS	_	12	PMOD
16	where	where	WRB	_	19	LOC
17	they	they	PRP	_	18	SBJ
18	are	be	VBP	_	15	NMOD
19	assumed	assume	VBN	_	18	VC
20	to	to	TO	_	19	OPRD
21	be	be	VB	_	20	IM
22	associated	associate	VBN	_	21	VC
23	with	with	IN	_	22	ADV
24	membranes	membrane	NNS	_	23	PMOD
25	.	.	.	_	3	P

1	These	these	DT	_	2	NMOD
2	membranes	membrane	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	exclusively	exclusively	RB	_	3	ADV
5	plasma	plasma	NN	_	6	NMOD
6	membranes	membrane	NNS	_	3	PRD
7	as	as	IN	_	3	ADV
8	red	red	JJ	_	10	NMOD
9	blood	blood	NN	_	10	NMOD
10	cells	cell	NNS	_	11	SBJ
11	are	be	VBP	_	7	SUB
12	free	free	JJ	_	11	PRD
13	of	of	IN	_	12	AMOD
14	any	any	DT	_	15	NMOD
15	organelles	organelle	NNS	_	13	PMOD
16	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	distribution	distribution	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	however	however	RB	_	3	ADV
5	not	not	RB	_	3	ADV
6	homogeneous	homogeneous	JJ	_	3	PRD
7	throughout	throughout	IN	_	3	LOC
8	the	the	DT	_	9	NMOD
9	gradient	gradient	NN	_	7	PMOD
10	.	.	.	_	3	P

1	This	this	DT	_	2	SBJ
2	could	could	MD	_	0	ROOT
3	reflect	reflect	VB	_	2	VC
4	the	the	DT	_	5	NMOD
5	binding	binding	NN	_	3	OBJ
6	of	of	IN	_	5	NMOD
7	annexin	annexin	NN	_	8	NMOD
8	A7	a0	NN	_	6	PMOD
9	to	to	IN	_	5	NMOD
10	membrane	membrane	NN	_	11	NMOD
11	subdomains	subdomains	NNS	_	9	PMOD
12	that	that	WDT	_	13	SBJ
13	have	have	VBP	_	11	NMOD
14	different	different	JJ	_	20	NMOD
15	lipid	lipid	NN	_	20	NMOD
16	or	or	CC	_	15	COORD
17	lipid	lipid	NN	_	19	NMOD
18	/	/	HYPH	_	17	P
19	protein	protein	NN	_	16	CONJ
20	composition	composition	NN	_	13	OBJ
21	as	as	IN	_	3	ADV
22	discussed	discuss	VBN	_	21	SUB
23	by	by	IN	_	22	LGS
24	Salzer	salzer	NNP	_	23	PMOD
25	et	et	FW	_	26	AMOD
26	al.	al.	FW	_	24	NMOD
27	[	[	-LRB-	_	28	P
28	7	0	CD	_	3	PRN
29	]	]	-RRB-	_	28	P
30	.	.	.	_	2	P

1	Likewise	likewise	RB	_	4	ADV
2	,	,	,	_	4	P
3	sorcin	sorcin	NN	_	4	SBJ
4	does	do	VBZ	_	0	ROOT
5	not	not	RB	_	4	ADV
6	exhibit	exhibit	VB	_	4	VC
7	a	a	DT	_	9	NMOD
8	homogeneous	homogeneous	JJ	_	9	NMOD
9	distribution	distribution	NN	_	6	OBJ
10	in	in	IN	_	6	LOC
11	the	the	DT	_	12	NMOD
12	gradient	gradient	NN	_	10	PMOD
13	.	.	.	_	4	P

1	Moreover	moreover	RB	_	4	ADV
2	,	,	,	_	4	P
3	it	it	PRP	_	4	SBJ
4	segregates	segregate	VBZ	_	0	ROOT
5	into	into	IN	_	4	ADV
6	vesicles	vesicle	NNS	_	5	PMOD
7	which	which	WDT	_	8	SBJ
8	are	be	VBP	_	6	NMOD
9	not	not	RB	_	8	ADV
10	associated	associate	VBN	_	8	VC
11	with	with	IN	_	10	ADV
12	annexin	annexin	NN	_	13	NMOD
13	A7	a0	NN	_	11	PMOD
14	(	(	-LRB-	_	15	P
15	Fig.	fig.	NN	_	4	PRN
16	3	0	CD	_	15	NMOD
17	)	)	-RRB-	_	15	P
18	.	.	.	_	4	P

1	We	we	PRP	_	3	SBJ
2	also	also	RB	_	3	ADV
3	tested	test	VBD	_	0	ROOT
4	platelets	platelet	NNS	_	3	OBJ
5	for	for	IN	_	3	PRP
6	annexin	annexin	NN	_	7	NMOD
7	A7	a0	NN	_	8	NMOD
8	expression	expression	NN	_	5	PMOD
9	and	and	CC	_	3	COORD
10	detected	detect	VBD	_	9	CONJ
11	the	the	DT	_	14	NMOD
12	47	0	CD	_	13	NMOD
13	kDa	kda	NN	_	14	NMOD
14	isoform	isoform	NN	_	10	OBJ
15	(	(	-LRB-	_	16	P
16	Fig.	fig.	NN	_	10	PRN
17	1	0	CD	_	16	NMOD
18	)	)	-RRB-	_	16	P
19	.	.	.	_	3	P

1	Figure	figure	NN	_	0	ROOT
2	3	0	CD	_	1	NMOD

1	Association	association	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	annexin	annexin	NN	_	4	NMOD
4	A7	a0	NN	_	2	PMOD
5	and	and	CC	_	4	COORD
6	sorcin	sorcin	NN	_	5	CONJ
7	with	with	IN	_	1	NMOD
8	distinct	distinct	JJ	_	14	NMOD
9	red	red	JJ	_	11	NMOD
10	blood	blood	NN	_	11	NMOD
11	cell	cell	NN	_	14	NMOD
12	plasma	plasma	NN	_	13	NMOD
13	membrane	membrane	NN	_	14	NMOD
14	fractions	fraction	NNS	_	7	PMOD
15	.	.	.	_	1	P

1	Lysed	lysed	VBN	_	5	NMOD
2	human	human	JJ	_	5	NMOD
3	red	red	JJ	_	5	NMOD
4	blood	blood	NN	_	5	NMOD
5	cells	cell	NNS	_	6	SBJ
6	were	be	VBD	_	0	ROOT
7	added	add	VBN	_	6	VC
8	to	to	IN	_	7	ADV
9	a	a	DT	_	14	NMOD
10	self	self	NN	_	11	AMOD
11	forming	form	VBG	_	14	NMOD
12	iodixanol	iodixanol	NN	_	14	NMOD
13	density	density	NN	_	14	NMOD
14	gradient	gradient	NN	_	8	PMOD
15	.	.	.	_	6	P

1	The	the	DT	_	2	NMOD
2	density	density	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	gradient	gradient	NN	_	3	PMOD
6	increases	increase	VBZ	_	0	ROOT
7	from	from	IN	_	6	ADV
8	left	left	JJ	_	7	PMOD
9	(	(	-LRB-	_	11	P
10	1.06	0	CD	_	11	NMOD
11	g	g	NNS	_	8	PRN
12	/	/	SYM	_	13	P
13	ml	ml	NN	_	11	NMOD
14	)	)	-RRB-	_	11	P
15	to	to	IN	_	7	PMOD
16	right	right	JJ	_	15	PMOD
17	(	(	-LRB-	_	19	P
18	1.20	0	CD	_	19	NMOD
19	g	g	NNS	_	16	PRN
20	/	/	SYM	_	21	P
21	ml	ml	NN	_	19	NMOD
22	)	)	-RRB-	_	19	P
23	.	.	.	_	6	P

1	Fractions	fraction	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	analysed	analyse	VBN	_	2	VC
4	by	by	IN	_	3	MNR
5	immunoblotting	immunoblotting	NN	_	4	PMOD
6	using	use	VBG	_	3	MNR
7	mAb	mab	NN	_	8	NMOD
8	203	0	CD	_	6	OBJ
9	–	–	SYM	_	10	P
10	217	0	CD	_	8	NMOD
11	and	and	CC	_	8	COORD
12	the	the	DT	_	15	NMOD
13	sorcin	sorcin	NN	_	15	NMOD
14	polyclonal	polyclonal	JJ	_	15	NMOD
15	antibody	antibody	NN	_	11	CONJ
16	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	lack	lack	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	annexin	annexin	NN	_	5	NMOD
5	A7	a0	NN	_	3	PMOD
6	changes	change	VBZ	_	0	ROOT
7	red	red	JJ	_	9	NMOD
8	blood	blood	NN	_	9	NMOD
9	cell	cell	NN	_	10	NMOD
10	morphology	morphology	NN	_	6	OBJ
11	and	and	CC	_	10	COORD
12	osmotic	osmotic	JJ	_	13	NMOD
13	resistance	resistance	NN	_	11	CONJ

1	As	as	IN	_	13	ADV
2	annexin	annexin	NN	_	3	NMOD
3	A7	a0	NN	_	4	SBJ
4	is	be	VBZ	_	1	SUB
5	a	a	DT	_	6	NMOD
6	component	component	NN	_	4	PRD
7	of	of	IN	_	6	NMOD
8	red	red	JJ	_	10	NMOD
9	blood	blood	NN	_	10	NMOD
10	cell	cell	NN	_	11	NMOD
11	vesicles	vesicle	NNS	_	7	PMOD
12	we	we	PRP	_	13	SBJ
13	studied	study	VBD	_	0	ROOT
14	the	the	DT	_	15	NMOD
15	consequences	consequence	NNS	_	13	OBJ
16	of	of	IN	_	15	NMOD
17	the	the	DT	_	18	NMOD
18	loss	loss	NN	_	16	PMOD
19	of	of	IN	_	18	NMOD
20	the	the	DT	_	21	NMOD
21	protein	protein	NN	_	19	PMOD
22	in	in	IN	_	13	LOC
23	the	the	DT	_	28	NMOD
24	anxA7	anxa0	NN	_	28	NMOD
25	-	-	SYM	_	24	P
26	/	/	HYPH	_	24	P
27	-	-	SYM	_	24	P
28	mouse	mouse	NN	_	22	PMOD
29	for	for	IN	_	13	PRP
30	red	red	JJ	_	32	NMOD
31	blood	blood	NN	_	32	NMOD
32	cell	cell	NN	_	33	NMOD
33	morphology	morphology	NN	_	29	PMOD
34	and	and	CC	_	33	COORD
35	osmotic	osmotic	JJ	_	36	NMOD
36	resistance	resistance	NN	_	34	CONJ
37	.	.	.	_	13	P

1	In	in	IN	_	22	LOC
2	a	a	DT	_	6	NMOD
3	standard	standard	JJ	_	6	NMOD
4	'	'	``	_	6	P
5	blood	blood	NN	_	6	NMOD
6	smear	smear	NN	_	1	PMOD
7	'	'	''	_	22	P
8	we	we	PRP	_	9	SBJ
9	did	do	VBD	_	22	DEP
10	not	not	RB	_	9	ADV
11	note	note	VB	_	9	VC
12	a	a	DT	_	13	NMOD
13	deformation	deformation	NN	_	11	OBJ
14	of	of	IN	_	13	NMOD
15	the	the	DT	_	16	NMOD
16	cells	cell	NNS	_	14	PMOD
17	,	,	,	_	22	P
18	however	however	RB	_	22	ADV
19	dark	dark	JJ	_	20	NMOD
20	field	field	NN	_	21	NMOD
21	microscopy	microscopy	NN	_	22	SBJ
22	revealed	reveal	VBD	_	0	ROOT
23	changes	change	NNS	_	22	OBJ
24	in	in	IN	_	23	NMOD
25	shape	shape	NN	_	24	PMOD
26	and	and	CC	_	25	COORD
27	diameter	diameter	NN	_	26	CONJ
28	of	of	IN	_	25	NMOD
29	the	the	DT	_	36	NMOD
30	anxA7	anxa0	JJ	_	36	NMOD
31	-	-	SYM	_	30	P
32	/	/	HYPH	_	30	P
33	-	-	SYM	_	30	P
34	red	red	JJ	_	36	NMOD
35	blood	blood	NN	_	36	NMOD
36	cells	cell	NNS	_	28	PMOD
37	.	.	.	_	22	P

1	They	they	PRP	_	2	SBJ
2	had	have	VBD	_	0	ROOT
3	a	a	DT	_	8	NMOD
4	statistically	statistically	RB	_	5	AMOD
5	significant	significant	JJ	_	8	NMOD
6	larger	large	JJR	_	8	NMOD
7	cell	cell	NN	_	8	NMOD
8	diameter	diameter	NN	_	2	OBJ
9	of	of	IN	_	8	NMOD
10	6.0	0	CD	_	11	NMOD
11	μm	μm	NN	_	9	PMOD
12	compared	compare	VBN	_	8	NMOD
13	to	to	IN	_	12	PMOD
14	wild	wild	JJ	_	15	NMOD
15	type	type	NN	_	13	PMOD
16	with	with	IN	_	15	NMOD
17	5.7	0	CD	_	18	NMOD
18	μm	μm	NNS	_	16	PMOD
19	(	(	-LRB-	_	26	P
20	p	p	NN	_	22	SBJ
21	=	=	SYM	_	22	P
22	0.015	0	CD	_	26	DEP
23	,	,	,	_	26	P
24	n	n	NN	_	26	SBJ
25	=	=	SYM	_	26	P
26	40	0	CD	_	8	PRN
27	)	)	-RRB-	_	26	P
28	,	,	,	_	8	P
29	a	a	DT	_	34	NMOD
30	remarkably	remarkably	RB	_	31	AMOD
31	lower	low	JJR	_	34	NMOD
32	emphasized	emphasize	VBN	_	34	NMOD
33	central	central	JJ	_	34	NMOD
34	impression	impression	NN	_	8	CONJ
35	and	and	CC	_	34	COORD
36	a	a	DT	_	39	NMOD
37	more	more	RBR	_	38	AMOD
38	flat	flat	JJ	_	39	NMOD
39	shape	shape	NN	_	35	CONJ
40	(	(	-LRB-	_	41	P
41	Fig.	fig.	NN	_	8	PRN
42	4	0	CD	_	41	NMOD
43	)	)	-RRB-	_	41	P
44	.	.	.	_	2	P

1	No	no	DT	_	3	NMOD
2	significant	significant	JJ	_	3	NMOD
3	change	change	NN	_	12	SBJ
4	in	in	IN	_	3	NMOD
5	the	the	DT	_	10	NMOD
6	mean	mean	JJ	_	8	NMOD
7	corpuscular	corpuscular	JJ	_	8	NMOD
8	volume	volume	NN	_	10	NMOD
9	(	(	-LRB-	_	10	P
10	MCV	mcv	NN	_	4	PMOD
11	)	)	-RRB-	_	12	P
12	was	be	VBD	_	0	ROOT
13	measured	measure	VBN	_	12	VC
14	with	with	IN	_	13	MNR
15	the	the	DT	_	19	NMOD
16	ADVIA	advia	NN	_	19	NMOD
17	120	0	CD	_	16	NMOD
18	cell	cell	NN	_	19	NMOD
19	counter	counter	NN	_	14	PMOD
20	.	.	.	_	12	P

1	Figure	figure	NN	_	0	ROOT
2	4	0	CD	_	1	NMOD

1	Dark	dark	JJ	_	2	NMOD
2	field	field	NN	_	3	NMOD
3	microscopy	microscopy	NN	_	0	ROOT
4	of	of	IN	_	3	NMOD
5	red	red	JJ	_	7	NMOD
6	blood	blood	NN	_	7	NMOD
7	cells	cell	NNS	_	4	PMOD
8	from	from	IN	_	7	NMOD
9	anxA7	anxa0	JJ	_	13	NMOD
10	-	-	SYM	_	9	P
11	/	/	HYPH	_	9	P
12	-	-	SYM	_	9	P
13	mutant	mutant	NN	_	20	NMOD
14	(	(	-LRB-	_	15	P
15	B	b	NN	_	13	PRN
16	)	)	-RRB-	_	15	P
17	and	and	CC	_	13	COORD
18	wild	wild	JJ	_	19	NMOD
19	type	type	NN	_	17	CONJ
20	mice	mouse	NNS	_	8	PMOD
21	(	(	-LRB-	_	22	P
22	A	a	NN	_	20	PRN
23	)	)	-RRB-	_	22	P
24	.	.	.	_	3	P

1	The	the	DT	_	4	NMOD
2	mean	mean	JJ	_	4	NMOD
3	cellular	cellular	JJ	_	4	NMOD
4	diameters	diameter	NNS	_	5	SBJ
5	are	be	VBP	_	0	ROOT
6	6.0	0	CD	_	7	NMOD
7	μm	μm	NNS	_	5	PRD
8	and	and	CC	_	7	COORD
9	5.7	0	CD	_	10	NMOD
10	μm	μm	NNS	_	8	CONJ
11	,	,	,	_	5	P
12	respectively	respectively	RB	_	5	ADV
13	.	.	.	_	5	P

1	The	the	DT	_	3	NMOD
2	size	size	NN	_	3	NMOD
3	differences	difference	NNS	_	4	SBJ
4	are	be	VBP	_	0	ROOT
5	statistically	statistically	RB	_	6	AMOD
6	significant	significant	JJ	_	4	PRD
7	(	(	-LRB-	_	14	P
8	p	p	NN	_	10	SBJ
9	=	=	SYM	_	10	P
10	0.015	0	CD	_	14	DEP
11	;	;	:	_	14	P
12	n	n	NN	_	14	SBJ
13	=	=	SYM	_	14	P
14	40	0	CD	_	4	PRN
15	)	)	-RRB-	_	14	P
16	.	.	.	_	4	P

1	Bar	bar	NN	_	0	ROOT
2	,	,	,	_	1	P
3	3	0	CD	_	4	NMOD
4	μm	μm	NNS	_	1	DEP
5	.	.	.	_	1	P

1	Shape	shape	NN	_	10	SBJ
2	and	and	CC	_	1	COORD
3	MCV	mcv	NN	_	2	CONJ
4	of	of	IN	_	1	NMOD
5	a	a	DT	_	8	NMOD
6	red	red	JJ	_	8	NMOD
7	blood	blood	NN	_	8	NMOD
8	cell	cell	NN	_	4	PMOD
9	essentially	essentially	RB	_	10	ADV
10	influence	influence	VB	_	0	ROOT
11	its	its	PRP$	_	12	NMOD
12	function	function	NN	_	10	OBJ
13	and	and	CC	_	12	COORD
14	capillary	capillary	JJ	_	15	NMOD
15	passage	passage	NN	_	13	CONJ
16	.	.	.	_	10	P

1	The	the	DT	_	4	NMOD
2	typical	typical	JJ	_	4	NMOD
3	biconcave	biconcave	NN	_	4	NMOD
4	form	form	NN	_	5	SBJ
5	depends	depend	VBZ	_	0	ROOT
6	on	on	IN	_	5	ADV
7	various	various	JJ	_	8	NMOD
8	influences	influence	NNS	_	6	PMOD
9	including	include	VBG	_	8	NMOD
10	the	the	DT	_	13	NMOD
11	membrane	membrane	NN	_	12	NMOD
12	lipid	lipid	NN	_	13	NMOD
13	composition	composition	NN	_	9	PMOD
14	and	and	CC	_	13	COORD
15	the	the	DT	_	17	NMOD
16	submembranous	submembranous	JJ	_	17	NMOD
17	cytoskeleton	cytoskeleton	NN	_	14	CONJ
18	[	[	-LRB-	_	19	P
19	32	0	CD	_	17	PRN
20	]	]	-RRB-	_	19	P
21	where	where	WRB	_	25	LOC
22	annexin	annexin	NN	_	23	NMOD
23	A7	a0	NN	_	24	SBJ
24	might	might	MD	_	17	NMOD
25	play	play	VB	_	24	VC
26	a	a	DT	_	27	NMOD
27	role	role	NN	_	25	OBJ
28	.	.	.	_	5	P

1	The	the	DT	_	3	NMOD
2	osmotic	osmotic	JJ	_	3	NMOD
3	resistance	resistance	NN	_	17	SBJ
4	,	,	,	_	3	P
5	which	which	WDT	_	6	SBJ
6	is	be	VBZ	_	3	NMOD
7	the	the	DT	_	8	NMOD
8	resistance	resistance	NN	_	6	PRD
9	towards	towards	IN	_	8	NMOD
10	changes	change	NNS	_	9	PMOD
11	in	in	IN	_	6	ADV
12	the	the	DT	_	15	NMOD
13	extracellular	extracellular	JJ	_	15	NMOD
14	ionic	ionic	JJ	_	15	NMOD
15	strength	strength	NN	_	11	PMOD
16	,	,	,	_	17	P
17	is	be	VBZ	_	0	ROOT
18	a	a	DT	_	20	NMOD
19	convenient	convenient	JJ	_	20	NMOD
20	assay	assay	NN	_	17	PRD
21	for	for	IN	_	20	NMOD
22	analysis	analysis	NN	_	21	PMOD
23	of	of	IN	_	22	NMOD
24	the	the	DT	_	28	NMOD
25	red	red	JJ	_	27	NMOD
26	blood	blood	NN	_	27	NMOD
27	cell	cell	NN	_	28	NMOD
28	integrity	integrity	NN	_	23	PMOD
29	.	.	.	_	17	P

1	It	it	PRP	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	measured	measure	VBN	_	2	VC
4	as	as	IN	_	3	ADV
5	the	the	DT	_	8	NMOD
6	sodium	sodium	NN	_	7	NMOD
7	chloride	chloride	NN	_	8	NMOD
8	concentration	concentration	NN	_	16	NMOD
9	at	at	IN	_	13	ADV
10	which	which	WDT	_	9	PMOD
11	cellular	cellular	JJ	_	12	NMOD
12	lysis	lysis	NN	_	13	SBJ
13	starts	start	VBZ	_	8	NMOD
14	(	(	-LRB-	_	16	P
15	minimal	minimal	JJ	_	16	NMOD
16	resistance	resistance	NN	_	4	PMOD
17	)	)	-RRB-	_	16	P
18	up	up	IN	_	16	NMOD
19	to	to	IN	_	18	PMOD
20	a	a	DT	_	22	NMOD
21	complete	complete	JJ	_	22	NMOD
22	lysis	lysis	NN	_	25	NMOD
23	(	(	-LRB-	_	25	P
24	maximal	maximal	JJ	_	25	NMOD
25	resistance	resistance	NN	_	19	PMOD
26	)	)	-RRB-	_	25	P
27	of	of	IN	_	25	NMOD
28	the	the	DT	_	29	NMOD
29	cells	cell	NNS	_	27	PMOD
30	[	[	-LRB-	_	31	P
31	33	0	CD	_	3	PRN
32	]	]	-RRB-	_	31	P
33	.	.	.	_	2	P

1	Osmotic	osmotic	JJ	_	2	NMOD
2	resistance	resistance	NN	_	3	SBJ
3	increases	increase	VBZ	_	0	ROOT
4	with	with	IN	_	3	ADV
5	higher	high	JJR	_	6	NMOD
6	MCV	mcv	NN	_	4	PMOD
7	,	,	,	_	6	P
8	larger	large	JJR	_	10	NMOD
9	surface	surface	NN	_	10	NMOD
10	area	area	NN	_	6	CONJ
11	and	and	CC	_	10	COORD
12	a	a	DT	_	14	NMOD
13	higher	high	JJR	_	14	NMOD
14	degree	degree	NN	_	11	CONJ
15	of	of	IN	_	14	NMOD
16	cellular	cellular	JJ	_	17	NMOD
17	metabolism	metabolism	NN	_	15	PMOD
18	stabilizing	stabilize	VBG	_	6	NMOD
19	the	the	DT	_	22	NMOD
20	intracellular	intracellular	JJ	_	22	NMOD
21	ion	ion	NN	_	22	NMOD
22	levels	level	NNS	_	18	OBJ
23	.	.	.	_	3	P

1	Aged	age	VBN	_	4	NMOD
2	red	red	JJ	_	4	NMOD
3	blood	blood	NN	_	4	NMOD
4	cells	cell	NNS	_	5	SBJ
5	show	show	VBP	_	0	ROOT
6	a	a	DT	_	8	NMOD
7	lowered	lowered	JJ	_	8	NMOD
8	MCV	mcv	NN	_	5	OBJ
9	and	and	CC	_	8	COORD
10	lower	low	JJR	_	12	NMOD
11	osmotic	osmotic	JJ	_	12	NMOD
12	resistance	resistance	NN	_	9	CONJ
13	[	[	-LRB-	_	14	P
14	33	0	CD	_	5	PRN
15	]	]	-RRB-	_	14	P
16	.	.	.	_	5	P

1	Similar	similar	JJ	_	2	NMOD
2	properties	property	NNS	_	3	SBJ
3	can	can	MD	_	0	ROOT
4	be	be	VB	_	3	VC
5	observed	observe	VBN	_	4	VC
6	in	in	IN	_	5	LOC
7	red	red	JJ	_	9	NMOD
8	blood	blood	NN	_	9	NMOD
9	cells	cell	NNS	_	6	PMOD
10	with	with	IN	_	9	NMOD
11	lowered	lower	VBN	_	13	NMOD
12	membrane	membrane	NN	_	13	NMOD
13	permeability	permeability	NN	_	10	PMOD
14	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	osmotic	osmotic	JJ	_	3	NMOD
3	resistance	resistance	NN	_	11	SBJ
4	of	of	IN	_	3	NMOD
5	annexin	annexin	NN	_	6	NMOD
6	A7	a0	NN	_	7	AMOD
7	deficient	deficient	JJ	_	10	NMOD
8	red	red	JJ	_	10	NMOD
9	blood	blood	NN	_	10	NMOD
10	cells	cell	NNS	_	4	PMOD
11	is	be	VBZ	_	0	ROOT
12	significantly	significantly	RB	_	13	AMOD
13	increased	increase	VBN	_	11	PRD
14	compared	compare	VBN	_	11	ADV
15	to	to	IN	_	14	PMOD
16	wild	wild	JJ	_	17	NMOD
17	type	type	NN	_	18	NMOD
18	cells	cell	NNS	_	15	PMOD
19	.	.	.	_	11	P

1	The	the	DT	_	4	NMOD
2	minimal	minimal	JJ	_	3	NMOD
3	resistance	resistance	NN	_	4	NMOD
4	value	value	NN	_	9	SBJ
5	of	of	IN	_	4	NMOD
6	knock	knock	NN	_	7	NMOD
7	out	out	NN	_	8	NMOD
8	cells	cell	NNS	_	5	PMOD
9	is	be	VBZ	_	0	ROOT
10	observed	observe	VBN	_	9	VC
11	in	in	IN	_	10	ADV
12	a	a	DT	_	16	NMOD
13	0.60	0	CD	_	14	NMOD
14	%	%	NN	_	16	NMOD
15	NaCl	nacl	NN	_	16	NMOD
16	solution	solution	NN	_	11	PMOD
17	versus	versus	CC	_	16	COORD
18	0.65	0	CD	_	19	NMOD
19	%	%	NN	_	17	CONJ
20	for	for	IN	_	19	NMOD
21	wild	wild	JJ	_	22	NMOD
22	type	type	NN	_	23	NMOD
23	cells	cell	NNS	_	20	PMOD
24	.	.	.	_	9	P

1	50	0	CD	_	2	NMOD
2	%	%	NN	_	3	NMOD
3	haemolysis	haemolysis	NN	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	achieved	achieve	VBN	_	4	VC
6	at	at	IN	_	5	ADV
7	0.516	0	CD	_	8	NMOD
8	%	%	NN	_	10	NMOD
9	NaCl	nacl	NN	_	10	NMOD
10	solution	solution	NN	_	6	PMOD
11	for	for	IN	_	10	NMOD
12	knock	knock	NN	_	13	NMOD
13	out	out	NN	_	11	PMOD
14	versus	versus	CC	_	10	COORD
15	0.564	0	CD	_	16	NMOD
16	%	%	NN	_	17	NMOD
17	NaCl	nacl	NN	_	14	CONJ
18	for	for	IN	_	17	NMOD
19	wild	wild	JJ	_	20	NMOD
20	type	type	NN	_	21	NMOD
21	cells	cell	NNS	_	18	PMOD
22	(	(	-LRB-	_	34	P
23	mean	mean	NN	_	24	NMOD
24	values	value	NNS	_	34	DEP
25	,	,	,	_	34	P
26	p	p	NN	_	28	SBJ
27	=	=	SYM	_	28	P
28	0.00066	0	CD	_	34	DEP
29	,	,	,	_	34	P
30	n	n	NN	_	32	SBJ
31	=	=	SYM	_	32	P
32	8	0	CD	_	34	DEP
33	;	;	:	_	34	P
34	Fig.	fig.	NN	_	5	PRN
35	5	0	CD	_	34	NMOD
36	)	)	-RRB-	_	34	P
37	.	.	.	_	4	P

1	The	the	DT	_	3	NMOD
2	resistance	resistance	NN	_	3	NMOD
3	width	width	NN	_	9	SBJ
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	8	NMOD
6	knock	knock	NN	_	7	NMOD
7	out	out	NN	_	8	NMOD
8	cells	cell	NNS	_	4	PMOD
9	is	be	VBZ	_	0	ROOT
10	slightly	slightly	RB	_	11	AMOD
11	lower	low	JJR	_	9	PRD
12	(	(	-LRB-	_	20	P
13	0.20	0	CD	_	14	NMOD
14	%	%	NN	_	19	NMOD
15	instead	instead	RB	_	16	ADV
16	of	of	IN	_	14	COORD
17	0.25	0	CD	_	18	NMOD
18	%	%	NN	_	16	CONJ
19	NaCl	nacl	NN	_	20	NMOD
20	solution	solution	NN	_	11	PRN
21	)	)	-RRB-	_	20	P
22	.	.	.	_	9	P

1	We	we	PRP	_	3	SBJ
2	also	also	RB	_	3	ADV
3	performed	perform	VBD	_	0	ROOT
4	direct	direct	JJ	_	5	NMOD
5	measurements	measurement	NNS	_	3	OBJ
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	12	NMOD
8	red	red	JJ	_	10	NMOD
9	blood	blood	NN	_	10	NMOD
10	cell	cell	NN	_	12	NMOD
11	membrane	membrane	NN	_	12	NMOD
12	deformability	deformability	NN	_	6	PMOD
13	,	,	,	_	3	P
14	to	to	TO	_	3	PRP
15	further	far	RBR	_	14	ADV
16	characterize	characterize	VB	_	14	IM
17	a	a	DT	_	19	NMOD
18	possible	possible	JJ	_	19	NMOD
19	role	role	NN	_	16	OBJ
20	of	of	IN	_	19	NMOD
21	annexin	annexin	NN	_	22	NMOD
22	A7	a0	NN	_	20	PMOD
23	on	on	IN	_	19	NMOD
24	the	the	DT	_	26	NMOD
25	membrane	membrane	NN	_	26	NMOD
26	stability	stability	NN	_	23	PMOD
27	.	.	.	_	3	P

1	With	with	IN	_	5	MNR
2	micropipette	micropipette	NN	_	3	NMOD
3	experiments	experiment	NNS	_	1	PMOD
4	we	we	PRP	_	5	SBJ
5	tried	try	VBD	_	0	ROOT
6	to	to	TO	_	5	OPRD
7	correlate	correlate	VB	_	6	IM
8	mechanical	mechanical	JJ	_	9	NMOD
9	characteristics	characteristic	NNS	_	7	OBJ
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	14	NMOD
12	red	red	JJ	_	14	NMOD
13	blood	blood	NN	_	14	NMOD
14	cells	cell	NNS	_	10	PMOD
15	with	with	IN	_	7	ADV
16	their	their	PRP$	_	17	NMOD
17	morphology	morphology	NN	_	15	PMOD
18	.	.	.	_	5	P

1	We	we	PRP	_	2	SBJ
2	could	could	MD	_	0	ROOT
3	not	not	RB	_	2	ADV
4	observe	observe	VB	_	2	VC
5	any	any	DT	_	8	NMOD
6	statistically	statistically	RB	_	7	AMOD
7	significant	significant	JJ	_	8	NMOD
8	difference	difference	NN	_	4	OBJ
9	of	of	IN	_	8	NMOD
10	values	value	NNS	_	9	PMOD
11	describing	describe	VBG	_	10	NMOD
12	membrane	membrane	NN	_	13	NMOD
13	rigidity	rigidity	NN	_	11	OBJ
14	and	and	CC	_	13	COORD
15	lysis	lysis	NN	_	16	NMOD
16	force	force	NN	_	14	CONJ
17	in	in	IN	_	4	ADV
18	these	these	DT	_	19	NMOD
19	experiments	experiment	NNS	_	17	PMOD
20	(	(	-LRB-	_	21	P
21	M.	m.	NNP	_	4	CIT
22	Heil	heil	NNP	_	21	DEP
23	,	,	,	_	22	P
24	B.	b.	NNP	_	22	CONJ
25	Hoffmann	hoffmann	NNP	_	21	DEP
26	and	and	CC	_	25	COORD
27	R.	r.	NNP	_	26	CONJ
28	Merkel	merkel	NNP	_	21	DEP
29	,	,	,	_	21	P
30	unpublished	unpublished	JJ	_	21	DEP
31	results	result	NNS	_	21	DEP
32	)	)	-RRB-	_	21	P
33	.	.	.	_	2	P

1	However	however	RB	_	11	ADV
2	,	,	,	_	11	P
3	the	the	DT	_	4	NMOD
4	distinction	distinction	NN	_	11	SBJ
5	observed	observe	VBN	_	4	NMOD
6	in	in	IN	_	5	ADV
7	the	the	DT	_	10	NMOD
8	osmotic	osmotic	JJ	_	9	NMOD
9	resistance	resistance	NN	_	10	NMOD
10	experiments	experiment	NNS	_	6	PMOD
11	was	be	VBD	_	0	ROOT
12	highly	highly	RB	_	13	AMOD
13	significant	significant	JJ	_	11	PRD
14	and	and	CC	_	11	COORD
15	reflects	reflect	VBZ	_	14	CONJ
16	a	a	DT	_	18	NMOD
17	mean	mean	JJ	_	18	NMOD
18	value	value	NN	_	15	OBJ
19	over	over	IN	_	18	NMOD
20	a	a	DT	_	22	NMOD
21	high	high	JJ	_	22	NMOD
22	number	number	NN	_	19	PMOD
23	of	of	IN	_	22	NMOD
24	different	different	JJ	_	27	NMOD
25	red	red	JJ	_	27	NMOD
26	blood	blood	NN	_	27	NMOD
27	cells	cell	NNS	_	23	PMOD
28	.	.	.	_	11	P

1	Figure	figure	NN	_	0	ROOT
2	5	0	CD	_	1	NMOD

1	Osmotic	osmotic	JJ	_	2	NMOD
2	resistance	resistance	NN	_	3	NMOD
3	curves	curve	NNS	_	0	ROOT
4	of	of	IN	_	3	NMOD
5	red	red	JJ	_	7	NMOD
6	blood	blood	NN	_	7	NMOD
7	cells	cell	NNS	_	4	PMOD
8	from	from	IN	_	3	NMOD
9	wild	wild	JJ	_	10	NMOD
10	type	type	NN	_	17	NMOD
11	and	and	CC	_	10	COORD
12	anxA7	anxa0	NN	_	11	CONJ
13	-	-	SYM	_	12	P
14	/	/	HYPH	_	12	P
15	-	-	SYM	_	12	P
16	mutant	mutant	JJ	_	17	NMOD
17	mice	mouse	NNS	_	8	PMOD
18	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	osmotic	osmotic	JJ	_	3	NMOD
3	resistance	resistance	NN	_	11	SBJ
4	towards	towards	IN	_	3	NMOD
5	changes	change	NNS	_	4	PMOD
6	in	in	IN	_	5	NMOD
7	the	the	DT	_	10	NMOD
8	extracellular	extracellular	JJ	_	10	NMOD
9	ionic	ionic	JJ	_	10	NMOD
10	strength	strength	NN	_	6	PMOD
11	is	be	VBZ	_	0	ROOT
12	a	a	DT	_	14	NMOD
13	convenient	convenient	JJ	_	14	NMOD
14	assay	assay	NN	_	11	PRD
15	for	for	IN	_	14	NMOD
16	analysis	analysis	NN	_	15	PMOD
17	of	of	IN	_	16	NMOD
18	the	the	DT	_	22	NMOD
19	red	red	JJ	_	21	NMOD
20	blood	blood	NN	_	21	NMOD
21	cell	cell	NN	_	22	NMOD
22	integrity	integrity	NN	_	17	PMOD
23	.	.	.	_	11	P

1	It	it	PRP	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	measured	measure	VBN	_	2	VC
4	as	as	IN	_	3	ADV
5	a	a	DT	_	8	NMOD
6	sodium	sodium	NN	_	7	NMOD
7	chloride	chloride	NN	_	8	NMOD
8	concentration	concentration	NN	_	4	PMOD
9	in	in	IN	_	13	ADV
10	which	which	WDT	_	9	PMOD
11	cellular	cellular	JJ	_	12	NMOD
12	lysis	lysis	NN	_	13	SBJ
13	starts	start	VBZ	_	8	NMOD
14	(	(	-LRB-	_	16	P
15	minimal	minimal	JJ	_	16	NMOD
16	resistance	resistance	NN	_	8	PRN
17	)	)	-RRB-	_	16	P
18	up	up	IN	_	8	NMOD
19	to	to	IN	_	18	PMOD
20	a	a	DT	_	22	NMOD
21	complete	complete	JJ	_	22	NMOD
22	lysis	lysis	NN	_	19	PMOD
23	(	(	-LRB-	_	25	P
24	maximal	maximal	JJ	_	25	NMOD
25	resistance	resistance	NN	_	22	PRN
26	)	)	-RRB-	_	25	P
27	of	of	IN	_	22	NMOD
28	a	a	DT	_	31	NMOD
29	red	red	JJ	_	31	NMOD
30	blood	blood	NN	_	31	NMOD
31	cell	cell	NN	_	27	PMOD
32	.	.	.	_	2	P

1	The	the	DT	_	3	NMOD
2	osmotic	osmotic	JJ	_	3	NMOD
3	resistance	resistance	NN	_	11	SBJ
4	of	of	IN	_	3	NMOD
5	annexin	annexin	NN	_	6	NMOD
6	A7	a0	NN	_	7	AMOD
7	deficient	deficient	JJ	_	10	NMOD
8	red	red	JJ	_	10	NMOD
9	blood	blood	NN	_	10	NMOD
10	cells	cell	NNS	_	4	PMOD
11	is	be	VBZ	_	0	ROOT
12	significantly	significantly	RB	_	13	AMOD
13	increased	increased	JJ	_	11	PRD
14	compared	compare	VBN	_	11	ADV
15	to	to	IN	_	14	PMOD
16	the	the	DT	_	17	NMOD
17	one	one	CD	_	15	PMOD
18	of	of	IN	_	17	NMOD
19	wild	wild	JJ	_	20	NMOD
20	type	type	NN	_	18	PMOD
21	(	(	-LRB-	_	28	P
22	p	p	NN	_	24	SBJ
23	=	=	SYM	_	24	P
24	0.00066	0	CD	_	28	DEP
25	;	;	:	_	28	P
26	n	n	NN	_	28	SBJ
27	=	=	SYM	_	28	P
28	8	0	CD	_	11	PRN
29	)	)	-RRB-	_	28	P
30	.	.	.	_	11	P

1	These	these	DT	_	2	NMOD
2	data	datum	NNS	_	3	SBJ
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	annexin	annexin	NN	_	6	NMOD
6	A7	a0	NN	_	7	SBJ
7	contributes	contribute	VBZ	_	4	SUB
8	to	to	IN	_	7	ADV
9	the	the	DT	_	10	NMOD
10	shape	shape	NN	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	red	red	JJ	_	14	NMOD
13	blood	blood	NN	_	14	NMOD
14	cells	cell	NNS	_	11	PMOD
15	and	and	CC	_	10	COORD
16	the	the	DT	_	18	NMOD
17	osmotic	osmotic	JJ	_	18	NMOD
18	resistance	resistance	NN	_	15	CONJ
19	.	.	.	_	3	P

1	As	as	IN	_	21	ADV
2	we	we	PRP	_	3	SBJ
3	have	have	VBP	_	1	SUB
4	not	not	RB	_	3	ADV
5	observed	observe	VBN	_	3	VC
6	a	a	DT	_	7	NMOD
7	binding	binding	NN	_	5	OBJ
8	of	of	IN	_	7	NMOD
9	annexin	annexin	NN	_	10	NMOD
10	A7	a0	NN	_	8	PMOD
11	to	to	IN	_	7	NMOD
12	F	f	NN	_	14	NMOD
13	-	-	HYPH	_	12	P
14	actin	actin	NN	_	11	PMOD
15	(	(	-LRB-	_	18	P
16	data	datum	NNS	_	18	SBJ
17	not	not	RB	_	18	ADV
18	shown	show	VBN	_	5	PRN
19	)	)	-RRB-	_	18	P
20	it	it	PRP	_	21	SBJ
21	could	could	MD	_	0	ROOT
22	do	do	VB	_	21	VC
23	so	so	RB	_	22	PRD
24	either	either	CC	_	25	COORD
25	by	by	IN	_	22	MNR
26	alteration	alteration	NN	_	25	PMOD
27	of	of	IN	_	26	NMOD
28	the	the	DT	_	30	NMOD
29	membrane	membrane	NN	_	30	NMOD
30	rigidity	rigidity	NN	_	27	PMOD
31	and	and	CC	_	25	COORD
32	/	/	HYPH	_	31	P
33	or	or	CC	_	31	COORD
34	by	by	IN	_	31	CONJ
35	affecting	affect	VBG	_	34	PMOD
36	the	the	DT	_	38	NMOD
37	ion	ion	NN	_	38	NMOD
38	homeostasis	homeostasis	NN	_	35	OBJ
39	.	.	.	_	21	P

1	The	the	DT	_	2	NMOD
2	lack	lack	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	annexin	annexin	NN	_	5	NMOD
5	A7	a0	NN	_	3	PMOD
6	affects	affect	VBZ	_	0	ROOT
7	primary	primary	JJ	_	8	NMOD
8	haemostasis	haemostasis	NN	_	6	OBJ
9	ex	ex	FW	_	10	AMOD
10	vivo	vivo	FW	_	6	LOC

1	The	the	DT	_	2	NMOD
2	use	use	NN	_	16	SBJ
3	of	of	IN	_	2	NMOD
4	an	an	DT	_	11	NMOD
5	advanced	advanced	JJ	_	11	NMOD
6	electronic	electronic	JJ	_	11	NMOD
7	cell	cell	NN	_	8	NMOD
8	counter	counter	NN	_	11	NMOD
9	/	/	HYPH	_	8	P
10	flow	flow	NN	_	11	NMOD
11	cytometer	cytometer	NN	_	13	NMOD
12	(	(	-LRB-	_	13	P
13	ADVIA	advia	NN	_	3	PMOD
14	120	0	CD	_	13	NMOD
15	)	)	-RRB-	_	16	P
16	allowed	allow	VBD	_	0	ROOT
17	us	us	PRP	_	18	SBJ
18	to	to	TO	_	16	OPRD
19	screen	screen	VB	_	18	IM
20	other	other	JJ	_	21	NMOD
21	parameters	parameter	NNS	_	19	OBJ
22	as	as	RB	_	23	AMOD
23	well	well	RB	_	19	ADV
24	despite	despite	IN	_	19	ADV
25	of	of	IN	_	24	PMOD
26	the	the	DT	_	30	NMOD
27	limited	limited	JJ	_	30	NMOD
28	murine	murine	JJ	_	30	NMOD
29	blood	blood	NN	_	30	NMOD
30	volume	volume	NN	_	24	PMOD
31	.	.	.	_	16	P

1	We	we	PRP	_	2	SBJ
2	analysed	analyse	VBD	_	0	ROOT
3	leukocytes	leukocyte	NNS	_	2	OBJ
4	,	,	,	_	3	P
5	red	red	JJ	_	7	NMOD
6	blood	blood	NN	_	7	NMOD
7	cells	cell	NNS	_	3	CONJ
8	,	,	,	_	7	P
9	haemoglobin	haemoglobin	NN	_	10	NMOD
10	content	content	NN	_	7	CONJ
11	,	,	,	_	10	P
12	haematocrit	haematocrit	NN	_	10	CONJ
13	,	,	,	_	12	P
14	mean	mean	JJ	_	16	NMOD
15	cellular	cellular	JJ	_	16	NMOD
16	volume	volume	NN	_	12	CONJ
17	,	,	,	_	16	P
18	mean	mean	JJ	_	20	NMOD
19	cellular	cellular	JJ	_	20	NMOD
20	haemoglobin	haemoglobin	NN	_	16	CONJ
21	,	,	,	_	20	P
22	mean	mean	JJ	_	24	NMOD
23	cellular	cellular	JJ	_	24	NMOD
24	haemoglobin	haemoglobin	NN	_	25	NMOD
25	concentration	concentration	NN	_	20	CONJ
26	,	,	,	_	25	P
27	platelets	platelet	NNS	_	25	CONJ
28	,	,	,	_	27	P
29	neutrophiles	neutrophile	NNS	_	27	CONJ
30	,	,	,	_	29	P
31	lymphocytes	lymphocyte	NNS	_	29	CONJ
32	,	,	,	_	31	P
33	monocytes	monocyte	NNS	_	31	CONJ
34	,	,	,	_	33	P
35	eosinophiles	eosinophile	NNS	_	33	CONJ
36	and	and	CC	_	35	COORD
37	basophiles	basophile	NNS	_	36	CONJ
38	.	.	.	_	2	P

1	In	in	IN	_	8	ADV
2	these	these	DT	_	3	NMOD
3	tests	test	NNS	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	whole	whole	JJ	_	6	NMOD
6	blood	blood	NN	_	4	PMOD
7	we	we	PRP	_	8	SBJ
8	found	find	VBD	_	0	ROOT
9	only	only	RB	_	8	ADV
10	a	a	DT	_	11	NMOD
11	change	change	NN	_	8	OBJ
12	in	in	IN	_	11	NMOD
13	the	the	DT	_	15	NMOD
14	platelet	platelet	NN	_	15	NMOD
15	numbers	number	NNS	_	12	PMOD
16	,	,	,	_	8	P
17	whereas	whereas	IN	_	8	ADV
18	all	all	DT	_	21	NMOD
19	other	other	JJ	_	21	NMOD
20	haematological	haematological	JJ	_	21	NMOD
21	parameters	parameter	NNS	_	22	SBJ
22	were	be	VBD	_	17	SUB
23	not	not	RB	_	22	ADV
24	affected	affect	VBN	_	22	VC
25	.	.	.	_	8	P

1	The	the	DT	_	4	NMOD
2	mean	mean	JJ	_	4	NMOD
3	platelet	platelet	NN	_	4	NMOD
4	counts	count	NNS	_	15	SBJ
5	from	from	IN	_	4	NMOD
6	wild	wild	JJ	_	7	NMOD
7	type	type	NN	_	14	NMOD
8	and	and	CC	_	7	COORD
9	anxA7	anxa0	NN	_	8	CONJ
10	-	-	SYM	_	9	P
11	/	/	HYPH	_	9	P
12	-	-	SYM	_	9	P
13	mutant	mutant	JJ	_	14	NMOD
14	mice	mouse	NNS	_	5	PMOD
15	are	be	VBP	_	0	ROOT
16	determined	determine	VBN	_	15	VC
17	as	as	IN	_	16	ADV
18	674	0	CD	_	17	PMOD
19	×	×	SYM	_	18	P
20	103	0	CD	_	18	QMOD
21	/	/	SYM	_	22	P
22	μl	μl	NNS	_	18	NMOD
23	and	and	CC	_	18	COORD
24	774	0	CD	_	23	CONJ
25	×	×	SYM	_	24	P
26	103	0	CD	_	24	QMOD
27	/	/	SYM	_	28	P
28	μl	μl	NNS	_	24	NMOD
29	,	,	,	_	16	P
30	respectively	respectively	RB	_	16	ADV
31	.	.	.	_	15	P

1	The	the	DT	_	3	NMOD
2	platelet	platelet	NN	_	3	NMOD
3	counts	count	NNS	_	8	SBJ
4	in	in	IN	_	3	LOC
5	knock	knock	NN	_	6	NMOD
6	out	out	NN	_	7	NMOD
7	mice	mouse	NNS	_	4	PMOD
8	are	be	VBP	_	0	ROOT
9	significantly	significantly	RB	_	10	AMOD
10	higher	high	JJR	_	8	PRD
11	(	(	-LRB-	_	26	P
12	p	p	NN	_	14	SBJ
13	=	=	SYM	_	14	P
14	0.0275	0	CD	_	26	DEP
15	;	;	:	_	26	P
16	n	n	NN	_	18	NMOD
17	knock	knock	NN	_	18	NMOD
18	out	out	NN	_	20	SBJ
19	=	=	SYM	_	20	P
20	11	0	CD	_	26	DEP
21	,	,	,	_	26	P
22	n	n	NN	_	24	NMOD
23	wild	wild	JJ	_	24	NMOD
24	type	type	NN	_	26	SBJ
25	=	=	SYM	_	26	P
26	14	0	CD	_	10	PRN
27	)	)	-RRB-	_	26	P
28	.	.	.	_	8	P

1	An	an	DT	_	2	NMOD
2	increase	increase	NN	_	6	SBJ
3	in	in	IN	_	2	NMOD
4	platelet	platelet	NN	_	5	NMOD
5	counts	count	NNS	_	3	PMOD
6	is	be	VBZ	_	0	ROOT
7	a	a	DT	_	10	NMOD
8	rather	rather	RB	_	9	AMOD
9	uncommon	uncommon	JJ	_	10	NMOD
10	disorder	disorder	NN	_	6	PRD
11	.	.	.	_	6	P

1	In	in	IN	_	7	LOC
2	humans	human	NNS	_	1	PMOD
3	,	,	,	_	7	P
4	platelet	platelet	NN	_	5	NMOD
5	counts	count	NNS	_	7	SBJ
6	normally	normally	RB	_	7	ADV
7	increase	increase	VBP	_	0	ROOT
8	only	only	RB	_	9	AMOD
9	transiently	transiently	RB	_	7	ADV
10	as	as	IN	_	7	ADV
11	in	in	IN	_	10	PMOD
12	reactive	reactive	JJ	_	13	NMOD
13	thrombocytosis	thrombocytosis	NN	_	11	PMOD
14	and	and	CC	_	11	COORD
15	under	under	IN	_	14	CONJ
16	postoperative	postoperative	JJ	_	17	NMOD
17	conditions	condition	NNS	_	15	PMOD
18	or	or	CC	_	7	COORD
19	are	be	VBP	_	18	CONJ
20	largely	largely	RB	_	19	ADV
21	increased	increase	VBN	_	19	VC
22	in	in	IN	_	21	ADV
23	neoplastic	neoplastic	JJ	_	24	NMOD
24	diseases	disease	NNS	_	22	PMOD
25	.	.	.	_	7	P

1	By	by	IN	_	10	ADV
2	contrast	contrast	NN	_	1	PMOD
3	,	,	,	_	10	P
4	the	the	DT	_	9	NMOD
5	anxA7	anxa0	NN	_	9	NMOD
6	-	-	SYM	_	5	P
7	/	/	HYPH	_	5	P
8	-	-	SYM	_	5	P
9	mice	mouse	NNS	_	10	SBJ
10	are	be	VBP	_	0	ROOT
11	healthy	healthy	JJ	_	10	PRD
12	and	and	CC	_	11	COORD
13	viable	viable	JJ	_	12	CONJ
14	.	.	.	_	10	P

1	Therefore	therefore	RB	_	3	ADV
2	we	we	PRP	_	3	SBJ
3	tested	test	VBD	_	0	ROOT
4	the	the	DT	_	6	NMOD
5	platelet	platelet	NN	_	6	NMOD
6	function	function	NN	_	3	OBJ
7	and	and	CC	_	3	COORD
8	performed	perform	VBD	_	7	CONJ
9	aggregometry	aggregometry	NN	_	10	NMOD
10	measurements	measurement	NNS	_	8	OBJ
11	with	with	IN	_	8	MNR
12	platelet	platelet	NN	_	13	AMOD
13	rich	rich	JJ	_	14	NMOD
14	plasma	plasma	NN	_	11	PMOD
15	.	.	.	_	3	P

1	Platelet	platelet	NN	_	2	NMOD
2	activation	activation	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	observed	observe	VBN	_	3	VC
5	as	as	IN	_	4	ADV
6	a	a	DT	_	8	NMOD
7	morphological	morphological	JJ	_	8	NMOD
8	change	change	NN	_	5	PMOD
9	from	from	IN	_	8	NMOD
10	the	the	DT	_	13	NMOD
11	resting	rest	VBG	_	13	NMOD
12	discoid	discoid	JJ	_	13	NMOD
13	state	state	NN	_	9	PMOD
14	to	to	IN	_	8	NMOD
15	activated	activate	VBN	_	17	NMOD
16	spherical	spherical	JJ	_	17	NMOD
17	cells	cell	NNS	_	14	PMOD
18	with	with	IN	_	17	NMOD
19	pseudopods	pseudopod	NNS	_	18	PMOD
20	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	morphological	morphological	JJ	_	3	NMOD
3	changes	change	NNS	_	4	SBJ
4	are	be	VBP	_	0	ROOT
5	due	due	IN	_	4	PRD
6	to	to	IN	_	5	PMOD
7	cytoskeletal	cytoskeletal	JJ	_	8	NMOD
8	rearrangements	rearrangement	NNS	_	5	PMOD
9	.	.	.	_	4	P

1	In	in	FW	_	2	AMOD
2	vitro	vitro	FW	_	6	LOC
3	the	the	DT	_	5	NMOD
4	activated	activate	VBN	_	5	NMOD
5	cells	cell	NNS	_	6	SBJ
6	form	form	VBP	_	0	ROOT
7	aggregates	aggregate	NNS	_	6	OBJ
8	recruiting	recruit	VBG	_	6	ADV
9	additional	additional	JJ	_	10	NMOD
10	cells	cell	NNS	_	8	OBJ
11	in	in	IN	_	8	ADV
12	the	the	DT	_	13	NMOD
13	solution	solution	NN	_	11	PMOD
14	thereby	thereby	RB	_	15	ADV
15	reducing	reduce	VBG	_	8	VC
16	its	its	PRP$	_	17	NMOD
17	cloudiness	cloudiness	NN	_	15	OBJ
18	.	.	.	_	6	P

1	Analysis	analysis	NN	_	20	SBJ
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	5	NMOD
4	transmission	transmission	NN	_	5	NMOD
5	values	value	NNS	_	2	PMOD
6	of	of	IN	_	5	NMOD
7	aggregation	aggregation	NN	_	8	NMOD
8	curves	curve	NNS	_	6	PMOD
9	after	after	IN	_	1	TMP
10	platelet	platelet	NN	_	11	NMOD
11	activation	activation	NN	_	9	PMOD
12	by	by	IN	_	11	NMOD
13	ristocetin	ristocetin	NN	_	14	NMOD
14	addition	addition	NN	_	12	PMOD
15	(	(	-LRB-	_	18	P
16	von	von	NN	_	17	NMOD
17	Willebrand	willebrand	NN	_	18	NMOD
18	cofactor	cofactor	NN	_	14	PRN
19	)	)	-RRB-	_	18	P
20	showed	show	VBD	_	0	ROOT
21	that	that	IN	_	20	OBJ
22	both	both	DT	_	23	NMOD
23	curves	curve	NNS	_	24	SBJ
24	differed	differ	VBD	_	21	SUB
25	significantly	significantly	RB	_	24	ADV
26	at	at	IN	_	24	TMP
27	the	the	DT	_	29	NMOD
28	time	time	NN	_	29	NMOD
29	point	point	NN	_	26	PMOD
30	of	of	IN	_	29	NMOD
31	seven	seven	CD	_	32	NMOD
32	seconds	second	NNS	_	30	PMOD
33	after	after	IN	_	32	NMOD
34	platelet	platelet	NN	_	35	NMOD
35	initiation	initiation	NN	_	33	PMOD
36	(	(	-LRB-	_	53	P
37	p	p	NN	_	39	SBJ
38	=	=	SYM	_	39	P
39	0.0287	0	CD	_	53	DEP
40	,	,	,	_	53	P
41	n	n	NN	_	43	NMOD
42	knock	knock	NN	_	43	NMOD
43	out	out	NN	_	45	SBJ
44	=	=	SYM	_	45	P
45	16	0	CD	_	53	DEP
46	,	,	,	_	53	P
47	n	n	NN	_	49	NMOD
48	wild	wild	JJ	_	49	NMOD
49	type	type	NN	_	51	SBJ
50	=	=	SYM	_	51	P
51	15	0	CD	_	53	DEP
52	;	;	:	_	53	P
53	Fig.	fig.	NN	_	24	PRN
54	6	0	CD	_	53	NMOD
55	)	)	-RRB-	_	53	P
56	.	.	.	_	20	P

1	Annexin	annexin	NN	_	2	NMOD
2	A7	a0	NN	_	3	AMOD
3	deficient	deficient	JJ	_	4	NMOD
4	platelets	platelet	NNS	_	5	SBJ
5	showed	show	VBD	_	0	ROOT
6	a	a	DT	_	10	NMOD
7	slightly	slightly	RB	_	8	AMOD
8	lowered	lower	VBN	_	10	NMOD
9	aggregation	aggregation	NN	_	10	NMOD
10	velocity	velocity	NN	_	5	OBJ
11	.	.	.	_	5	P

1	When	when	WRB	_	3	TMP
2	we	we	PRP	_	3	SBJ
3	compared	compare	VBD	_	31	TMP
4	the	the	DT	_	6	NMOD
5	aggregation	aggregation	NN	_	6	NMOD
6	curves	curve	NNS	_	3	OBJ
7	of	of	IN	_	6	NMOD
8	human	human	JJ	_	9	NMOD
9	platelets	platelet	NNS	_	7	PMOD
10	from	from	IN	_	9	NMOD
11	a	a	DT	_	13	NMOD
12	healthy	healthy	JJ	_	13	NMOD
13	donor	donor	NN	_	10	PMOD
14	with	with	IN	_	3	ADV
15	the	the	DT	_	16	NMOD
16	ones	one	NNS	_	14	PMOD
17	obtained	obtain	VBN	_	16	NMOD
18	from	from	IN	_	17	ADV
19	an	an	DT	_	20	NMOD
20	individual	individual	NN	_	18	PMOD
21	with	with	IN	_	20	NMOD
22	a	a	DT	_	28	NMOD
23	von	von	NN	_	24	NMOD
24	Willebrand	willebrand	NN	_	25	NMOD
25	factor	factor	NN	_	28	NMOD
26	type	type	NN	_	28	NMOD
27	1	0	CD	_	26	NMOD
28	defect	defect	NN	_	21	PMOD
29	,	,	,	_	31	P
30	we	we	PRP	_	31	SBJ
31	found	find	VBD	_	0	ROOT
32	that	that	IN	_	31	OBJ
33	the	the	DT	_	34	NMOD
34	difference	difference	NN	_	38	SBJ
35	in	in	IN	_	34	NMOD
36	the	the	DT	_	37	NMOD
37	curves	curve	NNS	_	35	PMOD
38	was	be	VBD	_	32	SUB
39	much	much	RB	_	41	AMOD
40	more	more	RBR	_	39	AMOD
41	pronounced	pronounced	JJ	_	38	PRD
42	as	as	IN	_	38	ADV
43	observed	observe	VBN	_	42	SUB
44	in	in	IN	_	43	ADV
45	our	our	PRP$	_	46	NMOD
46	studies	study	NNS	_	44	PMOD
47	of	of	IN	_	46	NMOD
48	healthy	healthy	JJ	_	50	NMOD
49	mouse	mouse	NN	_	50	NMOD
50	platelets	platelet	NNS	_	47	PMOD
51	and	and	CC	_	50	COORD
52	anxA7	anxa0	NN	_	56	NMOD
53	-	-	SYM	_	52	P
54	/	/	HYPH	_	52	P
55	-	-	SYM	_	52	P
56	platelets	platelet	NNS	_	51	CONJ
57	.	.	.	_	31	P

1	Furthermore	furthermore	RB	_	3	ADV
2	we	we	PRP	_	3	SBJ
3	found	find	VBD	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	murine	murine	JJ	_	6	NMOD
6	platelets	platelet	NNS	_	7	SBJ
7	responded	respond	VBD	_	4	SUB
8	immediately	immediately	RB	_	7	TMP
9	to	to	IN	_	7	ADV
10	the	the	DT	_	12	NMOD
11	initiating	initiate	VBG	_	12	NMOD
12	chemical	chemical	NN	_	9	PMOD
13	whereas	whereas	IN	_	7	ADV
14	human	human	JJ	_	15	NMOD
15	platelets	platelet	NNS	_	16	SBJ
16	have	have	VBP	_	13	SUB
17	a	a	DT	_	19	NMOD
18	lag	lag	NN	_	19	NMOD
19	phase	phase	NN	_	16	OBJ
20	[	[	-LRB-	_	21	P
21	23	0	CD	_	3	PRN
22	]	]	-RRB-	_	21	P
23	.	.	.	_	3	P

1	Figure	figure	NN	_	0	ROOT
2	6	0	CD	_	1	NMOD

1	Platelet	platelet	NN	_	2	NMOD
2	aggregation	aggregation	NN	_	3	NMOD
3	curves	curve	NNS	_	0	ROOT
4	from	from	IN	_	3	NMOD
5	platelet	platelet	NN	_	6	AMOD
6	rich	rich	JJ	_	7	NMOD
7	plasma	plasma	NN	_	4	PMOD
8	of	of	IN	_	7	NMOD
9	annexin	annexin	NN	_	10	NMOD
10	A7	a0	NN	_	12	NMOD
11	knock	knock	NN	_	12	NMOD
12	out	out	NN	_	16	NMOD
13	and	and	CC	_	12	COORD
14	wild	wild	JJ	_	15	NMOD
15	type	type	NN	_	13	CONJ
16	mice	mouse	NNS	_	8	PMOD
17	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	transmission	transmission	NN	_	3	NMOD
3	values	value	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	measured	measure	VBN	_	4	VC
6	with	with	IN	_	5	MNR
7	an	an	DT	_	9	NMOD
8	APACT	apact	NN	_	9	NMOD
9	photometer	photometer	NN	_	6	PMOD
10	and	and	CC	_	4	COORD
11	aggregation	aggregation	NN	_	12	SBJ
12	was	be	VBD	_	10	CONJ
13	initiated	initiate	VBN	_	12	VC
14	by	by	IN	_	13	MNR
15	adding	add	VBG	_	14	PMOD
16	ristocetin	ristocetin	NN	_	15	OBJ
17	.	.	.	_	4	P

1	The	the	DT	_	4	NMOD
2	first	$#ORD#$	JJ	_	4	NMOD
3	thirty	thirty	CD	_	4	NMOD
4	seconds	second	NNS	_	5	SBJ
5	are	be	VBP	_	0	ROOT
6	given	give	VBN	_	5	VC
7	.	.	.	_	5	P

1	Constant	constant	JJ	_	3	NMOD
2	platelet	platelet	NN	_	3	NMOD
3	counts	count	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	used	use	VBN	_	4	VC
6	throughout	throughout	IN	_	5	ADV
7	all	all	DT	_	8	NMOD
8	experiments	experiment	NNS	_	6	PMOD
9	.	.	.	_	4	P

1	The	the	DT	_	4	NMOD
2	aggregation	aggregation	NN	_	3	NMOD
3	curve	curve	NN	_	4	NMOD
4	data	datum	NNS	_	5	SBJ
5	were	be	VBD	_	19	DEP
6	analysed	analyse	VBN	_	5	VC
7	for	for	IN	_	6	PRP
8	slope	slope	NN	_	9	NMOD
9	values	value	NNS	_	7	PMOD
10	,	,	,	_	19	P
11	the	the	DT	_	14	NMOD
12	maximal	maximal	JJ	_	14	NMOD
13	aggregation	aggregation	NN	_	14	NMOD
14	amplitude	amplitude	NN	_	19	SBJ
15	of	of	IN	_	14	NMOD
16	every	every	DT	_	18	NMOD
17	single	single	JJ	_	18	NMOD
18	curve	curve	NN	_	15	PMOD
19	was	be	VBD	_	0	ROOT
20	set	set	VBN	_	19	VC
21	to	to	IN	_	20	ADV
22	100	0	CD	_	23	NMOD
23	%	%	NN	_	21	PMOD
24	.	.	.	_	19	P

1	Both	both	DT	_	3	NMOD
2	murine	murine	JJ	_	3	NMOD
3	curves	curve	NNS	_	4	SBJ
4	differ	differ	VBP	_	19	DEP
5	significantly	significantly	RB	_	4	ADV
6	at	at	IN	_	4	TMP
7	a	a	DT	_	9	NMOD
8	time	time	NN	_	9	NMOD
9	point	point	NN	_	6	PMOD
10	of	of	IN	_	9	NMOD
11	seven	seven	CD	_	12	NMOD
12	seconds	second	NNS	_	10	PMOD
13	after	after	IN	_	12	TMP
14	platelet	platelet	NN	_	15	NMOD
15	initiation	initiation	NN	_	13	PMOD
16	,	,	,	_	19	P
17	the	the	DT	_	18	NMOD
18	mutant	mutant	NN	_	19	SBJ
19	shows	show	VBZ	_	0	ROOT
20	a	a	DT	_	24	NMOD
21	slightly	slightly	RB	_	22	AMOD
22	lower	low	JJR	_	24	NMOD
23	aggregation	aggregation	NN	_	24	NMOD
24	velocity	velocity	NN	_	19	OBJ
25	(	(	-LRB-	_	74	P
26	p	p	NN	_	28	SBJ
27	=	=	SYM	_	28	P
28	0.0287	0	CD	_	74	DEP
29	,	,	,	_	74	P
30	n	n	NN	_	32	NMOD
31	knock	knock	NN	_	32	NMOD
32	out	out	NN	_	34	SBJ
33	=	=	SYM	_	34	P
34	16	0	CD	_	74	DEP
35	,	,	,	_	74	P
36	n	n	NN	_	38	NMOD
37	wild	wild	JJ	_	38	NMOD
38	type	type	NN	_	40	SBJ
39	=	=	SYM	_	40	P
40	15	0	CD	_	74	DEP
41	,	,	,	_	74	P
42	mean	mean	JJ	_	44	NMOD
43	knock	knock	NN	_	44	NMOD
44	out	out	NN	_	48	SBJ
45	=	=	SYM	_	48	P
46	67.7	0	CD	_	47	NMOD
47	%	%	NN	_	48	NMOD
48	transmission	transmission	NN	_	74	DEP
49	,	,	,	_	74	P
50	mean	mean	JJ	_	52	NMOD
51	wild	wild	JJ	_	52	NMOD
52	type	type	NN	_	56	SBJ
53	=	=	SYM	_	56	P
54	77.1	0	CD	_	55	NMOD
55	%	%	NN	_	56	NMOD
56	transmission	transmission	NN	_	74	DEP
57	,	,	,	_	74	P
58	standard	standard	JJ	_	59	NMOD
59	error	error	NN	_	61	NMOD
60	knock	knock	NN	_	61	NMOD
61	out	out	NN	_	65	SBJ
62	=	=	SYM	_	65	P
63	8.3	0	CD	_	64	NMOD
64	%	%	NN	_	65	NMOD
65	transmission	transmission	NN	_	74	DEP
66	,	,	,	_	74	P
67	standard	standard	JJ	_	68	NMOD
68	error	error	NN	_	70	NMOD
69	wild	wild	JJ	_	70	NMOD
70	type	type	NN	_	74	SBJ
71	=	=	SYM	_	74	P
72	13.8	0	CD	_	73	NMOD
73	%	%	NN	_	74	NMOD
74	transmission	transmission	NN	_	24	PRN
75	)	)	-RRB-	_	74	P
76	.	.	.	_	19	P

1	Murine	murine	JJ	_	2	NMOD
2	platelets	platelet	NNS	_	3	SBJ
3	react	react	VBP	_	0	ROOT
4	immediately	immediately	RB	_	3	TMP
5	to	to	IN	_	3	ADV
6	the	the	DT	_	8	NMOD
7	initiating	initiate	VBG	_	8	NMOD
8	chemical	chemical	NN	_	5	PMOD
9	and	and	CC	_	3	COORD
10	show	show	VBP	_	9	CONJ
11	no	no	DT	_	13	NMOD
12	lag	lag	NN	_	13	NMOD
13	phase	phase	NN	_	10	OBJ
14	like	like	IN	_	10	ADV
15	the	the	DT	_	18	NMOD
16	normal	normal	JJ	_	18	NMOD
17	human	human	JJ	_	18	NMOD
18	platelets	platelet	NNS	_	14	PMOD
19	.	.	.	_	3	P

1	For	for	IN	_	14	PRP
2	comparison	comparison	NN	_	1	PMOD
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	range	range	NN	_	3	PMOD
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	9	NMOD
8	platelet	platelet	NN	_	9	NMOD
9	impairment	impairment	NN	_	6	PMOD
10	slightly	slightly	RB	_	11	AMOD
11	affected	affect	VBN	_	13	NMOD
12	human	human	JJ	_	13	NMOD
13	platelets	platelet	NNS	_	14	SBJ
14	are	be	VBP	_	0	ROOT
15	shown	show	VBN	_	14	VC
16	as	as	RB	_	17	AMOD
17	well	well	RB	_	15	ADV
18	(	(	-LRB-	_	21	P
19	von	von	NNP	_	20	NMOD
20	Willebrand	willebrand	NNP	_	21	NMOD
21	syndrome	syndrome	NN	_	15	PRN
22	)	)	-RRB-	_	21	P
23	.	.	.	_	14	P

1	Discussion	discussion	NN	_	0	ROOT

1	Annexin	annexin	NN	_	2	NMOD
2	A7	a0	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	thought	think	VBN	_	3	VC
5	to	to	TO	_	4	OPRD
6	have	have	VB	_	5	IM
7	a	a	DT	_	8	NMOD
8	role	role	NN	_	6	OBJ
9	in	in	IN	_	6	ADV
10	vesicle	vesicle	NN	_	11	NMOD
11	fusion	fusion	NN	_	9	PMOD
12	and	and	CC	_	9	COORD
13	in	in	IN	_	12	CONJ
14	regulating	regulate	VBG	_	13	PMOD
15	and	and	CC	_	14	COORD
16	stabilizing	stabilize	VBG	_	15	CONJ
17	membrane	membrane	NN	_	18	NMOD
18	domains	domain	NNS	_	14	OBJ
19	[	[	-LRB-	_	20	P
20	1	0	CD	_	4	PRN
21	]	]	-RRB-	_	20	P
22	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	protein	protein	NN	_	3	SBJ
3	has	have	VBZ	_	16	DEP
4	been	be	VBN	_	3	VC
5	localized	localize	VBN	_	4	VC
6	to	to	IN	_	5	ADV
7	the	the	DT	_	9	NMOD
8	plasma	plasma	NN	_	9	NMOD
9	membrane	membrane	NN	_	6	PMOD
10	including	include	VBG	_	9	NMOD
11	raft	raft	NN	_	12	NMOD
12	subdomains	subdomains	NNS	_	10	PMOD
13	,	,	,	_	16	P
14	furthermore	furthermore	RB	_	16	ADV
15	it	it	PRP	_	16	SBJ
16	is	be	VBZ	_	0	ROOT
17	present	present	JJ	_	16	PRD
18	in	in	IN	_	16	LOC
19	the	the	DT	_	20	NMOD
20	cytosol	cytosol	NN	_	18	PMOD
21	where	where	WRB	_	24	LOC
22	it	it	PRP	_	23	SBJ
23	is	be	VBZ	_	20	NMOD
24	found	find	VBN	_	23	VC
25	on	on	IN	_	24	LOC
26	subcellular	subcellular	JJ	_	30	NMOD
27	vesicle	vesicle	NN	_	29	AMOD
28	-	-	HYPH	_	27	P
29	like	like	JJ	_	30	NMOD
30	structures	structure	NNS	_	25	PMOD
31	.	.	.	_	16	P

1	This	this	DT	_	2	NMOD
2	distribution	distribution	NN	_	3	SBJ
3	appears	appear	VBZ	_	0	ROOT
4	to	to	TO	_	3	OPRD
5	be	be	VB	_	4	IM
6	independent	independent	JJ	_	5	PRD
7	of	of	IN	_	6	AMOD
8	the	the	DT	_	12	NMOD
9	tissue	tissue	NN	_	12	NMOD
10	or	or	CC	_	9	COORD
11	cell	cell	NN	_	10	CONJ
12	type	type	NN	_	7	PMOD
13	analysed	analyse	VBN	_	12	NMOD
14	.	.	.	_	3	P

1	In	in	IN	_	10	LOC
2	specialized	specialize	VBN	_	6	NMOD
3	or	or	CC	_	2	COORD
4	terminally	terminally	RB	_	5	AMOD
5	differentiated	differentiate	VBN	_	3	CONJ
6	cells	cell	NNS	_	1	PMOD
7	,	,	,	_	10	P
8	expression	expression	NN	_	9	NMOD
9	levels	level	NNS	_	10	SBJ
10	increase	increase	VBP	_	0	ROOT
11	and	and	CC	_	10	COORD
12	frequently	frequently	RB	_	19	TMP
13	the	the	DT	_	14	NMOD
14	larger	large	JJR	_	19	SBJ
15	of	of	IN	_	14	NMOD
16	the	the	DT	_	18	NMOD
17	two	two	CD	_	18	NMOD
18	isoforms	isoforms	NNS	_	15	PMOD
19	is	be	VBZ	_	11	CONJ
20	being	be	VBG	_	19	VC
21	expressed	express	VBN	_	20	VC
22	[	[	-LRB-	_	27	P
23	6	0	CD	_	27	NMOD
24	,	,	,	_	27	P
25	34	0	CD	_	27	NMOD
26	,	,	,	_	27	P
27	35	0	CD	_	10	PRN
28	]	]	-RRB-	_	27	P
29	.	.	.	_	10	P

1	Red	red	JJ	_	3	NMOD
2	blood	blood	NN	_	3	NMOD
3	cells	cell	NNS	_	15	SBJ
4	,	,	,	_	3	P
5	which	which	WDT	_	6	SBJ
6	were	be	VBD	_	3	NMOD
7	thought	think	VBN	_	6	VC
8	to	to	TO	_	7	OPRD
9	be	be	VB	_	8	IM
10	devoid	devoid	JJ	_	9	PRD
11	of	of	IN	_	10	AMOD
12	annexin	annexin	NN	_	13	NMOD
13	A7	a0	NN	_	11	PMOD
14	,	,	,	_	15	P
15	were	be	VBD	_	0	ROOT
16	recently	recently	RB	_	15	TMP
17	shown	show	VBN	_	15	VC
18	to	to	TO	_	17	OPRD
19	harbor	harbor	VB	_	18	IM
20	the	the	DT	_	23	NMOD
21	47	0	CD	_	22	NMOD
22	kDa	kda	NN	_	23	NMOD
23	isoform	isoform	NN	_	19	OBJ
24	together	together	RB	_	25	PMOD
25	with	with	IN	_	23	NMOD
26	its	its	PRP$	_	28	NMOD
27	binding	bind	VBG	_	28	NMOD
28	partner	partner	NN	_	29	NMOD
29	sorcin	sorcin	NN	_	25	PMOD
30	[	[	-LRB-	_	31	P
31	7	0	CD	_	17	PRN
32	]	]	-RRB-	_	31	P
33	.	.	.	_	15	P

1	We	we	PRP	_	2	SBJ
2	showed	show	VBD	_	0	ROOT
3	the	the	DT	_	4	NMOD
4	presence	presence	NN	_	2	OBJ
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	9	NMOD
7	51	0	CD	_	8	NMOD
8	kDa	kda	NN	_	9	NMOD
9	isoform	isoform	NN	_	5	PMOD
10	as	as	RB	_	11	AMOD
11	well	well	RB	_	2	ADV
12	,	,	,	_	2	P
13	adding	add	VBG	_	2	ADV
14	red	red	JJ	_	16	NMOD
15	blood	blood	NN	_	16	NMOD
16	cells	cell	NNS	_	13	OBJ
17	to	to	IN	_	13	ADV
18	the	the	DT	_	19	NMOD
19	list	list	NN	_	17	PMOD
20	of	of	IN	_	19	NMOD
21	cells	cell	NNS	_	20	PMOD
22	that	that	WDT	_	23	SBJ
23	harbor	harbor	VBP	_	21	NMOD
24	this	this	DT	_	25	NMOD
25	isoform	isoform	NN	_	23	OBJ
26	.	.	.	_	2	P

1	Salzer	salzer	NNP	_	22	DEP
2	et	et	FW	_	3	AMOD
3	al.	al.	FW	_	1	NMOD
4	[	[	-LRB-	_	5	P
5	7	0	CD	_	1	PRN
6	]	]	-RRB-	_	5	P
7	not	not	RB	_	1	COORD
8	only	only	RB	_	7	ADV
9	demonstrated	demonstrate	VBD	_	7	CONJ
10	the	the	DT	_	11	NMOD
11	presence	presence	NN	_	9	OBJ
12	of	of	IN	_	11	NMOD
13	annexin	annexin	NN	_	14	NMOD
14	A7	a0	NN	_	12	PMOD
15	in	in	IN	_	9	LOC
16	red	red	JJ	_	18	NMOD
17	blood	blood	NN	_	18	NMOD
18	cells	cell	NNS	_	15	PMOD
19	,	,	,	_	22	P
20	they	they	PRP	_	22	SBJ
21	also	also	RB	_	22	ADV
22	showed	show	VBD	_	0	ROOT
23	that	that	IN	_	22	OBJ
24	annexin	annexin	NN	_	25	NMOD
25	A7	a0	NN	_	28	SBJ
26	and	and	CC	_	25	COORD
27	sorcin	sorcin	NN	_	26	CONJ
28	were	be	VBD	_	23	SUB
29	enriched	enriched	JJ	_	28	PRD
30	in	in	IN	_	28	LOC
31	membrane	membrane	NN	_	32	NMOD
32	raft	raft	NN	_	33	NMOD
33	domains	domain	NNS	_	30	PMOD
34	of	of	IN	_	33	NMOD
35	nanovesicles	nanovesicles	NNS	_	34	PMOD
36	formed	form	VBN	_	35	NMOD
37	from	from	IN	_	36	ADV
38	red	red	JJ	_	40	NMOD
39	blood	blood	NN	_	40	NMOD
40	cells	cell	NNS	_	37	PMOD
41	in	in	FW	_	42	AMOD
42	vitro	vitro	FW	_	36	LOC
43	.	.	.	_	22	P

1	Raft	raft	NN	_	2	NMOD
2	domains	domain	NNS	_	5	SBJ
3	in	in	IN	_	5	ADV
4	general	general	JJ	_	3	PMOD
5	are	be	VBP	_	0	ROOT
6	considered	consider	VBN	_	5	VC
7	key	key	JJ	_	8	NMOD
8	players	player	NNS	_	6	OPRD
9	in	in	IN	_	8	NMOD
10	membrane	membrane	NN	_	11	NMOD
11	organization	organization	NN	_	9	PMOD
12	and	and	CC	_	9	COORD
13	in	in	IN	_	12	CONJ
14	mediating	mediate	VBG	_	13	PMOD
15	the	the	DT	_	17	NMOD
16	vesiculation	vesiculation	NN	_	17	NMOD
17	process	process	NN	_	14	OBJ
18	.	.	.	_	5	P

1	They	they	PRP	_	2	SBJ
2	result	result	VBP	_	0	ROOT
3	from	from	IN	_	2	ADV
4	the	the	DT	_	5	NMOD
5	clustering	clustering	NN	_	3	PMOD
6	of	of	IN	_	5	NMOD
7	sphingolipids	sphingolipids	NNS	_	6	PMOD
8	and	and	CC	_	7	COORD
9	cholesterol	cholesterol	NN	_	8	CONJ
10	in	in	IN	_	5	LOC
11	the	the	DT	_	13	NMOD
12	outer	out	JJ	_	13	NMOD
13	leaflet	leaflet	NN	_	10	PMOD
14	of	of	IN	_	13	NMOD
15	the	the	DT	_	16	NMOD
16	membrane	membrane	NN	_	14	PMOD
17	connected	connect	VBN	_	16	NMOD
18	to	to	IN	_	17	ADV
19	phospholipids	phospholipid	NNS	_	18	PMOD
20	and	and	CC	_	19	COORD
21	cholesterol	cholesterol	NN	_	20	CONJ
22	in	in	IN	_	17	LOC
23	the	the	DT	_	25	NMOD
24	inner	inner	JJ	_	25	NMOD
25	leaflet	leaflet	NN	_	22	PMOD
26	and	and	CC	_	2	COORD
27	are	be	VBP	_	26	CONJ
28	enriched	enriched	JJ	_	27	PRD
29	in	in	IN	_	27	LOC
30	special	special	JJ	_	31	NMOD
31	proteins	protein	NNS	_	29	PMOD
32	.	.	.	_	2	P

1	Biochemically	biochemically	RB	_	3	ADV
2	rafts	raft	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	defined	define	VBN	_	3	VC
5	as	as	IN	_	4	ADV
6	membranes	membrane	NNS	_	5	PMOD
7	that	that	WDT	_	8	SBJ
8	are	be	VBP	_	6	NMOD
9	resistant	resistant	JJ	_	8	PRD
10	to	to	IN	_	9	AMOD
11	extraction	extraction	NN	_	10	PMOD
12	by	by	IN	_	11	NMOD
13	cold	cold	JJ	_	15	NMOD
14	Triton	triton	NN	_	15	NMOD
15	X	x	NN	_	12	PMOD
16	-	-	HYPH	_	15	P
17	100	0	CD	_	15	NMOD
18	and	and	CC	_	3	COORD
19	can	can	MD	_	18	CONJ
20	be	be	VB	_	19	VC
21	floated	float	VBN	_	20	VC
22	to	to	IN	_	21	ADV
23	low	low	JJ	_	24	NMOD
24	densities	density	NNS	_	22	PMOD
25	in	in	IN	_	21	ADV
26	sucrose	sucrose	NN	_	27	NMOD
27	gradient	gradient	NN	_	28	NMOD
28	centrifugation	centrifugation	NN	_	25	PMOD
29	[	[	-LRB-	_	30	P
30	36	0	CD	_	21	PRN
31	]	]	-RRB-	_	30	P
32	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	findings	finding	NNS	_	17	SBJ
3	of	of	IN	_	2	NMOD
4	Caohuy	caohuy	NNP	_	3	PMOD
5	et	et	FW	_	6	AMOD
6	al.	al.	FW	_	4	NMOD
7	[	[	-LRB-	_	8	P
8	37	0	CD	_	4	PRN
9	]	]	-RRB-	_	8	P
10	that	that	IN	_	2	NMOD
11	annexin	annexin	NN	_	12	NMOD
12	A7	a0	NN	_	13	SBJ
13	mediates	mediate	VBZ	_	10	SUB
14	membrane	membrane	NN	_	15	NMOD
15	aggregation	aggregation	NN	_	13	OBJ
16	also	also	RB	_	17	ADV
17	suggested	suggest	VBD	_	0	ROOT
18	that	that	IN	_	17	OBJ
19	annexin	annexin	NN	_	20	NMOD
20	A7	a0	NN	_	21	SBJ
21	is	be	VBZ	_	18	SUB
22	an	an	DT	_	24	NMOD
23	essential	essential	JJ	_	24	NMOD
24	component	component	NN	_	21	PRD
25	during	during	IN	_	21	TMP
26	vesiculation	vesiculation	NN	_	25	PMOD
27	.	.	.	_	17	P

1	In	in	IN	_	4	ADV
2	addition	addition	NN	_	1	PMOD
3	they	they	PRP	_	4	SBJ
4	reported	report	VBD	_	0	ROOT
5	a	a	DT	_	7	NMOD
6	further	further	JJ	_	7	NMOD
7	activation	activation	NN	_	4	OBJ
8	of	of	IN	_	7	NMOD
9	the	the	DT	_	11	NMOD
10	vesiculation	vesiculation	NN	_	11	NMOD
11	process	process	NN	_	8	PMOD
12	by	by	IN	_	7	NMOD
13	GTP	gtp	NN	_	12	PMOD
14	and	and	CC	_	4	COORD
15	proposed	propose	VBD	_	14	CONJ
16	that	that	IN	_	15	OBJ
17	annexin	annexin	NN	_	18	NMOD
18	A7	a0	NN	_	19	SBJ
19	acts	act	VBZ	_	16	SUB
20	as	as	IN	_	19	ADV
21	a	a	DT	_	22	NMOD
22	GTPase	gtpase	NN	_	20	PMOD
23	.	.	.	_	4	P

1	Similarly	similarly	RB	_	7	ADV
2	,	,	,	_	7	P
3	the	the	DT	_	4	NMOD
4	presence	presence	NN	_	7	SBJ
5	of	of	IN	_	4	NMOD
6	GTP	gtp	NN	_	5	PMOD
7	enhanced	enhance	VBD	_	0	ROOT
8	the	the	DT	_	9	NMOD
9	secretion	secretion	NN	_	7	OBJ
10	of	of	IN	_	9	NMOD
11	surfactant	surfactant	NN	_	10	PMOD
12	by	by	IN	_	9	NMOD
13	annexin	annexin	NN	_	14	NMOD
14	A7	a0	NN	_	12	PMOD
15	.	.	.	_	7	P

1	These	these	DT	_	2	NMOD
2	results	result	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	thought	think	VBN	_	3	VC
5	to	to	TO	_	4	OPRD
6	support	support	VB	_	5	IM
7	a	a	DT	_	9	NMOD
8	direct	direct	JJ	_	9	NMOD
9	role	role	NN	_	6	OBJ
10	for	for	IN	_	9	NMOD
11	annexin	annexin	NN	_	12	NMOD
12	A7	a0	NN	_	10	PMOD
13	in	in	IN	_	9	NMOD
14	surfactant	surfactant	JJ	_	15	NMOD
15	secretion	secretion	NN	_	13	PMOD
16	,	,	,	_	3	P
17	but	but	CC	_	3	COORD
18	in	in	IN	_	26	ADV
19	these	these	DT	_	20	NMOD
20	studies	study	NNS	_	18	PMOD
21	annexin	annexin	NN	_	22	NMOD
22	A7	a0	NN	_	23	AMOD
23	mediated	mediate	VBN	_	25	NMOD
24	membrane	membrane	NN	_	25	NMOD
25	fusion	fusion	NN	_	26	SBJ
26	was	be	VBD	_	17	CONJ
27	separated	separate	VBN	_	26	VC
28	from	from	IN	_	27	ADV
29	a	a	DT	_	34	NMOD
30	second	$#ORD#$	JJ	_	34	NMOD
31	GTP	gtp	NN	_	33	AMOD
32	-	-	HYPH	_	31	P
33	dependent	dependent	JJ	_	34	NMOD
34	mechanism	mechanism	NN	_	28	PMOD
35	[	[	-LRB-	_	36	P
36	38	0	CD	_	27	PRN
37	]	]	-RRB-	_	36	P
38	.	.	.	_	3	P

1	Having	have	VBG	_	8	ADV
2	an	an	DT	_	6	NMOD
3	annexin	annexin	NN	_	4	NMOD
4	A7	a0	NN	_	6	NMOD
5	knockout	knockout	NN	_	6	NMOD
6	mouse	mouse	NN	_	1	OBJ
7	we	we	PRP	_	8	SBJ
8	tested	test	VBD	_	0	ROOT
9	the	the	DT	_	10	NMOD
10	involvement	involvement	NN	_	8	OBJ
11	of	of	IN	_	10	NMOD
12	annexin	annexin	NN	_	13	NMOD
13	A7	a0	NN	_	11	PMOD
14	in	in	IN	_	10	NMOD
15	budding	budding	NN	_	14	PMOD
16	of	of	IN	_	15	NMOD
17	red	red	JJ	_	19	NMOD
18	blood	blood	NN	_	19	NMOD
19	cell	cell	NN	_	20	NMOD
20	vesicles	vesicle	NNS	_	16	PMOD
21	.	.	.	_	8	P

1	Our	our	PRP$	_	2	NMOD
2	data	datum	NNS	_	3	SBJ
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	the	the	DT	_	6	NMOD
6	efficiency	efficiency	NN	_	13	SBJ
7	of	of	IN	_	6	NMOD
8	micro	micro	AFX	_	12	NMOD
9	-	-	HYPH	_	8	P
10	and	and	CC	_	8	COORD
11	nanovesicle	nanovesicle	NN	_	10	CONJ
12	formation	formation	NN	_	7	PMOD
13	is	be	VBZ	_	4	SUB
14	not	not	RB	_	13	ADV
15	significantly	significantly	RB	_	16	AMOD
16	different	different	JJ	_	13	PRD
17	in	in	IN	_	13	LOC
18	wild	wild	JJ	_	19	NMOD
19	type	type	NN	_	24	NMOD
20	and	and	CC	_	19	COORD
21	mutant	mutant	JJ	_	20	CONJ
22	red	red	JJ	_	24	NMOD
23	blood	blood	NN	_	24	NMOD
24	cells	cell	NNS	_	17	PMOD
25	.	.	.	_	3	P

1	Likewise	likewise	RB	_	16	ADV
2	,	,	,	_	16	P
3	Dictyostelium	dictyostelium	NNP	_	4	NMOD
4	discoideum	discoideum	NNP	_	5	NMOD
5	cells	cell	NNS	_	16	SBJ
6	,	,	,	_	5	P
7	in	in	IN	_	13	ADV
8	which	which	WDT	_	7	PMOD
9	the	the	DT	_	12	NMOD
10	single	single	JJ	_	12	NMOD
11	annexin	annexin	NN	_	12	NMOD
12	gene	gene	NN	_	13	SBJ
13	was	be	VBD	_	5	NMOD
14	inactivated	inactivated	JJ	_	13	PRD
15	,	,	,	_	16	P
16	were	be	VBD	_	0	ROOT
17	not	not	RB	_	16	ADV
18	impaired	impaired	JJ	_	16	PRD
19	in	in	IN	_	18	AMOD
20	processes	process	NNS	_	19	PMOD
21	requiring	require	VBG	_	20	NMOD
22	membrane	membrane	NN	_	23	NMOD
23	fusion	fusion	NN	_	21	OBJ
24	[	[	-LRB-	_	26	P
25	[	[	-LRB-	_	26	P
26	39	0	CD	_	16	PRN
27	]	]	-RRB-	_	26	P
28	;	;	:	_	26	P
29	and	and	CC	_	26	COORD
30	data	datum	NNS	_	29	CONJ
31	unpublished	unpublished	JJ	_	30	NMOD
32	]	]	-RRB-	_	26	P
33	.	.	.	_	16	P

1	It	it	PRP	_	2	SBJ
2	might	might	MD	_	0	ROOT
3	well	well	RB	_	2	ADV
4	be	be	VB	_	2	VC
5	that	that	IN	_	4	PRD
6	the	the	DT	_	8	NMOD
7	observed	observe	VBN	_	8	NMOD
8	fusion	fusion	NN	_	22	SBJ
9	of	of	IN	_	8	NMOD
10	phospholipid	phospholipid	NN	_	11	NMOD
11	layers	layer	NNS	_	9	PMOD
12	by	by	IN	_	8	NMOD
13	annexin	annexin	NN	_	14	NMOD
14	A7	a0	NN	_	12	PMOD
15	in	in	IN	_	8	NMOD
16	the	the	DT	_	17	NMOD
17	presence	presence	NN	_	15	PMOD
18	of	of	IN	_	17	NMOD
19	high	high	JJ	_	21	NMOD
20	Ca2+	ca0+	NN	_	21	NMOD
21	concentrations	concentration	NNS	_	18	PMOD
22	may	may	MD	_	5	SUB
23	turn	turn	VB	_	22	VC
24	out	out	RP	_	23	PRT
25	to	to	TO	_	23	OPRD
26	be	be	VB	_	25	IM
27	an	an	DT	_	30	NMOD
28	in	in	FW	_	29	AMOD
29	vitro	vitro	FW	_	30	NMOD
30	effect	effect	NN	_	26	PRD
31	.	.	.	_	2	P

1	Similarly	similarly	RB	_	14	ADV
2	,	,	,	_	14	P
3	the	the	DT	_	5	NMOD
4	high	high	JJ	_	5	NMOD
5	abundance	abundance	NN	_	14	SBJ
6	of	of	IN	_	5	NMOD
7	annexin	annexin	NN	_	8	NMOD
8	A7	a0	NN	_	6	PMOD
9	in	in	IN	_	5	LOC
10	micro	micro	AFX	_	9	PMOD
11	-	-	HYPH	_	10	P
12	and	and	CC	_	10	COORD
13	nanovesicles	nanovesicles	NNS	_	12	CONJ
14	might	might	MD	_	0	ROOT
15	be	be	VB	_	14	VC
16	fortuitous	fortuitous	JJ	_	15	PRD
17	as	as	IN	_	15	ADV
18	a	a	DT	_	20	NMOD
19	significant	significant	JJ	_	20	NMOD
20	percentage	percentage	NN	_	39	SBJ
21	of	of	IN	_	20	NMOD
22	the	the	DT	_	26	NMOD
23	red	red	JJ	_	25	NMOD
24	blood	blood	NN	_	25	NMOD
25	cell	cell	NN	_	26	NMOD
26	membrane	membrane	NN	_	21	PMOD
27	,	,	,	_	26	P
28	with	with	IN	_	32	ADV
29	which	which	WDT	_	28	PMOD
30	annexin	annexin	NN	_	31	NMOD
31	A7	a0	NN	_	32	SBJ
32	associates	associate	VBZ	_	26	NMOD
33	when	when	WRB	_	37	TMP
34	the	the	DT	_	36	NMOD
35	Ca2+	ca0+	NN	_	36	NMOD
36	levels	level	NNS	_	37	SBJ
37	rise	rise	VBP	_	32	TMP
38	,	,	,	_	39	P
39	appears	appear	VBZ	_	17	SUB
40	to	to	TO	_	39	OPRD
41	be	be	VB	_	40	IM
42	involved	involve	VBN	_	41	VC
43	in	in	IN	_	42	ADV
44	the	the	DT	_	45	NMOD
45	formation	formation	NN	_	43	PMOD
46	of	of	IN	_	45	NMOD
47	exovesicles	exovesicles	NNS	_	46	PMOD
48	.	.	.	_	14	P

1	Furthermore	furthermore	RB	_	16	ADV
2	,	,	,	_	16	P
3	the	the	DT	_	4	NMOD
4	distribution	distribution	NN	_	16	SBJ
5	of	of	IN	_	4	NMOD
6	both	both	DT	_	9	NMOD
7	annexin	annexin	NN	_	8	NMOD
8	A7	a0	NN	_	9	NMOD
9	isoforms	isoforms	NNS	_	5	PMOD
10	in	in	IN	_	4	NMOD
11	gradients	gradient	NNS	_	10	PMOD
12	of	of	IN	_	11	NMOD
13	red	red	JJ	_	15	NMOD
14	blood	blood	NN	_	15	NMOD
15	cells	cell	NNS	_	12	PMOD
16	indicates	indicate	VBZ	_	0	ROOT
17	a	a	DT	_	18	NMOD
18	function	function	NN	_	16	OBJ
19	which	which	WDT	_	20	SBJ
20	differs	differ	VBZ	_	18	NMOD
21	from	from	IN	_	20	ADV
22	organizing	organize	VBG	_	21	PMOD
23	subcellular	subcellular	JJ	_	24	NMOD
24	membranes	membrane	NNS	_	22	OBJ
25	or	or	CC	_	24	COORD
26	membrane	membrane	NN	_	27	NMOD
27	pathways	pathway	NNS	_	25	CONJ
28	.	.	.	_	16	P

1	Whereas	whereas	IN	_	23	ADV
2	annexin	annexin	NN	_	3	NMOD
3	A2	a0	NN	_	4	SBJ
4	is	be	VBZ	_	1	SUB
5	tightly	tightly	RB	_	6	ADV
6	associated	associate	VBN	_	4	VC
7	with	with	IN	_	6	ADV
8	endosomes	endosomes	NNS	_	7	PMOD
9	and	and	CC	_	6	COORD
10	may	may	MD	_	9	CONJ
11	have	have	VB	_	10	VC
12	functions	function	NNS	_	11	OBJ
13	in	in	IN	_	11	ADV
14	membrane	membrane	NN	_	15	NMOD
15	fusion	fusion	NN	_	13	PMOD
16	and	and	CC	_	15	COORD
17	the	the	DT	_	19	NMOD
18	endosomal	endosomal	JJ	_	19	NMOD
19	pathway	pathway	NN	_	16	CONJ
20	,	,	,	_	23	P
21	annexin	annexin	NN	_	22	NMOD
22	A7	a0	NN	_	23	SBJ
23	distributes	distribute	VBZ	_	0	ROOT
24	with	with	IN	_	23	ADV
25	plasma	plasma	NN	_	26	NMOD
26	membrane	membrane	NN	_	28	NMOD
27	raft	raft	NN	_	28	NMOD
28	domains	domain	NNS	_	24	PMOD
29	of	of	IN	_	28	NMOD
30	different	different	JJ	_	31	NMOD
31	types	type	NNS	_	29	PMOD
32	and	and	CC	_	31	COORD
33	densities	density	NNS	_	32	CONJ
34	.	.	.	_	23	P

1	Interestingly	interestingly	RB	_	16	ADV
2	,	,	,	_	16	P
3	in	in	IN	_	16	LOC
4	vesicles	vesicle	NNS	_	3	PMOD
5	of	of	IN	_	4	NMOD
6	red	red	JJ	_	8	NMOD
7	blood	blood	NN	_	8	NMOD
8	cells	cell	NNS	_	5	PMOD
9	lacking	lack	VBG	_	8	NMOD
10	annexin	annexin	NN	_	11	NMOD
11	A7	a0	NN	_	9	OBJ
12	the	the	DT	_	13	NMOD
13	amount	amount	NN	_	16	SBJ
14	of	of	IN	_	13	NMOD
15	sorcin	sorcin	NN	_	14	PMOD
16	is	be	VBZ	_	0	ROOT
17	lowered	lower	VBN	_	16	VC
18	,	,	,	_	17	P
19	indicating	indicate	VBG	_	17	ADV
20	that	that	IN	_	19	OBJ
21	its	its	PRP$	_	22	NMOD
22	localisation	localisation	NN	_	23	SBJ
23	is	be	VBZ	_	20	SUB
24	affected	affect	VBN	_	23	VC
25	by	by	IN	_	24	LGS
26	the	the	DT	_	27	NMOD
27	loss	loss	NN	_	25	PMOD
28	of	of	IN	_	27	NMOD
29	annexin	annexin	NN	_	30	NMOD
30	A7	a0	NN	_	28	PMOD
31	or	or	CC	_	23	COORD
32	its	its	PRP$	_	33	NMOD
33	expression	expression	NN	_	39	SBJ
34	during	during	IN	_	33	TMP
35	red	red	JJ	_	37	NMOD
36	blood	blood	NN	_	37	NMOD
37	cell	cell	NN	_	38	NMOD
38	development	development	NN	_	34	PMOD
39	was	be	VBD	_	31	CONJ
40	reduced	reduce	VBN	_	39	VC
41	.	.	.	_	16	P

1	Having	have	VBG	_	15	ADV
2	excluded	exclude	VBN	_	1	VC
3	a	a	DT	_	5	NMOD
4	direct	direct	JJ	_	5	NMOD
5	role	role	NN	_	2	OBJ
6	in	in	IN	_	5	NMOD
7	vesicle	vesicle	NN	_	8	NMOD
8	formation	formation	NN	_	6	PMOD
9	and	and	CC	_	8	COORD
10	membrane	membrane	NN	_	11	NMOD
11	fusion	fusion	NN	_	9	CONJ
12	,	,	,	_	15	P
13	annexin	annexin	NN	_	14	NMOD
14	A7	a0	NN	_	15	SBJ
15	might	might	MD	_	0	ROOT
16	act	act	VB	_	15	VC
17	by	by	IN	_	16	MNR
18	its	its	PRP$	_	19	NMOD
19	property	property	NN	_	17	PMOD
20	as	as	IN	_	19	NMOD
21	Ca2+	ca0+	NN	_	23	AMOD
22	-	-	HYPH	_	21	P
23	binding	bind	VBG	_	24	NMOD
24	protein	protein	NN	_	20	PMOD
25	[	[	-LRB-	_	26	P
26	17	0	CD	_	16	PRN
27	]	]	-RRB-	_	26	P
28	.	.	.	_	15	P

1	Previous	previous	JJ	_	2	NMOD
2	results	result	NNS	_	16	SBJ
3	in	in	IN	_	8	ADV
4	which	which	WDT	_	3	PMOD
5	annexin	annexin	NN	_	6	NMOD
6	A7	a0	NN	_	7	SBJ
7	was	be	VBD	_	2	NMOD
8	shown	show	VBN	_	7	VC
9	to	to	TO	_	8	OPRD
10	play	play	VB	_	9	IM
11	a	a	DT	_	12	NMOD
12	role	role	NN	_	10	OBJ
13	in	in	IN	_	10	ADV
14	membrane	membrane	NN	_	15	NMOD
15	aggregation	aggregation	NN	_	13	PMOD
16	might	might	MD	_	0	ROOT
17	be	be	VB	_	16	VC
18	explained	explain	VBN	_	17	VC
19	by	by	IN	_	18	LGS
20	a	a	DT	_	22	NMOD
21	supportive	supportive	JJ	_	22	NMOD
22	function	function	NN	_	19	PMOD
23	of	of	IN	_	22	NMOD
24	annexin	annexin	NN	_	25	NMOD
25	A7	a0	NN	_	23	PMOD
26	in	in	IN	_	27	SUB
27	that	that	IN	_	18	ADV
28	it	it	PRP	_	29	SBJ
29	interferes	interfere	VBZ	_	27	SUB
30	with	with	IN	_	29	ADV
31	the	the	DT	_	34	NMOD
32	local	local	JJ	_	34	NMOD
33	Ca2+	ca0+	NN	_	34	NMOD
34	homeostasis	homeostasis	NN	_	30	PMOD
35	thus	thus	RB	_	36	ADV
36	influencing	influence	VBG	_	29	ADV
37	membrane	membrane	NN	_	38	NMOD
38	organization	organization	NN	_	36	OBJ
39	.	.	.	_	16	P

1	As	as	IN	_	21	ADV
2	the	the	DT	_	3	NMOD
3	annexins	annexins	NNS	_	4	SBJ
4	belong	belong	VBP	_	1	SUB
5	to	to	IN	_	4	ADV
6	a	a	DT	_	13	NMOD
7	wide	wide	RB	_	8	AMOD
8	spread	spread	VBN	_	13	NMOD
9	and	and	CC	_	8	COORD
10	evolutionarily	evolutionarily	RB	_	11	AMOD
11	conserved	conserve	VBN	_	9	CONJ
12	protein	protein	NN	_	13	NMOD
13	family	family	NN	_	5	PMOD
14	,	,	,	_	21	P
15	redundant	redundant	NN	_	20	NMOD
16	,	,	,	_	15	P
17	but	but	CC	_	15	COORD
18	not	not	RB	_	17	ADV
19	identical	identical	JJ	_	17	CONJ
20	functions	function	NNS	_	21	SBJ
21	are	be	VBP	_	0	ROOT
22	expected	expect	VBN	_	21	VC
23	.	.	.	_	21	P

1	However	however	RB	_	20	ADV
2	,	,	,	_	20	P
3	so	so	RB	_	4	AMOD
4	far	far	RB	_	20	TMP
5	no	no	DT	_	7	NMOD
6	other	other	JJ	_	7	NMOD
7	members	member	NNS	_	20	SBJ
8	of	of	IN	_	7	NMOD
9	the	the	DT	_	11	NMOD
10	annexin	annexin	NN	_	11	NMOD
11	family	family	NN	_	8	PMOD
12	,	,	,	_	11	P
13	which	which	WDT	_	14	SBJ
14	may	may	MD	_	11	NMOD
15	substitute	substitute	VB	_	14	VC
16	for	for	IN	_	15	ADV
17	annexin	annexin	NN	_	18	NMOD
18	A7	a0	NN	_	16	PMOD
19	,	,	,	_	20	P
20	have	have	VBP	_	0	ROOT
21	been	be	VBN	_	20	VC
22	described	describe	VBN	_	21	VC
23	in	in	IN	_	22	LOC
24	red	red	JJ	_	26	NMOD
25	blood	blood	NN	_	26	NMOD
26	cells	cell	NNS	_	23	PMOD
27	.	.	.	_	20	P

1	The	the	DT	_	3	NMOD
2	structural	structural	JJ	_	3	NMOD
3	basis	base	NN	_	13	SBJ
4	for	for	IN	_	3	NMOD
5	the	the	DT	_	6	NMOD
6	elasticy	elasticy	NN	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	red	red	JJ	_	10	NMOD
9	blood	blood	NN	_	10	NMOD
10	cells	cell	NNS	_	7	PMOD
11	in	in	IN	_	10	NMOD
12	circulation	circulation	NN	_	11	PMOD
13	are	be	VBP	_	0	ROOT
14	long	long	JJ	_	15	NMOD
15	range	range	NN	_	17	NMOD
16	molecular	molecular	JJ	_	17	NMOD
17	functions	function	NNS	_	13	PRD
18	of	of	IN	_	17	NMOD
19	the	the	DT	_	21	NMOD
20	plasma	plasma	NN	_	21	NMOD
21	membrane	membrane	NN	_	18	PMOD
22	and	and	CC	_	21	COORD
23	the	the	DT	_	26	NMOD
24	membrane	membrane	NN	_	25	AMOD
25	associated	associate	VBN	_	26	NMOD
26	part	part	NN	_	22	CONJ
27	of	of	IN	_	26	NMOD
28	the	the	DT	_	29	NMOD
29	cytoskeleton	cytoskeleton	NN	_	27	PMOD
30	[	[	-LRB-	_	31	P
31	40	0	CD	_	13	PRN
32	-	-	SYM	_	33	P
33	43	0	CD	_	31	NMOD
34	]	]	-RRB-	_	31	P
35	.	.	.	_	13	P

1	Major	major	JJ	_	2	NMOD
2	constituents	constituent	NNS	_	7	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	membrane	membrane	NN	_	6	NMOD
6	skeleton	skeleton	NN	_	3	PMOD
7	are	be	VBP	_	0	ROOT
8	spectrin	spectrin	NN	_	9	NMOD
9	tetramers	tetramers	NNS	_	7	PRD
10	linked	link	VBN	_	9	NMOD
11	together	together	RB	_	10	ADV
12	by	by	IN	_	10	LGS
13	short	short	JJ	_	15	NMOD
14	actin	actin	NN	_	15	NMOD
15	filaments	filament	NNS	_	12	PMOD
16	and	and	CC	_	15	COORD
17	several	several	JJ	_	19	NMOD
18	other	other	JJ	_	19	NMOD
19	proteins	protein	NNS	_	16	CONJ
20	covering	cover	VBG	_	19	NMOD
21	the	the	DT	_	24	NMOD
22	entire	entire	JJ	_	24	NMOD
23	cytoplasmic	cytoplasmic	JJ	_	24	NMOD
24	surface	surface	NN	_	20	OBJ
25	of	of	IN	_	24	NMOD
26	the	the	DT	_	30	NMOD
27	red	red	JJ	_	29	NMOD
28	blood	blood	NN	_	29	NMOD
29	cell	cell	NN	_	30	NMOD
30	membrane	membrane	NN	_	25	PMOD
31	[	[	-LRB-	_	32	P
32	44	0	CD	_	7	PRN
33	]	]	-RRB-	_	32	P
34	.	.	.	_	7	P

1	Membrane	membrane	NN	_	2	NMOD
2	cholesterol	cholesterol	NN	_	3	SBJ
3	diminishes	diminish	VBZ	_	0	ROOT
4	red	red	JJ	_	6	NMOD
5	blood	blood	NN	_	6	NMOD
6	cell	cell	NN	_	7	NMOD
7	haemolysis	haemolysis	NN	_	3	OBJ
8	by	by	IN	_	7	NMOD
9	the	the	DT	_	11	NMOD
10	complement	complement	NN	_	11	NMOD
11	complex	complex	NN	_	8	PMOD
12	,	,	,	_	3	P
13	whereas	whereas	IN	_	3	ADV
14	depletion	depletion	NN	_	18	SBJ
15	of	of	IN	_	14	NMOD
16	raft	raft	NN	_	17	NMOD
17	cholesterol	cholesterol	NN	_	15	PMOD
18	abrogates	abrogate	VBZ	_	13	SUB
19	association	association	NN	_	18	OBJ
20	of	of	IN	_	19	NMOD
21	all	all	DT	_	23	NMOD
22	raft	raft	NN	_	23	NMOD
23	proteins	protein	NNS	_	20	PMOD
24	with	with	IN	_	18	ADV
25	no	no	DT	_	27	NMOD
26	significant	significant	JJ	_	27	NMOD
27	effect	effect	NN	_	24	PMOD
28	on	on	IN	_	27	NMOD
29	areas	area	NNS	_	28	PMOD
30	in	in	IN	_	29	NMOD
31	the	the	DT	_	32	NMOD
32	rest	rest	NN	_	30	PMOD
33	of	of	IN	_	32	NMOD
34	the	the	DT	_	36	NMOD
35	cell	cell	NN	_	36	NMOD
36	membrane	membrane	NN	_	33	PMOD
37	and	and	CC	_	29	COORD
38	deformability	deformability	NN	_	37	CONJ
39	[	[	-LRB-	_	42	P
40	45	0	CD	_	42	NMOD
41	,	,	,	_	42	P
42	46	0	CD	_	3	PRN
43	]	]	-RRB-	_	42	P
44	.	.	.	_	3	P

1	Annexin	annexin	NN	_	2	NMOD
2	A7	a0	NN	_	8	NMOD
3	knock	knock	NN	_	4	NMOD
4	out	out	NN	_	5	NMOD
5	mouse	mouse	NN	_	8	NMOD
6	red	red	JJ	_	8	NMOD
7	blood	blood	NN	_	8	NMOD
8	cells	cell	NNS	_	9	SBJ
9	show	show	VBP	_	0	ROOT
10	a	a	DT	_	13	NMOD
11	more	more	RBR	_	12	AMOD
12	flat	flat	JJ	_	13	NMOD
13	shape	shape	NN	_	9	OBJ
14	and	and	CC	_	9	COORD
15	have	have	VBP	_	14	CONJ
16	a	a	DT	_	19	NMOD
17	higher	high	JJR	_	19	NMOD
18	osmotic	osmotic	JJ	_	19	NMOD
19	resistance	resistance	NN	_	15	OBJ
20	.	.	.	_	9	P

1	The	the	DT	_	2	NMOD
2	presence	presence	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	annexin	annexin	NN	_	5	NMOD
5	A7	a0	NN	_	3	PMOD
6	may	may	MD	_	0	ROOT
7	alter	alter	VB	_	6	VC
8	the	the	DT	_	10	NMOD
9	membrane	membrane	NN	_	10	NMOD
10	flexibility	flexibility	NN	_	7	OBJ
11	in	in	IN	_	12	SUB
12	that	that	IN	_	7	ADV
13	it	it	PRP	_	14	SBJ
14	supports	support	VBZ	_	12	SUB
15	the	the	DT	_	19	NMOD
16	typical	typical	JJ	_	19	NMOD
17	biconcave	biconcave	NN	_	19	NMOD
18	membrane	membrane	NN	_	19	NMOD
19	shape	shape	NN	_	14	OBJ
20	and	and	CC	_	14	COORD
21	leads	lead	VBZ	_	20	CONJ
22	to	to	IN	_	21	ADV
23	a	a	DT	_	27	NMOD
24	lower	low	JJR	_	27	NMOD
25	minimal	minimal	JJ	_	27	NMOD
26	osmotic	osmotic	JJ	_	27	NMOD
27	resistance	resistance	NN	_	22	PMOD
28	.	.	.	_	6	P

1	Annexin	annexin	NN	_	2	NMOD
2	A7	a0	NN	_	3	SBJ
3	does	do	VBZ	_	0	ROOT
4	not	not	RB	_	3	ADV
5	appear	appear	VB	_	3	VC
6	to	to	TO	_	5	OPRD
7	have	have	VB	_	6	IM
8	an	an	DT	_	9	NMOD
9	influence	influence	NN	_	7	OBJ
10	on	on	IN	_	9	NMOD
11	plasma	plasma	NN	_	12	NMOD
12	membrane	membrane	NN	_	13	NMOD
13	integrity	integrity	NN	_	14	NMOD
14	itself	itself	PRP	_	10	PMOD
15	as	as	IN	_	7	ADV
16	the	the	DT	_	20	NMOD
17	maximal	maximal	JJ	_	20	NMOD
18	osmotic	osmotic	JJ	_	19	NMOD
19	resistance	resistance	NN	_	20	NMOD
20	value	value	NN	_	21	SBJ
21	stays	stay	VBZ	_	15	SUB
22	constant	constant	JJ	_	21	PRD
23	.	.	.	_	3	P

1	Ca2+	ca0+	NN	_	5	NMOD
2	and	and	CC	_	1	COORD
3	membrane	membrane	NN	_	4	AMOD
4	skeletal	skeletal	JJ	_	2	CONJ
5	proteins	protein	NNS	_	6	SBJ
6	are	be	VBP	_	0	ROOT
7	known	know	VBN	_	6	VC
8	to	to	TO	_	7	OPRD
9	play	play	VB	_	8	IM
10	key	key	JJ	_	11	NMOD
11	roles	role	NNS	_	9	OBJ
12	on	on	IN	_	9	ADV
13	the	the	DT	_	18	NMOD
14	red	red	JJ	_	16	NMOD
15	blood	blood	NN	_	16	NMOD
16	cell	cell	NN	_	18	NMOD
17	membrane	membrane	NN	_	18	NMOD
18	shape	shape	NN	_	12	PMOD
19	and	and	CC	_	18	COORD
20	stability	stability	NN	_	19	CONJ
21	[	[	-LRB-	_	22	P
22	47	0	CD	_	7	PRN
23	]	]	-RRB-	_	22	P
24	.	.	.	_	6	P

1	Annexins	annexins	NNS	_	2	SBJ
2	have	have	VBP	_	14	DEP
3	been	be	VBN	_	2	VC
4	reported	report	VBN	_	3	VC
5	to	to	TO	_	4	OPRD
6	bind	bind	VB	_	5	IM
7	directly	directly	RB	_	6	MNR
8	to	to	IN	_	6	ADV
9	F	f	NN	_	11	NMOD
10	-	-	HYPH	_	9	P
11	actin	actin	NN	_	8	PMOD
12	,	,	,	_	14	P
13	we	we	PRP	_	14	SBJ
14	could	could	MD	_	0	ROOT
15	however	however	RB	_	14	ADV
16	exclude	exclude	VB	_	14	VC
17	such	such	JJ	_	19	NMOD
18	an	an	DT	_	19	NMOD
19	activity	activity	NN	_	16	OBJ
20	for	for	IN	_	16	ADV
21	annexin	annexin	NN	_	22	NMOD
22	A7	a0	NN	_	20	PMOD
23	.	.	.	_	14	P

1	Nevertheless	nevertheless	RB	_	3	ADV
2	it	it	PRP	_	3	SBJ
3	might	might	MD	_	0	ROOT
4	interact	interact	VB	_	3	VC
5	with	with	IN	_	4	ADV
6	other	other	JJ	_	7	NMOD
7	components	component	NNS	_	5	PMOD
8	and	and	CC	_	4	COORD
9	have	have	VBP	_	8	CONJ
10	a	a	DT	_	11	NMOD
11	role	role	NN	_	9	OBJ
12	in	in	IN	_	9	ADV
13	organizing	organize	VBG	_	12	PMOD
14	the	the	DT	_	16	NMOD
15	membrane	membrane	NN	_	16	NMOD
16	cytoskeleton	cytoskeleton	NN	_	13	OBJ
17	,	,	,	_	4	P
18	controlling	control	VBG	_	4	ADV
19	raft	raft	NN	_	20	NMOD
20	protein	protein	NN	_	21	NMOD
21	associations	association	NNS	_	18	OBJ
22	or	or	CC	_	18	COORD
23	influencing	influence	VBG	_	22	CONJ
24	the	the	DT	_	26	NMOD
25	ionic	ionic	JJ	_	26	NMOD
26	strength	strength	NN	_	23	OBJ
27	of	of	IN	_	26	NMOD
28	red	red	JJ	_	30	NMOD
29	blood	blood	NN	_	30	NMOD
30	cells	cell	NNS	_	27	PMOD
31	on	on	IN	_	18	MNR
32	its	its	PRP$	_	33	NMOD
33	own	own	JJ	_	31	PMOD
34	or	or	CC	_	31	COORD
35	by	by	IN	_	34	CONJ
36	interfering	interfere	VBG	_	35	PMOD
37	with	with	IN	_	36	ADV
38	other	other	JJ	_	40	NMOD
39	signaling	signaling	NN	_	40	NMOD
40	pathways	pathway	NNS	_	37	PMOD
41	.	.	.	_	3	P

1	As	as	IN	_	6	ADV
2	discussed	discuss	VBN	_	1	SUB
3	above	above	RB	_	2	ADV
4	annexin	annexin	NN	_	5	NMOD
5	A7	a0	NN	_	6	SBJ
6	could	could	MD	_	0	ROOT
7	be	be	VB	_	6	VC
8	involved	involve	VBN	_	7	VC
9	in	in	IN	_	8	ADV
10	the	the	DT	_	13	NMOD
11	cytoplasmic	cytoplasmic	JJ	_	12	NMOD
12	Ca2+	ca0+	NN	_	13	NMOD
13	homeostasis	homeostasis	NN	_	9	PMOD
14	.	.	.	_	6	P

1	It	it	PRP	_	2	SBJ
2	has	have	VBZ	_	0	ROOT
3	been	be	VBN	_	2	VC
4	demonstrated	demonstrate	VBN	_	3	VC
5	that	that	IN	_	4	OBJ
6	micromolar	micromolar	JJ	_	7	NMOD
7	changes	change	NNS	_	13	SBJ
8	of	of	IN	_	7	NMOD
9	the	the	DT	_	12	NMOD
10	intracellular	intracellular	JJ	_	12	NMOD
11	Ca2+	ca0+	NN	_	12	NMOD
12	concentration	concentration	NN	_	8	PMOD
13	exert	exert	VBP	_	5	SUB
14	a	a	DT	_	16	NMOD
15	profound	profound	JJ	_	16	NMOD
16	effect	effect	NN	_	13	OBJ
17	on	on	IN	_	16	NMOD
18	the	the	DT	_	20	NMOD
19	membrane	membrane	NN	_	20	NMOD
20	properties	property	NNS	_	17	PMOD
21	that	that	WDT	_	22	SBJ
22	regulate	regulate	VBP	_	20	NMOD
23	red	red	JJ	_	25	NMOD
24	blood	blood	NN	_	25	NMOD
25	cell	cell	NN	_	26	NMOD
26	deformability	deformability	NN	_	22	OBJ
27	[	[	-LRB-	_	30	P
28	48	0	CD	_	30	NMOD
29	,	,	,	_	30	P
30	49	0	CD	_	4	PRN
31	]	]	-RRB-	_	30	P
32	.	.	.	_	2	P

1	Furthermore	furthermore	RB	_	6	ADV
2	,	,	,	_	6	P
3	the	the	DT	_	5	NMOD
4	intracellular	intracellular	JJ	_	5	NMOD
5	Ca2+	ca0+	NN	_	6	SBJ
6	was	be	VBD	_	0	ROOT
7	shown	show	VBN	_	6	VC
8	to	to	TO	_	7	OPRD
9	regulate	regulate	VB	_	8	IM
10	the	the	DT	_	12	NMOD
11	membrane	membrane	NN	_	12	NMOD
12	stability	stability	NN	_	9	OBJ
13	through	through	IN	_	9	MNR
14	modulation	modulation	NN	_	13	PMOD
15	of	of	IN	_	14	NMOD
16	cytoskeletal	cytoskeletal	JJ	_	17	NMOD
17	protein	protein	NN	_	18	NMOD
18	interactions	interaction	NNS	_	15	PMOD
19	[	[	-LRB-	_	20	P
20	50	0	CD	_	7	PRN
21	]	]	-RRB-	_	20	P
22	.	.	.	_	6	P

1	Ca2+	ca0+	NN	_	3	SBJ
2	also	also	RB	_	3	ADV
3	induces	induce	VBZ	_	0	ROOT
4	a	a	DT	_	7	NMOD
5	transbilayer	transbilayer	NN	_	7	NMOD
6	phospholipid	phospholipid	NN	_	7	NMOD
7	redistribution	redistribution	NN	_	3	OBJ
8	inducing	induce	VBG	_	7	NMOD
9	a	a	DT	_	11	NMOD
10	shape	shape	NN	_	11	NMOD
11	change	change	NN	_	8	OBJ
12	of	of	IN	_	11	NMOD
13	red	red	JJ	_	15	NMOD
14	blood	blood	NN	_	15	NMOD
15	cells	cell	NNS	_	12	PMOD
16	[	[	-LRB-	_	17	P
17	51	0	CD	_	3	PRN
18	]	]	-RRB-	_	17	P
19	.	.	.	_	3	P

1	In	in	IN	_	6	ADV
2	addition	addition	NN	_	1	PMOD
3	,	,	,	_	6	P
4	Ca2+	ca0+	NN	_	5	NMOD
5	ions	ion	NNS	_	6	SBJ
6	can	can	MD	_	0	ROOT
7	drive	drive	VB	_	6	VC
8	spiculation	spiculation	NN	_	7	OBJ
9	of	of	IN	_	8	NMOD
10	the	the	DT	_	12	NMOD
11	membrane	membrane	NN	_	12	NMOD
12	bilayer	bilayer	NN	_	9	PMOD
13	without	without	IN	_	7	MNR
14	involving	involve	VBG	_	13	PMOD
15	the	the	DT	_	16	NMOD
16	cytoskeleton	cytoskeleton	NN	_	14	OBJ
17	[	[	-LRB-	_	18	P
18	52	0	CD	_	7	PRN
19	]	]	-RRB-	_	18	P
20	.	.	.	_	6	P

1	We	we	PRP	_	2	SBJ
2	have	have	VBP	_	0	ROOT
3	also	also	RB	_	2	ADV
4	observed	observe	VBN	_	2	VC
5	a	a	DT	_	6	NMOD
6	defect	defect	NN	_	4	OBJ
7	in	in	IN	_	6	NMOD
8	platelet	platelet	NN	_	9	NMOD
9	function	function	NN	_	7	PMOD
10	in	in	IN	_	4	LOC
11	the	the	DT	_	14	NMOD
12	annexin	annexin	NN	_	13	NMOD
13	A7	a0	NN	_	14	NMOD
14	mutant	mutant	NN	_	10	PMOD
15	.	.	.	_	2	P

1	In	in	IN	_	10	ADV
2	the	the	DT	_	5	NMOD
3	platelet	platelet	NN	_	4	NMOD
4	aggregation	aggregation	NN	_	5	NMOD
5	experiments	experiment	NNS	_	1	PMOD
6	the	the	DT	_	9	NMOD
7	initial	initial	JJ	_	9	NMOD
8	aggregation	aggregation	NN	_	9	NMOD
9	velocity	velocity	NN	_	10	SBJ
10	was	be	VBD	_	0	ROOT
11	slightly	slightly	RB	_	15	AMOD
12	,	,	,	_	11	P
13	but	but	CC	_	11	COORD
14	significantly	significantly	RB	_	13	CONJ
15	lower	low	JJR	_	10	PRD
16	in	in	IN	_	10	LOC
17	platelets	platelet	NNS	_	16	PMOD
18	lacking	lack	VBG	_	17	NMOD
19	annexin	annexin	NN	_	20	NMOD
20	A7	a0	NN	_	18	OBJ
21	.	.	.	_	10	P

1	These	these	DT	_	2	NMOD
2	data	datum	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	not	not	RB	_	3	ADV
5	reflected	reflect	VBN	_	3	VC
6	by	by	IN	_	5	LGS
7	a	a	DT	_	8	NMOD
8	change	change	NN	_	6	PMOD
9	in	in	IN	_	8	NMOD
10	the	the	DT	_	14	NMOD
11	in	in	FW	_	12	AMOD
12	vivo	vivo	FW	_	14	NMOD
13	bleeding	bleeding	NN	_	14	NMOD
14	time	time	NN	_	9	PMOD
15	.	.	.	_	3	P

1	However	however	RB	_	8	ADV
2	the	the	DT	_	4	NMOD
3	reaction	reaction	NN	_	4	NMOD
4	speed	speed	NN	_	8	SBJ
5	of	of	IN	_	4	NMOD
6	murine	murine	JJ	_	7	NMOD
7	platelets	platelet	NNS	_	5	PMOD
8	is	be	VBZ	_	0	ROOT
9	much	much	RB	_	10	AMOD
10	higher	high	JJR	_	8	PRD
11	than	than	IN	_	10	AMOD
12	those	those	DT	_	11	PMOD
13	of	of	IN	_	12	NMOD
14	human	human	JJ	_	13	PMOD
15	and	and	CC	_	8	COORD
16	due	due	IN	_	22	PRP
17	to	to	IN	_	16	PMOD
18	the	the	DT	_	20	NMOD
19	technical	technical	JJ	_	20	NMOD
20	setup	setup	NN	_	16	PMOD
21	we	we	PRP	_	22	SBJ
22	might	might	MD	_	15	CONJ
23	have	have	VB	_	22	VC
24	missed	miss	VBN	_	23	VC
25	larger	large	JJR	_	26	NMOD
26	changes	change	NNS	_	24	OBJ
27	in	in	IN	_	24	LOC
28	the	the	DT	_	30	NMOD
29	mouse	mouse	NN	_	30	NMOD
30	samples	sample	NNS	_	27	PMOD
31	.	.	.	_	8	P

1	The	the	DT	_	3	NMOD
2	immediate	immediate	JJ	_	3	NMOD
3	reaction	reaction	NN	_	16	SBJ
4	of	of	IN	_	3	NMOD
5	mouse	mouse	NN	_	6	NMOD
6	platelets	platelet	NNS	_	4	PMOD
7	and	and	CC	_	3	COORD
8	the	the	DT	_	9	NMOD
9	absence	absence	NN	_	7	CONJ
10	of	of	IN	_	9	NMOD
11	a	a	DT	_	13	NMOD
12	lag	lag	NN	_	13	NMOD
13	phase	phase	NN	_	10	PMOD
14	after	after	IN	_	13	TMP
15	triggering	triggering	NN	_	14	PMOD
16	may	may	MD	_	0	ROOT
17	be	be	VB	_	16	VC
18	caused	cause	VBN	_	17	VC
19	by	by	IN	_	18	LGS
20	an	an	DT	_	24	NMOD
21	immediately	immediately	RB	_	22	AMOD
22	initiated	initiate	VBN	_	24	NMOD
23	thrombin	thrombin	NN	_	24	NMOD
24	generation	generation	NN	_	19	PMOD
25	[	[	-LRB-	_	26	P
26	22	0	CD	_	18	PRN
27	]	]	-RRB-	_	26	P
28	.	.	.	_	16	P

1	As	as	IN	_	18	ADV
2	known	know	VBN	_	1	SUB
3	from	from	IN	_	2	ADV
4	the	the	DT	_	9	NMOD
5	frequent	frequent	JJ	_	9	NMOD
6	human	human	JJ	_	9	NMOD
7	vWF	vwf	NN	_	9	NMOD
8	-	-	HYPH	_	7	P
9	syndrome	syndrome	NN	_	3	PMOD
10	or	or	CC	_	9	COORD
11	other	other	JJ	_	13	NMOD
12	haemostatic	haemostatic	JJ	_	13	NMOD
13	diseases	disease	NNS	_	10	CONJ
14	,	,	,	_	18	P
15	small	small	JJ	_	16	NMOD
16	defects	defect	NNS	_	18	SBJ
17	often	often	RB	_	18	TMP
18	are	be	VBP	_	0	ROOT
19	clinically	clinically	RB	_	20	AMOD
20	silent	silent	JJ	_	18	PRD
21	and	and	CC	_	18	COORD
22	do	do	VBP	_	21	CONJ
23	not	not	RB	_	22	ADV
24	result	result	VB	_	22	VC
25	in	in	IN	_	24	ADV
26	physiological	physiological	JJ	_	27	NMOD
27	changes	change	NNS	_	25	PMOD
28	under	under	IN	_	18	ADV
29	normal	normal	JJ	_	30	NMOD
30	conditions	condition	NNS	_	28	PMOD
31	.	.	.	_	18	P

1	Only	only	RB	_	2	PMOD
2	in	in	IN	_	25	ADV
3	situations	situation	NNS	_	2	PMOD
4	with	with	IN	_	3	NMOD
5	severe	severe	JJ	_	7	NMOD
6	physical	physical	JJ	_	7	NMOD
7	injury	injury	NN	_	4	PMOD
8	,	,	,	_	25	P
9	distinct	distinct	JJ	_	11	NMOD
10	environmental	environmental	JJ	_	11	NMOD
11	influences	influence	NNS	_	25	SBJ
12	or	or	CC	_	11	COORD
13	additional	additional	JJ	_	14	NMOD
14	platelet	platelet	NN	_	12	CONJ
15	attributes	attribute	VBZ	_	14	NMOD
16	like	like	IN	_	14	NMOD
17	the	the	DT	_	24	NMOD
18	platelet	platelet	NN	_	19	NMOD
19	antigen	antigen	NN	_	24	NMOD
20	polymorphism	polymorphism	NN	_	24	NMOD
21	[	[	-LRB-	_	22	P
22	53	0	CD	_	24	PRN
23	]	]	-RRB-	_	22	P
24	differences	difference	NNS	_	16	PMOD
25	might	might	MD	_	0	ROOT
26	become	become	VB	_	25	VC
27	apparent	apparent	JJ	_	26	PRD
28	.	.	.	_	25	P

1	Conclusions	conclusion	NNS	_	0	ROOT

1	In	in	IN	_	5	ADV
2	this	this	DT	_	3	NMOD
3	paper	paper	NN	_	1	PMOD
4	we	we	PRP	_	5	SBJ
5	report	report	VBP	_	0	ROOT
6	the	the	DT	_	7	NMOD
7	presence	presence	NN	_	5	OBJ
8	of	of	IN	_	7	NMOD
9	both	both	CC	_	12	COORD
10	annexin	annexin	NN	_	11	NMOD
11	A7	a0	NN	_	12	NMOD
12	isoforms	isoforms	NNS	_	8	PMOD
13	in	in	IN	_	7	LOC
14	red	red	JJ	_	16	NMOD
15	blood	blood	NN	_	16	NMOD
16	cells	cell	NNS	_	13	PMOD
17	where	where	WRB	_	19	LOC
18	they	they	PRP	_	19	SBJ
19	are	be	VBP	_	16	NMOD
20	abundant	abundant	JJ	_	19	PRD
21	in	in	IN	_	19	LOC
22	nanovesicles	nanovesicles	NNS	_	21	PMOD
23	that	that	WDT	_	24	SBJ
24	form	form	VBP	_	22	NMOD
25	upon	upon	IN	_	24	TMP
26	Ca2+	ca0+	NN	_	27	NMOD
27	addition	addition	NN	_	25	PMOD
28	.	.	.	_	5	P

1	The	the	DT	_	2	NMOD
2	proteins	protein	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	however	however	RB	_	3	ADV
5	not	not	RB	_	3	ADV
6	required	require	VBN	_	3	VC
7	for	for	IN	_	6	PRP
8	the	the	DT	_	10	NMOD
9	vesiculation	vesiculation	NN	_	10	NMOD
10	process	process	NN	_	7	PMOD
11	.	.	.	_	3	P

1	They	they	PRP	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	also	also	RB	_	2	ADV
4	not	not	RB	_	2	ADV
5	essential	essential	JJ	_	2	PRD
6	for	for	IN	_	5	AMOD
7	the	the	DT	_	8	NMOD
8	formation	formation	NN	_	6	PMOD
9	of	of	IN	_	8	NMOD
10	specific	specific	JJ	_	12	NMOD
11	membrane	membrane	NN	_	12	NMOD
12	domains	domain	NNS	_	9	PMOD
13	such	such	JJ	_	14	PMOD
14	as	as	IN	_	12	NMOD
15	lipid	lipid	NN	_	16	NMOD
16	rafts	raft	NNS	_	14	PMOD
17	,	,	,	_	2	P
18	as	as	IN	_	2	ADV
19	exogenously	exogenously	RB	_	20	AMOD
20	added	add	VBN	_	23	NMOD
21	recombinant	recombinant	JJ	_	23	NMOD
22	annexin	annexin	NN	_	23	NMOD
23	A7	a0	NN	_	18	PMOD
24	redistributed	redistribute	VBN	_	23	NMOD
25	to	to	IN	_	24	ADV
26	similar	similar	JJ	_	27	NMOD
27	positions	position	NNS	_	25	PMOD
28	in	in	IN	_	23	NMOD
29	a	a	DT	_	31	NMOD
30	density	density	NN	_	31	NMOD
31	gradient	gradient	NN	_	28	PMOD
32	containing	contain	VBG	_	31	NMOD
33	membranes	membrane	NNS	_	32	OBJ
34	derived	derive	VBN	_	33	NMOD
35	from	from	IN	_	34	ADV
36	red	red	JJ	_	38	NMOD
37	blood	blood	NN	_	38	NMOD
38	cells	cell	NNS	_	35	PMOD
39	of	of	IN	_	38	NMOD
40	anxA7	anxa0	NN	_	44	NMOD
41	-	-	SYM	_	40	P
42	/	/	HYPH	_	40	P
43	-	-	SYM	_	40	P
44	mice	mouse	NNS	_	39	PMOD
45	.	.	.	_	2	P

1	The	the	DT	_	5	NMOD
2	observed	observe	VBN	_	5	NMOD
3	cell	cell	NN	_	4	NMOD
4	shape	shape	NN	_	5	NMOD
5	change	change	NN	_	11	SBJ
6	of	of	IN	_	5	NMOD
7	erythrocytes	erythrocyte	NNS	_	6	PMOD
8	lacking	lack	VBG	_	7	NMOD
9	annexin	annexin	NN	_	10	NMOD
10	A7	a0	NN	_	8	OBJ
11	might	might	MD	_	0	ROOT
12	be	be	VB	_	11	VC
13	due	due	IN	_	12	PRD
14	to	to	IN	_	13	PMOD
15	alterations	alteration	NNS	_	13	PMOD
16	in	in	IN	_	15	LOC
17	the	the	DT	_	19	NMOD
18	erythrocyte	erythrocyte	NN	_	19	NMOD
19	cytoskeleton	cytoskeleton	NN	_	16	PMOD
20	.	.	.	_	11	P

1	As	as	IN	_	15	ADV
2	a	a	DT	_	4	NMOD
3	direct	direct	JJ	_	4	NMOD
4	interaction	interaction	NN	_	9	SBJ
5	with	with	IN	_	4	NMOD
6	F	f	NN	_	8	NMOD
7	-	-	HYPH	_	6	P
8	actin	actin	NN	_	5	PMOD
9	was	be	VBD	_	1	SUB
10	ruled	rule	VBN	_	9	VC
11	out	out	RP	_	10	PRT
12	,	,	,	_	15	P
13	this	this	DT	_	14	NMOD
14	effect	effect	NN	_	15	SBJ
15	might	might	MD	_	0	ROOT
16	be	be	VB	_	15	VC
17	mediated	mediate	VBN	_	16	VC
18	by	by	IN	_	17	LGS
19	annexin	annexin	NN	_	24	NMOD
20	's	's	POS	_	19	NMOD
21	Ca2+	ca0+	NN	_	23	AMOD
22	-	-	HYPH	_	21	P
23	binding	bind	VBG	_	24	NMOD
24	activity	activity	NN	_	18	PMOD
25	.	.	.	_	15	P

1	Methods	method	NNS	_	0	ROOT

1	Acquisition	acquisition	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	murine	murine	JJ	_	6	NMOD
4	and	and	CC	_	3	COORD
5	human	human	JJ	_	4	CONJ
6	blood	blood	NN	_	7	NMOD
7	samples	sample	NNS	_	2	PMOD

1	Blood	blood	NN	_	30	SBJ
2	from	from	IN	_	1	NMOD
3	129Sv	0sv	NN	_	11	NMOD
4	wild	wild	JJ	_	5	NMOD
5	type	type	NN	_	11	NMOD
6	and	and	CC	_	5	COORD
7	annexin	annexin	NN	_	8	NMOD
8	A7	a0	NN	_	6	CONJ
9	knock	knock	NN	_	10	NMOD
10	out	out	NN	_	11	NMOD
11	mice	mouse	NNS	_	2	PMOD
12	(	(	-LRB-	_	13	P
13	anxA7	anxa0	NN	_	11	PRN
14	-	-	SYM	_	13	P
15	/	/	HYPH	_	13	P
16	-	-	SYM	_	13	P
17	)	)	-RRB-	_	13	P
18	kept	keep	VBN	_	1	NMOD
19	under	under	IN	_	18	ADV
20	pathogen	pathogen	NN	_	22	AMOD
21	-	-	HYPH	_	20	P
22	free	free	JJ	_	23	NMOD
23	conditions	condition	NNS	_	19	PMOD
24	and	and	CC	_	18	COORD
25	fed	feed	VBN	_	24	CONJ
26	with	with	IN	_	25	MNR
27	regular	regular	JJ	_	28	NMOD
28	food	food	NN	_	26	PMOD
29	,	,	,	_	30	P
30	was	be	VBD	_	0	ROOT
31	collected	collect	VBN	_	30	VC
32	in	in	IN	_	31	ADV
33	1	0	CD	_	34	NMOD
34	ml	ml	NN	_	35	NMOD
35	syringes	syrinx	NNS	_	32	PMOD
36	with	with	IN	_	31	MNR
37	a	a	DT	_	40	NMOD
38	22	0	CD	_	39	NMOD
39	gauge	gauge	NN	_	40	NMOD
40	needle	needle	NN	_	41	SBJ
41	punctating	punctating	VBG	_	36	PMOD
42	the	the	DT	_	45	NMOD
43	right	right	JJ	_	45	NMOD
44	cardiac	cardiac	JJ	_	45	NMOD
45	ventricle	ventricle	NN	_	41	OBJ
46	immediately	immediately	RB	_	47	ADV
47	after	after	IN	_	41	ADV
48	they	they	PRP	_	49	SBJ
49	had	have	VBD	_	47	SUB
50	been	be	VBN	_	49	VC
51	killed	kill	VBN	_	50	VC
52	by	by	IN	_	51	MNR
53	cervical	cervical	JJ	_	54	NMOD
54	dislocation	dislocation	NN	_	52	PMOD
55	.	.	.	_	30	P

1	Coagulation	coagulation	NN	_	3	SBJ
2	generally	generally	RB	_	3	ADV
3	was	be	VBD	_	0	ROOT
4	inhibited	inhibit	VBN	_	3	VC
5	with	with	IN	_	4	MNR
6	1	0	CD	_	9	NMOD
7	/	/	SYM	_	6	P
8	10	0	CD	_	6	QMOD
9	volume	volume	NN	_	5	PMOD
10	of	of	IN	_	9	NMOD
11	10	0	CD	_	12	NMOD
12	mM	mm	NN	_	13	NMOD
13	NaEDTA	naedta	NN	_	10	PMOD
14	,	,	,	_	13	P
15	pH	ph	NN	_	13	APPO
16	7.5	0	CD	_	15	NMOD
17	,	,	,	_	9	P
18	already	already	RB	_	19	ADV
19	present	present	JJ	_	9	NMOD
20	in	in	IN	_	19	LOC
21	the	the	DT	_	22	NMOD
22	syringe	syringe	NN	_	20	PMOD
23	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	mice	mouse	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	killed	kill	VBN	_	3	VC
5	by	by	IN	_	4	MNR
6	cervical	cervical	JJ	_	7	NMOD
7	dislocation	dislocation	NN	_	5	PMOD
8	in	in	IN	_	4	ADV
9	order	order	NN	_	8	PMOD
10	to	to	TO	_	9	NMOD
11	avoid	avoid	VB	_	10	IM
12	any	any	DT	_	13	NMOD
13	effect	effect	NN	_	11	OBJ
14	of	of	IN	_	13	NMOD
15	anaesthetic	anaesthetic	JJ	_	16	NMOD
16	chemicals	chemical	NNS	_	14	PMOD
17	on	on	IN	_	13	NMOD
18	blood	blood	NN	_	19	NMOD
19	parameters	parameter	NNS	_	17	PMOD
20	.	.	.	_	3	P

1	The	the	DT	_	6	NMOD
2	wild	wild	JJ	_	3	NMOD
3	type	type	NN	_	6	NMOD
4	and	and	CC	_	3	COORD
5	mutant	mutant	JJ	_	4	CONJ
6	mice	mouse	NNS	_	7	SBJ
7	were	be	VBD	_	0	ROOT
8	matched	match	VBN	_	7	VC
9	regarding	regard	VBG	_	8	MNR
10	their	their	PRP$	_	11	NMOD
11	age	age	NN	_	9	PMOD
12	,	,	,	_	11	P
13	weight	weight	NN	_	11	CONJ
14	and	and	CC	_	13	COORD
15	sex	sex	NN	_	14	CONJ
16	.	.	.	_	7	P

1	The	the	DT	_	2	NMOD
2	daytime	daytime	NN	_	12	SBJ
3	of	of	IN	_	2	NMOD
4	blood	blood	NN	_	5	NMOD
5	collection	collection	NN	_	3	PMOD
6	,	,	,	_	2	P
7	sampling	sample	VBG	_	8	NMOD
8	site	site	NN	_	2	CONJ
9	and	and	CC	_	8	COORD
10	collection	collection	NN	_	11	NMOD
11	method	method	NN	_	9	CONJ
12	were	be	VBD	_	0	ROOT
13	kept	keep	VBN	_	12	VC
14	constant	constant	JJ	_	13	OPRD
15	during	during	IN	_	13	TMP
16	all	all	DT	_	17	NMOD
17	experiments	experiment	NNS	_	15	PMOD
18	.	.	.	_	12	P

1	A	a	DT	_	6	NMOD
2	typical	typical	JJ	_	6	NMOD
3	murine	murine	JJ	_	5	NMOD
4	blood	blood	NN	_	5	NMOD
5	sample	sample	NN	_	6	NMOD
6	volume	volume	NN	_	7	SBJ
7	consisted	consist	VBD	_	0	ROOT
8	of	of	IN	_	7	ADV
9	550	0	CD	_	10	NMOD
10	μl	μl	NN	_	8	PMOD
11	,	,	,	_	7	P
12	with	with	IN	_	7	ADV
13	variations	variation	NNS	_	12	PMOD
14	ranging	range	VBG	_	13	NMOD
15	from	from	IN	_	14	ADV
16	200	0	CD	_	17	NMOD
17	μl	μl	NNS	_	15	PMOD
18	to	to	IN	_	15	PMOD
19	900	0	CD	_	20	NMOD
20	μl	μl	NNS	_	18	PMOD
21	.	.	.	_	7	P

1	Human	human	JJ	_	3	NMOD
2	blood	blood	NN	_	3	NMOD
3	samples	sample	NNS	_	7	SBJ
4	from	from	IN	_	3	NMOD
5	the	the	DT	_	6	NMOD
6	authors	author	NNS	_	4	PMOD
7	were	be	VBD	_	0	ROOT
8	collected	collect	VBN	_	7	VC
9	by	by	IN	_	8	MNR
10	vein	vein	NN	_	11	NMOD
11	puncture	puncture	NN	_	9	PMOD
12	using	use	VBG	_	8	MNR
13	common	common	JJ	_	16	NMOD
14	EDTA	edta	NNS	_	16	NMOD
15	-	-	HYPH	_	14	P
16	monovettes	monovettes	NNS	_	12	OBJ
17	(	(	-LRB-	_	18	P
18	Sarstedt	sarstedt	NNP	_	8	PRN
19	)	)	-RRB-	_	18	P
20	.	.	.	_	7	P

1	We	we	PRP	_	2	SBJ
2	performed	perform	VBD	_	0	ROOT
3	our	our	PRP$	_	4	NMOD
4	studies	study	NNS	_	2	OBJ
5	using	use	VBG	_	2	MNR
6	well	well	RB	_	7	AMOD
7	standardized	standardized	JJ	_	9	NMOD
8	sampling	sampling	NN	_	9	NMOD
9	conditions	condition	NNS	_	5	OBJ
10	,	,	,	_	2	P
11	as	as	IN	_	2	PRP
12	differences	difference	NNS	_	26	SBJ
13	in	in	IN	_	12	NMOD
14	the	the	DT	_	17	NMOD
15	blood	blood	NN	_	16	NMOD
16	sampling	sampling	NN	_	17	NMOD
17	site	site	NN	_	13	PMOD
18	,	,	,	_	12	P
19	for	for	IN	_	21	PMOD
20	example	example	NN	_	19	PMOD
21	between	between	IN	_	12	NMOD
22	tail	tail	NN	_	21	PMOD
23	and	and	CC	_	22	COORD
24	heart	heart	NN	_	23	CONJ
25	,	,	,	_	26	P
26	show	show	VBP	_	11	SUB
27	large	large	JJ	_	28	NMOD
28	changes	change	NNS	_	26	OBJ
29	in	in	IN	_	28	NMOD
30	all	all	DT	_	33	NMOD
31	cell	cell	NN	_	32	NMOD
32	type	type	NN	_	33	NMOD
33	counts	count	NNS	_	29	PMOD
34	.	.	.	_	2	P

1	First	$#ORD#$	JJ	_	5	NMOD
2	and	and	CC	_	1	COORD
3	second	$#ORD#$	JJ	_	2	CONJ
4	sample	sample	NN	_	5	NMOD
5	draw	draw	NN	_	6	SBJ
6	affect	affect	VBP	_	0	ROOT
7	blood	blood	NN	_	8	NMOD
8	measurements	measurement	NNS	_	6	OBJ
9	,	,	,	_	6	P
10	too	too	RB	_	6	ADV
11	[	[	-LRB-	_	12	P
12	22	0	CD	_	6	PRN
13	]	]	-RRB-	_	12	P
14	.	.	.	_	6	P

1	Also	also	RB	_	11	ADV
2	the	the	DT	_	4	NMOD
3	genetic	genetic	JJ	_	4	NMOD
4	background	background	NN	_	11	SBJ
5	in	in	IN	_	4	LOC
6	common	common	JJ	_	10	NMOD
7	laboratory	laboratory	NN	_	10	NMOD
8	and	and	CC	_	7	COORD
9	transgenic	transgenic	JJ	_	8	CONJ
10	mice	mouse	NNS	_	5	PMOD
11	affects	affect	VBZ	_	0	ROOT
12	the	the	DT	_	13	NMOD
13	phenotype	phenotype	NN	_	11	OBJ
14	.	.	.	_	11	P

1	A	a	DT	_	2	NMOD
2	change	change	NN	_	8	SBJ
3	from	from	IN	_	2	NMOD
4	one	one	CD	_	5	NMOD
5	strain	strain	NN	_	3	PMOD
6	to	to	IN	_	2	NMOD
7	another	another	DT	_	6	PMOD
8	may	may	MD	_	0	ROOT
9	protect	protect	VB	_	8	VC
10	mice	mouse	NNS	_	9	OBJ
11	from	from	IN	_	9	ADV
12	effects	effect	NNS	_	11	PMOD
13	of	of	IN	_	12	NMOD
14	the	the	DT	_	18	NMOD
15	primarily	primarily	RB	_	16	AMOD
16	induced	induce	VBN	_	18	NMOD
17	genetic	genetic	JJ	_	18	NMOD
18	defect	defect	NN	_	13	PMOD
19	.	.	.	_	8	P

1	For	for	IN	_	8	ADV
2	example	example	NN	_	1	PMOD
3	,	,	,	_	8	P
4	BALB	balb	NN	_	6	NMOD
5	/	/	HYPH	_	4	P
6	c	c	NN	_	7	NMOD
7	mice	mouse	NNS	_	8	SBJ
8	have	have	VBP	_	0	ROOT
9	a	a	DT	_	12	NMOD
10	significantly	significantly	RB	_	11	AMOD
11	increased	increase	VBN	_	12	NMOD
12	velocity	velocity	NN	_	8	OBJ
13	of	of	IN	_	12	NMOD
14	platelet	platelet	NN	_	15	NMOD
15	aggregation	aggregation	NN	_	13	PMOD
16	as	as	IN	_	8	ADV
17	compared	compare	VBN	_	16	PMOD
18	to	to	IN	_	17	PMOD
19	129Sv	0sv	NN	_	20	NMOD
20	mice	mouse	NNS	_	18	PMOD
21	,	,	,	_	20	P
22	which	which	WDT	_	23	SBJ
23	were	be	VBD	_	20	NMOD
24	used	use	VBN	_	23	VC
25	throughout	throughout	IN	_	24	TMP
26	this	this	DT	_	27	NMOD
27	study	study	NN	_	25	PMOD
28	[	[	-LRB-	_	29	P
29	23	0	CD	_	8	PRN
30	]	]	-RRB-	_	29	P
31	.	.	.	_	8	P

1	Self	self	NN	_	2	AMOD
2	forming	form	VBG	_	5	NMOD
3	iodixanol	iodixanol	NN	_	5	NMOD
4	density	density	NN	_	5	NMOD
5	gradients	gradient	NNS	_	0	ROOT
6	of	of	IN	_	5	NMOD
7	human	human	JJ	_	10	NMOD
8	red	red	JJ	_	10	NMOD
9	blood	blood	NN	_	10	NMOD
10	cells	cell	NNS	_	6	PMOD

1	The	the	DT	_	3	NMOD
2	subcellular	subcellular	JJ	_	3	NMOD
3	distribution	distribution	NN	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	annexin	annexin	NN	_	6	NMOD
6	A7	a0	NN	_	4	PMOD
7	was	be	VBD	_	0	ROOT
8	addressed	address	VBN	_	7	VC
9	according	accord	VBG	_	8	ADV
10	to	to	IN	_	9	PMOD
11	[	[	-LRB-	_	10	P
12	24	0	CD	_	10	PMOD
13	]	]	-RRB-	_	7	P
14	.	.	.	_	7	P

1	Red	red	JJ	_	3	NMOD
2	blood	blood	NN	_	3	NMOD
3	cells	cell	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	centrifuged	centrifuge	VBN	_	4	VC
6	and	and	CC	_	5	COORD
7	washed	wash	VBN	_	6	CONJ
8	in	in	IN	_	7	MNR
9	isotonic	isotonic	JJ	_	12	NMOD
10	buffered	buffer	VBN	_	11	NMOD
11	salt	salt	NN	_	12	NMOD
12	solution	solution	NN	_	8	PMOD
13	,	,	,	_	7	P
14	collected	collect	VBN	_	7	CONJ
15	in	in	IN	_	14	ADV
16	ice	ice	NN	_	17	AMOD
17	cold	cold	JJ	_	19	NMOD
18	lysis	lysis	NN	_	19	NMOD
19	buffer	buffer	NN	_	15	PMOD
20	(	(	-LRB-	_	40	P
21	20	0	CD	_	22	NMOD
22	mM	mm	NN	_	23	NMOD
23	Hepes	hepes	NNS	_	40	DEP
24	,	,	,	_	23	P
25	pH	ph	NN	_	23	APPO
26	7.4	0	CD	_	25	NMOD
27	,	,	,	_	23	P
28	200	0	CD	_	29	NMOD
29	μM	μm	NN	_	30	NMOD
30	CaCl2	cacl0	NN	_	23	CONJ
31	,	,	,	_	30	P
32	0.25	0	CD	_	33	NMOD
33	M	m	NN	_	34	NMOD
34	sucrose	sucrose	NN	_	30	CONJ
35	,	,	,	_	34	P
36	and	and	CC	_	34	COORD
37	proteinase	proteinase	NN	_	38	NMOD
38	inhibitors	inhibitor	NNS	_	36	CONJ
39	(	(	-LRB-	_	40	P
40	Roche	roche	NNP	_	19	PRN
41	)	)	-RRB-	_	40	P
42	)	)	-RRB-	_	40	P
43	,	,	,	_	14	P
44	homogenized	homogenize	VBN	_	14	CONJ
45	by	by	IN	_	44	MNR
46	a	a	DT	_	50	NMOD
47	loosely	loosely	RB	_	48	AMOD
48	fitting	fitting	JJ	_	50	NMOD
49	dounce	dounce	NN	_	50	NMOD
50	homogenizer	homogenizer	NN	_	45	PMOD
51	and	and	CC	_	50	COORD
52	additional	additional	JJ	_	53	NMOD
53	passages	passage	NNS	_	51	CONJ
54	through	through	IN	_	53	NMOD
55	a	a	DT	_	58	NMOD
56	22	0	CD	_	57	NMOD
57	gauge	gauge	NN	_	58	NMOD
58	needle	needle	NN	_	54	PMOD
59	.	.	.	_	4	P

1	A	a	DT	_	5	NMOD
2	50	0	CD	_	3	NMOD
3	%	%	NN	_	5	NMOD
4	iodixanol	iodixanol	NN	_	5	NMOD
5	solution	solution	NN	_	6	SBJ
6	was	be	VBD	_	0	ROOT
7	established	establish	VBN	_	6	VC
8	by	by	IN	_	7	MNR
9	mixing	mix	VBG	_	8	PMOD
10	Optiprep	optiprep	NN	_	11	NMOD
11	solution	solution	NN	_	9	OBJ
12	(	(	-LRB-	_	17	P
13	60	0	CD	_	14	NMOD
14	%	%	NN	_	15	NMOD
15	iodixanol	iodixanol	NN	_	17	DEP
16	;	;	:	_	17	P
17	Sigma	sigma	NN	_	11	PRN
18	)	)	-RRB-	_	17	P
19	with	with	IN	_	9	ADV
20	buffer	buffer	NN	_	19	PMOD
21	(	(	-LRB-	_	35	P
22	120	0	CD	_	23	NMOD
23	mM	mm	NN	_	24	NMOD
24	Hepes	hepes	NNS	_	35	DEP
25	,	,	,	_	24	P
26	pH	ph	NN	_	24	APPO
27	7.4	0	CD	_	26	NMOD
28	,	,	,	_	35	P
29	1.2	0	CD	_	30	NMOD
30	mM	mm	NN	_	31	NMOD
31	CaCl2	cacl0	NN	_	35	DEP
32	,	,	,	_	35	P
33	0.25	0	CD	_	34	NMOD
34	M	m	NN	_	35	NMOD
35	sucrose	sucrose	NN	_	20	PRN
36	)	)	-RRB-	_	35	P
37	.	.	.	_	6	P

1	Seven	seven	CD	_	2	NMOD
2	parts	part	NNS	_	9	SBJ
3	of	of	IN	_	2	NMOD
4	this	this	DT	_	8	NMOD
5	50	0	CD	_	6	NMOD
6	%	%	NN	_	8	NMOD
7	iodixanol	iodixanol	NN	_	8	NMOD
8	solution	solution	NN	_	3	PMOD
9	were	be	VBD	_	0	ROOT
10	mixed	mix	VBN	_	9	VC
11	with	with	IN	_	10	ADV
12	thirteen	thirteen	CD	_	13	NMOD
13	parts	part	NNS	_	11	PMOD
14	of	of	IN	_	13	NMOD
15	the	the	DT	_	19	NMOD
16	red	red	JJ	_	18	NMOD
17	blood	blood	NN	_	18	NMOD
18	cell	cell	NN	_	19	NMOD
19	solution	solution	NN	_	14	PMOD
20	,	,	,	_	10	P
21	generating	generate	VBG	_	10	ADV
22	a	a	DT	_	24	NMOD
23	gradient	gradient	NN	_	24	NMOD
24	solution	solution	NN	_	21	OBJ
25	containing	contain	VBG	_	24	NMOD
26	17.5	0	CD	_	27	NMOD
27	%	%	NN	_	28	NMOD
28	iodixanol	iodixanol	NN	_	25	OBJ
29	.	.	.	_	9	P

1	The	the	DT	_	2	NMOD
2	mixture	mixture	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	filled	fill	VBN	_	3	VC
5	into	into	IN	_	4	ADV
6	a	a	DT	_	8	NMOD
7	centrifuge	centrifuge	JJ	_	8	NMOD
8	tube	tube	NN	_	5	PMOD
9	underlayed	underlay	VBN	_	8	NMOD
10	by	by	IN	_	9	AMOD
11	cushions	cushion	NNS	_	10	PMOD
12	of	of	IN	_	11	NMOD
13	30	0	CD	_	14	NMOD
14	%	%	NN	_	18	NMOD
15	and	and	CC	_	14	COORD
16	35	0	CD	_	17	NMOD
17	%	%	NN	_	15	CONJ
18	iodixanol	iodixanol	NN	_	12	PMOD
19	and	and	CC	_	4	COORD
20	centrifuged	centrifuge	VBN	_	19	CONJ
21	for	for	IN	_	20	TMP
22	3	0	CD	_	23	NMOD
23	hours	hour	NNS	_	21	PMOD
24	at	at	IN	_	20	ADV
25	270,000	0	CD	_	27	NMOD
26	×	×	SYM	_	27	P
27	g	g	NN	_	24	PMOD
28	in	in	IN	_	20	ADV
29	a	a	DT	_	34	NMOD
30	SW41	sw0	NN	_	31	NMOD
31	Ti	ti	NNP	_	34	NMOD
32	swing	swing	NN	_	33	NMOD
33	out	out	NN	_	34	NMOD
34	rotor	rotor	NN	_	28	PMOD
35	(	(	-LRB-	_	36	P
36	Beckman	beckman	NN	_	34	PRN
37	)	)	-RRB-	_	36	P
38	to	to	TO	_	4	PRP
39	achieve	achieve	VB	_	38	IM
40	a	a	DT	_	44	NMOD
41	nearly	nearly	RB	_	42	AMOD
42	linear	linear	JJ	_	44	NMOD
43	density	density	NN	_	44	NMOD
44	gradient	gradient	NN	_	39	OBJ
45	(	(	-LRB-	_	48	P
46	approximately	approximately	RB	_	48	NMOD
47	1.06	0	CD	_	48	NMOD
48	g	g	NNS	_	44	PRN
49	/	/	SYM	_	50	P
50	ml	ml	NN	_	48	NMOD
51	to	to	IN	_	48	NMOD
52	1.20	0	CD	_	53	NMOD
53	g	g	NNS	_	51	PMOD
54	/	/	SYM	_	55	P
55	ml	ml	NN	_	53	NMOD
56	)	)	-RRB-	_	48	P
57	[	[	-LRB-	_	58	P
58	24	0	CD	_	4	PRN
59	]	]	-RRB-	_	58	P
60	.	.	.	_	3	P

1	Fractions	fraction	NNS	_	5	SBJ
2	of	of	IN	_	1	NMOD
3	0.6	0	CD	_	4	NMOD
4	ml	ml	NN	_	2	PMOD
5	were	be	VBD	_	0	ROOT
6	collected	collect	VBN	_	5	VC
7	from	from	IN	_	6	ADV
8	the	the	DT	_	9	NMOD
9	top	top	NN	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	12	NMOD
12	gradient	gradient	NN	_	10	PMOD
13	by	by	IN	_	6	MNR
14	a	a	DT	_	17	NMOD
15	1	0	CD	_	16	NMOD
16	ml	ml	NN	_	17	NMOD
17	syringe	syringe	NN	_	13	PMOD
18	without	without	IN	_	6	MNR
19	using	use	VBG	_	18	PMOD
20	a	a	DT	_	21	NMOD
21	needle	needle	NN	_	19	OBJ
22	and	and	CC	_	6	COORD
23	immediately	immediately	RB	_	24	TMP
24	frozen	freeze	VBN	_	22	CONJ
25	in	in	IN	_	24	MNR
26	liquid	liquid	JJ	_	27	NMOD
27	nitrogen	nitrogen	NN	_	25	PMOD
28	for	for	IN	_	24	PRP
29	further	further	JJ	_	30	NMOD
30	use	use	NN	_	28	PMOD
31	.	.	.	_	5	P

1	Exovesicle	exovesicle	NN	_	2	NMOD
2	generation	generation	NN	_	0	ROOT
3	from	from	IN	_	2	NMOD
4	human	human	JJ	_	9	NMOD
5	and	and	CC	_	4	COORD
6	murine	murine	JJ	_	5	CONJ
7	red	red	JJ	_	9	NMOD
8	blood	blood	NN	_	9	NMOD
9	cells	cell	NNS	_	3	PMOD

1	Red	red	JJ	_	3	NMOD
2	blood	blood	NN	_	3	NMOD
3	cells	cell	NNS	_	5	SBJ
4	naturally	naturally	RB	_	5	ADV
5	can	can	MD	_	0	ROOT
6	form	form	VB	_	5	VC
7	hemoglobin	hemoglobin	NN	_	8	AMOD
8	containing	contain	VBG	_	9	NMOD
9	exovesicles	exovesicles	NNS	_	6	OBJ
10	.	.	.	_	5	P

1	In	in	FW	_	2	AMOD
2	vitro	vitro	FW	_	6	LOC
3	these	these	DT	_	5	NMOD
4	vesicle	vesicle	NN	_	5	NMOD
5	formation	formation	NN	_	6	SBJ
6	is	be	VBZ	_	0	ROOT
7	Ca2+	ca0+	NN	_	8	AMOD
8	induced	induce	VBN	_	6	PRD
9	.	.	.	_	6	P

1	Freshly	freshly	RB	_	2	AMOD
2	collected	collect	VBN	_	8	NMOD
3	lithium	lithium	NN	_	5	NMOD
4	-	-	HYPH	_	3	P
5	heparin	heparin	NN	_	8	NMOD
6	anticoagulated	anticoagulated	VBN	_	8	NMOD
7	blood	blood	NN	_	8	NMOD
8	samples	sample	NNS	_	9	SBJ
9	were	be	VBD	_	0	ROOT
10	centrifuged	centrifuge	VBN	_	9	VC
11	for	for	IN	_	10	TMP
12	5	0	CD	_	13	NMOD
13	minutes	minute	NNS	_	11	PMOD
14	at	at	IN	_	10	ADV
15	400	0	CD	_	17	NMOD
16	×	×	SYM	_	17	P
17	g	g	NN	_	14	PMOD
18	and	and	CC	_	17	COORD
19	4	0	CD	_	20	NMOD
20	°C	°c	NN	_	18	CONJ
21	.	.	.	_	9	P

1	The	the	DT	_	2	NMOD
2	erythrocytes	erythrocyte	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	washed	wash	VBN	_	3	VC
5	five	five	CD	_	6	NMOD
6	times	time	NNS	_	4	TMP
7	with	with	IN	_	4	MNR
8	20	0	CD	_	9	NMOD
9	mM	mm	NN	_	10	NMOD
10	Hepes	hepes	NNS	_	7	PMOD
11	,	,	,	_	10	P
12	pH	ph	NN	_	10	APPO
13	7.5	0	CD	_	12	NMOD
14	,	,	,	_	10	P
15	and	and	CC	_	10	COORD
16	150	0	CD	_	17	NMOD
17	mM	mm	NN	_	18	NMOD
18	NaCl	nacl	NN	_	15	CONJ
19	(	(	-LRB-	_	21	P
20	washing	wash	VBG	_	21	NMOD
21	buffer	buffer	NN	_	18	PRN
22	)	)	-RRB-	_	21	P
23	.	.	.	_	3	P

1	A	a	DT	_	2	NMOD
2	volume	volume	NN	_	10	SBJ
3	of	of	IN	_	2	NMOD
4	500	0	CD	_	5	NMOD
5	μl	μl	NN	_	9	NMOD
6	washed	wash	VBN	_	9	NMOD
7	red	red	JJ	_	9	NMOD
8	blood	blood	NN	_	9	NMOD
9	cells	cell	NNS	_	3	PMOD
10	were	be	VBD	_	0	ROOT
11	combined	combine	VBN	_	10	VC
12	with	with	IN	_	11	ADV
13	3	0	CD	_	14	NMOD
14	ml	ml	NN	_	12	PMOD
15	of	of	IN	_	14	NMOD
16	vesiculation	vesiculation	NN	_	17	NMOD
17	buffer	buffer	NN	_	15	PMOD
18	(	(	-LRB-	_	32	P
19	20	0	CD	_	20	NMOD
20	mM	mm	NN	_	21	NMOD
21	Hepes	hepes	NNS	_	32	DEP
22	,	,	,	_	21	P
23	pH	ph	NN	_	21	APPO
24	7.5	0	CD	_	23	NMOD
25	,	,	,	_	32	P
26	150	0	CD	_	27	NMOD
27	mM	mm	NN	_	28	NMOD
28	NaCl	nacl	NN	_	32	DEP
29	,	,	,	_	32	P
30	1	0	CD	_	31	NMOD
31	mM	mm	NN	_	32	NMOD
32	CaCl2	cacl0	NN	_	17	PRN
33	adjusted	adjust	VBN	_	32	NMOD
34	to	to	IN	_	33	ADV
35	5	0	CD	_	36	NMOD
36	μM	μm	NN	_	39	NMOD
37	Ca2+	ca0+	NN	_	39	NMOD
38	ionophore	ionophore	NN	_	39	NMOD
39	A23187	a0	NN	_	34	PMOD
40	)	)	-RRB-	_	32	P
41	and	and	CC	_	11	COORD
42	incubated	incubate	VBN	_	41	CONJ
43	for	for	IN	_	42	TMP
44	30	0	CD	_	45	NMOD
45	minutes	minute	NNS	_	43	PMOD
46	at	at	IN	_	42	ADV
47	37°C	0°c	NN	_	46	PMOD
48	.	.	.	_	10	P

1	After	after	IN	_	4	TMP
2	incubation	incubation	NN	_	1	PMOD
3	EDTA	edta	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	added	add	VBN	_	4	VC
6	to	to	IN	_	5	ADV
7	the	the	DT	_	8	NMOD
8	solution	solution	NN	_	6	PMOD
9	to	to	IN	_	5	ADV
10	a	a	DT	_	12	NMOD
11	final	final	JJ	_	12	NMOD
12	concentration	concentration	NN	_	9	PMOD
13	of	of	IN	_	12	NMOD
14	5	0	CD	_	15	NMOD
15	mM	mm	NN	_	13	PMOD
16	and	and	CC	_	5	COORD
17	centrifuged	centrifuge	VBN	_	16	CONJ
18	for	for	IN	_	17	TMP
19	5	0	CD	_	20	NMOD
20	minutes	minute	NNS	_	18	PMOD
21	at	at	IN	_	17	ADV
22	400	0	CD	_	24	NMOD
23	×	×	SYM	_	24	P
24	g	g	NN	_	21	PMOD
25	and	and	CC	_	24	COORD
26	4°C	0°c	NN	_	25	CONJ
27	.	.	.	_	4	P

1	The	the	DT	_	2	NMOD
2	supernatant	supernatant	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	collected	collect	VBN	_	3	VC
5	and	and	CC	_	4	COORD
6	centrifuged	centrifuge	VBN	_	5	CONJ
7	for	for	IN	_	6	TMP
8	20	0	CD	_	9	NMOD
9	minutes	minute	NNS	_	7	PMOD
10	at	at	IN	_	6	ADV
11	15,000	0	CD	_	13	NMOD
12	×	×	SYM	_	13	P
13	g	g	NN	_	10	PMOD
14	and	and	CC	_	13	COORD
15	4°C	0°c	NN	_	14	CONJ
16	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	resulting	result	VBG	_	3	NMOD
3	pellet	pellet	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	resuspended	resuspend	VBN	_	4	VC
6	in	in	IN	_	5	ADV
7	washing	wash	VBG	_	8	NMOD
8	buffer	buffer	NN	_	6	PMOD
9	and	and	CC	_	5	COORD
10	centrifuged	centrifuge	VBN	_	9	CONJ
11	at	at	IN	_	10	ADV
12	400	0	CD	_	14	NMOD
13	×	×	SYM	_	14	P
14	g	g	NN	_	11	PMOD
15	again	again	RB	_	10	TMP
16	to	to	TO	_	5	PRP
17	collect	collect	VB	_	16	IM
18	a	a	DT	_	19	NMOD
19	supernatant	supernatant	NN	_	17	OBJ
20	enriched	enrich	VBN	_	19	NMOD
21	with	with	IN	_	20	ADV
22	red	red	JJ	_	24	NMOD
23	blood	blood	NN	_	24	NMOD
24	cell	cell	NN	_	25	NMOD
25	microvesicles	microvesicles	NNS	_	21	PMOD
26	.	.	.	_	4	P

1	The	the	DT	_	2	NMOD
2	supernatant	supernatant	NN	_	9	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	8	NMOD
5	15,000	0	CD	_	7	NMOD
6	×	×	SYM	_	7	P
7	g	g	NN	_	8	NMOD
8	step	step	NN	_	3	PMOD
9	was	be	VBD	_	0	ROOT
10	further	far	RBR	_	9	ADV
11	centrifuged	centrifuge	VBN	_	9	VC
12	for	for	IN	_	11	TMP
13	60	0	CD	_	14	NMOD
14	minutes	minute	NNS	_	12	PMOD
15	at	at	IN	_	11	ADV
16	100,000	0	CD	_	18	NMOD
17	×	×	SYM	_	18	P
18	g	g	NN	_	15	PMOD
19	and	and	CC	_	18	COORD
20	4°C	0°c	NN	_	19	CONJ
21	.	.	.	_	9	P

1	The	the	DT	_	3	NMOD
2	final	final	JJ	_	3	NMOD
3	pellet	pellet	NN	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	this	this	DT	_	6	NMOD
6	step	step	NN	_	4	PMOD
7	was	be	VBD	_	0	ROOT
8	resuspended	resuspend	VBN	_	7	VC
9	in	in	IN	_	8	ADV
10	washing	wash	VBG	_	11	NMOD
11	buffer	buffer	NN	_	9	PMOD
12	and	and	CC	_	8	COORD
13	centrifuged	centrifuge	VBN	_	12	CONJ
14	at	at	IN	_	13	ADV
15	15,000	0	CD	_	17	NMOD
16	×	×	SYM	_	17	P
17	g	g	NN	_	14	PMOD
18	again	again	RB	_	13	TMP
19	to	to	TO	_	8	PRP
20	purify	purify	VB	_	19	IM
21	a	a	DT	_	22	NMOD
22	supernatant	supernatant	NN	_	20	OBJ
23	enriched	enrich	VBN	_	22	NMOD
24	in	in	IN	_	23	LOC
25	nanovesicles	nanovesicles	NNS	_	24	PMOD
26	according	accord	VBG	_	20	ADV
27	to	to	IN	_	26	PMOD
28	[	[	-LRB-	_	27	P
29	7	0	CD	_	31	NMOD
30	,	,	,	_	31	P
31	20	0	CD	_	27	PMOD
32	]	]	-RRB-	_	7	P
33	.	.	.	_	7	P

1	The	the	DT	_	2	NMOD
2	vesicles	vesicle	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	assayed	assay	VBN	_	3	VC
5	for	for	IN	_	4	ADV
6	acetylcholine	acetylcholine	NN	_	7	NMOD
7	esterase	esterase	NN	_	8	NMOD
8	activity	activity	NN	_	5	PMOD
9	and	and	CC	_	4	COORD
10	used	use	VBN	_	9	CONJ
11	for	for	IN	_	10	PRP
12	further	further	JJ	_	13	NMOD
13	analysis	analysis	NN	_	11	PMOD
14	.	.	.	_	3	P

1	Acetylcholine	acetylcholine	NN	_	2	NMOD
2	esterase	esterase	NN	_	3	NMOD
3	assay	assay	NN	_	0	ROOT

1	A	a	DT	_	4	NMOD
2	30	0	CD	_	3	NMOD
3	μl	μl	NN	_	4	NMOD
4	sample	sample	NN	_	10	SBJ
5	of	of	IN	_	4	NMOD
6	red	red	JJ	_	8	NMOD
7	blood	blood	NN	_	8	NMOD
8	cell	cell	NN	_	9	NMOD
9	vesicles	vesicle	NNS	_	5	PMOD
10	was	be	VBD	_	0	ROOT
11	mixed	mix	VBN	_	10	VC
12	with	with	IN	_	11	ADV
13	an	an	DT	_	15	NMOD
14	equal	equal	JJ	_	15	NMOD
15	volume	volume	NN	_	12	PMOD
16	of	of	IN	_	15	NMOD
17	buffer	buffer	NN	_	16	PMOD
18	(	(	-LRB-	_	33	P
19	20	0	CD	_	20	NMOD
20	mM	mm	NN	_	21	NMOD
21	Hepes	hepes	NN	_	33	DEP
22	,	,	,	_	21	P
23	pH	ph	NN	_	21	APPO
24	7.6	0	CD	_	23	NMOD
25	,	,	,	_	33	P
26	150	0	CD	_	27	NMOD
27	mM	mm	NN	_	28	NMOD
28	NaCl	nacl	NN	_	33	DEP
29	,	,	,	_	33	P
30	0.5	0	CD	_	31	NMOD
31	%	%	NN	_	33	NMOD
32	Triton	triton	NN	_	33	NMOD
33	X	x	NN	_	17	PRN
34	-	-	HYPH	_	33	P
35	100	0	CD	_	33	NMOD
36	)	)	-RRB-	_	33	P
37	,	,	,	_	11	P
38	vortexed	vortexed	VBN	_	11	CONJ
39	and	and	CC	_	38	COORD
40	incubated	incubate	VBN	_	39	CONJ
41	for	for	IN	_	40	TMP
42	5	0	CD	_	43	NMOD
43	minutes	minute	NNS	_	41	PMOD
44	at	at	IN	_	40	ADV
45	37°C	0°c	NN	_	44	PMOD
46	.	.	.	_	10	P

1	Subsequently	subsequently	RB	_	55	TMP
2	640	0	CD	_	3	NMOD
3	μl	μl	NN	_	6	NMOD
4	sodium	sodium	NN	_	5	NMOD
5	phosphate	phosphate	NN	_	6	NMOD
6	buffer	buffer	NN	_	55	SBJ
7	(	(	-LRB-	_	10	P
8	100	0	CD	_	9	NMOD
9	mM	mm	NN	_	10	NMOD
10	Na2PO4	na0po0	NN	_	6	PRN
11	,	,	,	_	10	P
12	pH	ph	NN	_	10	APPO
13	7.6	0	CD	_	12	NMOD
14	)	)	-RRB-	_	10	P
15	,	,	,	_	6	P
16	50	0	CD	_	17	NMOD
17	μl	μl	NN	_	18	NMOD
18	DTNB	dtnb	NN	_	6	CONJ
19	(	(	-LRB-	_	35	P
20	5	0	CD	_	25	NMOD
21	,	,	,	_	25	P
22	5	0	CD	_	25	NMOD
23	'	'	SYM	_	22	P
24	-	-	HYPH	_	22	P
25	dithiobis	dithiobis	NN	_	35	DEP
26	-	-	HYPH	_	25	P
27	(	(	-LRB-	_	31	P
28	2	0	CD	_	31	NMOD
29	-	-	HYPH	_	28	P
30	nitrobenzoic	nitrobenzoic	JJ	_	31	NMOD
31	acid	acid	NN	_	35	PRN
32	)	)	-RRB-	_	31	P
33	,	,	,	_	35	P
34	10	0	CD	_	35	NMOD
35	mM	mm	NN	_	18	PRN
36	in	in	IN	_	35	NMOD
37	sodium	sodium	NN	_	38	NMOD
38	phosphate	phosphate	NN	_	39	NMOD
39	buffer	buffer	NN	_	36	PMOD
40	)	)	-RRB-	_	35	P
41	,	,	,	_	18	P
42	and	and	CC	_	18	COORD
43	50	0	CD	_	44	NMOD
44	μl	μl	NN	_	46	NMOD
45	acetylthiocholine	acetylthiocholine	NN	_	46	NMOD
46	chloride	chloride	NN	_	42	CONJ
47	(	(	-LRB-	_	51	P
48	12	0	CD	_	51	NMOD
49	,	,	,	_	51	P
50	5	0	CD	_	51	NMOD
51	mM	mm	NN	_	46	PRN
52	in	in	IN	_	51	NMOD
53	H2O	h0o	NN	_	52	PMOD
54	)	)	-RRB-	_	51	P
55	were	be	VBD	_	0	ROOT
56	added	add	VBN	_	55	VC
57	.	.	.	_	55	P

1	The	the	DT	_	2	NMOD
2	reaction	reaction	NN	_	3	SBJ
3	took	take	VBD	_	0	ROOT
4	place	place	NN	_	3	OBJ
5	at	at	IN	_	3	ADV
6	room	room	NN	_	7	NMOD
7	temperature	temperature	NN	_	5	PMOD
8	and	and	CC	_	3	COORD
9	was	be	VBD	_	8	CONJ
10	measured	measure	VBN	_	9	VC
11	photometrically	photometrically	RB	_	10	MNR
12	at	at	IN	_	10	MNR
13	a	a	DT	_	14	NMOD
14	wavelength	wavelength	NN	_	12	PMOD
15	of	of	IN	_	14	NMOD
16	405	0	CD	_	17	NMOD
17	nm	nm	NNS	_	15	PMOD
18	according	accord	VBG	_	10	MNR
19	to	to	IN	_	18	PMOD
20	the	the	DT	_	23	NMOD
21	Ellmann	ellmann	NNP	_	23	NMOD
22	'	'	POS	_	23	NMOD
23	method	method	NN	_	19	PMOD
24	[	[	-LRB-	_	25	P
25	25	0	CD	_	10	PRN
26	]	]	-RRB-	_	25	P
27	.	.	.	_	3	P

1	Determination	determination	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	5	NMOD
4	osmotic	osmotic	JJ	_	5	NMOD
5	resistance	resistance	NN	_	2	PMOD
6	of	of	IN	_	5	NMOD
7	red	red	JJ	_	9	NMOD
8	blood	blood	NN	_	9	NMOD
9	cells	cell	NNS	_	6	PMOD

1	A	a	DT	_	7	NMOD
2	Na2HPO4	na0hpo0	NN	_	4	NMOD
3	/	/	HYPH	_	2	P
4	NaH2PO4	nah0po0	NN	_	5	AMOD
5	buffered	buffer	VBN	_	7	NMOD
6	NaCl	nacl	NN	_	7	NMOD
7	gradient	gradient	NN	_	9	NMOD
8	(	(	-LRB-	_	9	P
9	pH	ph	NN	_	18	SBJ
10	7.4	0	CD	_	9	NMOD
11	)	)	-RRB-	_	9	P
12	comprised	comprise	VBN	_	9	NMOD
13	of	of	IN	_	12	ADV
14	the	the	DT	_	17	NMOD
15	following	follow	VBG	_	17	NMOD
16	NaCl	nacl	NN	_	17	NMOD
17	steps	step	NNS	_	13	PMOD
18	was	be	VBD	_	0	ROOT
19	used	use	VBN	_	18	VC
20	for	for	IN	_	19	PRP
21	this	this	DT	_	22	NMOD
22	assay	assay	NN	_	20	PMOD
23	:	:	:	_	19	P
24	0.90	0	CD	_	25	NMOD
25	%	%	NN	_	17	NMOD
26	,	,	,	_	25	P
27	0.65	0	CD	_	28	NMOD
28	%	%	NN	_	25	APPO
29	,	,	,	_	28	P
30	0.60	0	CD	_	31	NMOD
31	%	%	NN	_	28	APPO
32	,	,	,	_	31	P
33	0.55	0	CD	_	34	NMOD
34	%	%	NN	_	31	APPO
35	,	,	,	_	34	P
36	0.50	0	CD	_	37	NMOD
37	%	%	NN	_	34	APPO
38	,	,	,	_	37	P
39	0.45	0	CD	_	40	NMOD
40	%	%	NN	_	37	APPO
41	,	,	,	_	40	P
42	0.40	0	CD	_	43	NMOD
43	%	%	NN	_	40	APPO
44	,	,	,	_	43	P
45	0.35	0	CD	_	46	NMOD
46	%	%	NN	_	43	APPO
47	,	,	,	_	46	P
48	0.30	0	CD	_	49	NMOD
49	%	%	NN	_	46	APPO
50	,	,	,	_	49	P
51	0.10	0	CD	_	52	NMOD
52	%	%	NN	_	49	APPO
53	.	.	.	_	18	P

1	For	for	IN	_	16	ADV
2	each	each	DT	_	3	NMOD
3	step	step	NN	_	1	PMOD
4	5	0	CD	_	5	NMOD
5	ml	ml	NNS	_	16	SBJ
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	10	NMOD
8	gradient	gradient	NN	_	10	NMOD
9	step	step	NN	_	10	NMOD
10	solution	solution	NN	_	6	PMOD
11	and	and	CC	_	5	COORD
12	50	0	CD	_	13	NMOD
13	μl	μl	NN	_	15	NMOD
14	blood	blood	NN	_	15	NMOD
15	sample	sample	NN	_	11	CONJ
16	were	be	VBD	_	0	ROOT
17	carefully	carefully	RB	_	16	ADV
18	inverted	invert	VBN	_	16	VC
19	four	four	CD	_	20	NMOD
20	times	time	NNS	_	18	TMP
21	and	and	CC	_	18	COORD
22	incubated	incubate	VBN	_	21	CONJ
23	for	for	IN	_	22	TMP
24	30	0	CD	_	25	NMOD
25	minutes	minute	NNS	_	23	PMOD
26	in	in	IN	_	22	ADV
27	the	the	DT	_	28	NMOD
28	dark	dark	NN	_	26	PMOD
29	.	.	.	_	16	P

1	Samples	sample	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	carefully	carefully	RB	_	2	ADV
4	inverted	invert	VBN	_	2	VC
5	again	again	RB	_	4	TMP
6	and	and	CC	_	4	COORD
7	centrifuged	centrifuge	VBN	_	6	CONJ
8	at	at	IN	_	7	ADV
9	1,500	0	CD	_	11	NMOD
10	×	×	SYM	_	11	P
11	g	g	NN	_	8	PMOD
12	for	for	IN	_	7	TMP
13	10	0	CD	_	14	NMOD
14	minutes	minute	NNS	_	12	PMOD
15	.	.	.	_	2	P

1	From	from	IN	_	14	ADV
2	1	0	CD	_	3	NMOD
3	ml	ml	NN	_	4	NMOD
4	supernatant	supernatant	NN	_	1	PMOD
5	of	of	IN	_	4	NMOD
6	each	each	DT	_	7	NMOD
7	step	step	NN	_	5	PMOD
8	the	the	DT	_	9	NMOD
9	extinction	extinction	NN	_	14	SBJ
10	at	at	IN	_	9	NMOD
11	546	0	CD	_	12	NMOD
12	nm	nm	NN	_	13	NMOD
13	wavelength	wavelength	NN	_	10	PMOD
14	was	be	VBD	_	0	ROOT
15	measured	measure	VBN	_	14	VC
16	.	.	.	_	14	P

1	The	the	DT	_	2	NMOD
2	experiment	experiment	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	performed	perform	VBN	_	3	VC
5	at	at	IN	_	4	ADV
6	room	room	NN	_	7	NMOD
7	temperature	temperature	NN	_	5	PMOD
8	.	.	.	_	3	P

1	Platelet	platelet	NN	_	2	NMOD
2	aggregation	aggregation	NN	_	3	NMOD
3	assay	assay	NN	_	0	ROOT

1	Approximately	approximately	RB	_	2	QMOD
2	500	0	CD	_	3	NMOD
3	μl	μl	NNS	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	murine	murine	JJ	_	6	NMOD
6	blood	blood	NN	_	4	PMOD
7	were	be	VBD	_	0	ROOT
8	centrifuged	centrifuge	VBN	_	7	VC
9	at	at	IN	_	8	ADV
10	200	0	CD	_	12	NMOD
11	×	×	SYM	_	12	P
12	g	g	NN	_	9	PMOD
13	for	for	IN	_	8	TMP
14	15	0	CD	_	15	NMOD
15	minutes	minute	NNS	_	13	PMOD
16	.	.	.	_	7	P

1	The	the	DT	_	3	NMOD
2	resulting	result	VBG	_	3	NMOD
3	supernatants	supernatant	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	transferred	transfer	VBN	_	4	VC
6	to	to	IN	_	5	ADV
7	new	new	JJ	_	8	NMOD
8	tubes	tube	NNS	_	6	PMOD
9	and	and	CC	_	5	COORD
10	used	use	VBN	_	9	CONJ
11	as	as	IN	_	10	MNR
12	platelet	platelet	NN	_	13	AMOD
13	rich	rich	JJ	_	14	NMOD
14	plasma	plasma	NN	_	16	NMOD
15	(	(	-LRB-	_	16	P
16	PRP	prp	NN	_	11	PMOD
17	)	)	-RRB-	_	4	P
18	.	.	.	_	4	P

1	The	the	DT	_	4	NMOD
2	platelet	platelet	NN	_	3	NMOD
3	aggregation	aggregation	NN	_	4	NMOD
4	measurements	measurement	NNS	_	5	SBJ
5	were	be	VBD	_	0	ROOT
6	done	do	VBN	_	5	VC
7	according	accord	VBG	_	6	MNR
8	to	to	IN	_	7	PMOD
9	the	the	DT	_	10	NMOD
10	method	method	NN	_	8	PMOD
11	developed	develop	VBN	_	10	NMOD
12	by	by	IN	_	11	LGS
13	Born	born	NNP	_	12	PMOD
14	and	and	CC	_	13	COORD
15	Cross	cross	NNP	_	14	CONJ
16	[	[	-LRB-	_	17	P
17	26	0	CD	_	13	PRN
18	]	]	-RRB-	_	17	P
19	using	use	VBG	_	6	ADV
20	an	an	DT	_	22	NMOD
21	APACT	apact	NN	_	22	NMOD
22	photometer	photometer	NN	_	19	OBJ
23	(	(	-LRB-	_	28	P
24	Labor	labor	NN	_	28	DEP
25	,	,	,	_	28	P
26	Ahrendsburg	ahrendsburg	NN	_	28	DEP
27	,	,	,	_	28	P
28	FRG	frg	NN	_	22	PRN
29	)	)	-RRB-	_	28	P
30	and	and	CC	_	22	COORD
31	the	the	DT	_	33	NMOD
32	APACT	apact	NN	_	33	NMOD
33	software	software	NN	_	30	CONJ
34	(	(	-LRB-	_	35	P
35	APACT	apact	NN	_	33	PRN
36	1.4	0	CD	_	35	NMOD
37	)	)	-RRB-	_	35	P
38	.	.	.	_	5	P

1	Subsequently	subsequently	RB	_	6	TMP
2	samples	sample	NNS	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	PRP	prp	NN	_	3	PMOD
6	were	be	VBD	_	0	ROOT
7	adjusted	adjust	VBN	_	6	VC
8	with	with	IN	_	7	ADV
9	buffer	buffer	NN	_	8	PMOD
10	(	(	-LRB-	_	19	P
11	5	0	CD	_	12	NMOD
12	mM	mm	NN	_	13	NMOD
13	Hepes	hepes	NN	_	19	DEP
14	,	,	,	_	19	P
15	150	0	CD	_	16	NMOD
16	mM	mm	NN	_	17	NMOD
17	NaCl	nacl	NN	_	19	DEP
18	,	,	,	_	19	P
19	pH	ph	NN	_	9	PRN
20	7.3	0	CD	_	19	NMOD
21	)	)	-RRB-	_	19	P
22	to	to	IN	_	7	ADV
23	250,000	0	CD	_	24	NMOD
24	platelets	platelet	NNS	_	22	PMOD
25	/	/	SYM	_	26	P
26	μl	μl	NN	_	24	NMOD
27	.	.	.	_	6	P

1	A	a	DT	_	4	NMOD
2	constant	constant	JJ	_	4	NMOD
3	platelet	platelet	NN	_	4	NMOD
4	count	count	NN	_	5	SBJ
5	was	be	VBD	_	0	ROOT
6	used	use	VBN	_	5	VC
7	throughout	throughout	RB	_	6	ADV
8	allowing	allow	VBG	_	6	ADV
9	comparisons	comparison	NNS	_	8	OBJ
10	between	between	IN	_	9	NMOD
11	wild	wild	JJ	_	12	NMOD
12	type	type	NN	_	19	NMOD
13	and	and	CC	_	12	COORD
14	knock	knock	NN	_	15	NMOD
15	out	out	NN	_	13	CONJ
16	murine	murine	JJ	_	19	NMOD
17	and	and	CC	_	16	COORD
18	human	human	JJ	_	17	CONJ
19	samples	sample	NNS	_	10	PMOD
20	.	.	.	_	5	P

1	250	0	CD	_	2	NMOD
2	μl	μl	NN	_	4	NMOD
3	adjusted	adjust	VBN	_	4	NMOD
4	platelets	platelet	NNS	_	5	SBJ
5	were	be	VBD	_	0	ROOT
6	prewarmed	prewarmed	VBN	_	5	VC
7	to	to	IN	_	6	ADV
8	37°C	0°c	NN	_	7	PMOD
9	and	and	CC	_	6	COORD
10	used	use	VBN	_	9	CONJ
11	in	in	IN	_	10	ADV
12	the	the	DT	_	13	NMOD
13	assay	assay	NN	_	11	PMOD
14	,	,	,	_	5	P
15	and	and	CC	_	5	COORD
16	the	the	DT	_	18	NMOD
17	aggregation	aggregation	NN	_	18	NMOD
18	process	process	NN	_	19	SBJ
19	was	be	VBD	_	15	CONJ
20	started	start	VBN	_	19	VC
21	by	by	IN	_	20	MNR
22	adding	add	VBG	_	21	PMOD
23	25	0	CD	_	24	NMOD
24	μl	μl	NN	_	22	OBJ
25	of	of	IN	_	24	NMOD
26	a	a	DT	_	33	NMOD
27	prewarmed	prewarmed	JJ	_	33	NMOD
28	16.5	0	CD	_	29	NMOD
29	mg	mg	NN	_	33	NMOD
30	/	/	SYM	_	31	P
31	ml	ml	NN	_	29	NMOD
32	ristocetin	ristocetin	NN	_	33	NMOD
33	solution	solution	NN	_	25	PMOD
34	(	(	-LRB-	_	42	P
35	DiaMed	diamed	NNP	_	36	NMOD
36	Diagnostica	diagnostica	NNP	_	42	DEP
37	,	,	,	_	42	P
38	Bensheim	bensheim	NNP	_	42	DEP
39	,	,	,	_	42	P
40	FRG	frg	NNP	_	42	DEP
41	;	;	:	_	42	P
42	concentration	concentration	NN	_	33	PRN
43	in	in	IN	_	42	NMOD
44	the	the	DT	_	45	NMOD
45	assay	assay	NN	_	43	PMOD
46	:	:	:	_	42	P
47	1.5	0	CD	_	48	NMOD
48	mg	mg	NNS	_	42	DEP
49	/	/	SYM	_	50	P
50	ml	ml	NN	_	48	NMOD
51	)	)	-RRB-	_	42	P
52	,	,	,	_	33	P
53	a	a	DT	_	54	NMOD
54	reagent	reagent	NN	_	33	APPO
55	which	which	WDT	_	56	SBJ
56	worked	work	VBD	_	54	NMOD
57	reliably	reliably	RB	_	56	ADV
58	in	in	IN	_	56	ADV
59	our	our	PRP$	_	60	NMOD
60	hands	hand	NNS	_	58	PMOD
61	with	with	IN	_	56	ADV
62	mouse	mouse	NN	_	65	NMOD
63	and	and	CC	_	62	COORD
64	human	human	JJ	_	63	CONJ
65	platelets	platelet	NNS	_	61	PMOD
66	.	.	.	_	5	P

1	Each	each	DT	_	3	NMOD
2	murine	murine	JJ	_	3	NMOD
3	assay	assay	NN	_	4	SBJ
4	represents	represent	VBZ	_	0	ROOT
5	a	a	DT	_	7	NMOD
6	different	different	JJ	_	7	NMOD
7	animal	animal	NN	_	4	OBJ
8	.	.	.	_	4	P

1	Analyses	analysis	NNS	_	6	SBJ
2	of	of	IN	_	1	NMOD
3	human	human	JJ	_	5	NMOD
4	blood	blood	NN	_	5	NMOD
5	samples	sample	NNS	_	2	PMOD
6	were	be	VBD	_	0	ROOT
7	performed	perform	VBN	_	6	VC
8	as	as	IN	_	7	ADV
9	described	describe	VBN	_	8	SUB
10	in	in	IN	_	9	ADV
11	the	the	DT	_	12	NMOD
12	manufacturer	manufacturer	NN	_	14	NMOD
13	's	's	POS	_	12	NMOD
14	protocol	protocol	NN	_	10	PMOD
15	.	.	.	_	6	P

1	Several	several	JJ	_	3	NMOD
2	repeated	repeated	JJ	_	3	NMOD
3	measurements	measurement	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	done	do	VBN	_	4	VC
6	per	per	IN	_	5	ADV
7	human	human	JJ	_	8	NMOD
8	individual	individual	NN	_	6	PMOD
9	to	to	TO	_	5	PRP
10	control	control	VB	_	9	IM
11	the	the	DT	_	12	NMOD
12	reproducibility	reproducibility	NN	_	10	OBJ
13	.	.	.	_	4	P

1	The	the	DT	_	5	NMOD
2	acquired	acquire	VBN	_	5	NMOD
3	aggregation	aggregation	NN	_	4	NMOD
4	curve	curve	NN	_	5	NMOD
5	data	datum	NNS	_	14	SBJ
6	,	,	,	_	5	P
7	measured	measure	VBN	_	5	NMOD
8	as	as	IN	_	7	MNR
9	ascending	ascend	VBG	_	10	NMOD
10	degree	degree	NN	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	transmission	transmission	NN	_	11	PMOD
13	,	,	,	_	14	P
14	were	be	VBD	_	0	ROOT
15	analysed	analyse	VBN	_	14	VC
16	for	for	IN	_	15	PRP
17	maximal	maximal	JJ	_	19	NMOD
18	slope	slope	NN	_	19	NMOD
19	values	value	NNS	_	16	PMOD
20	,	,	,	_	15	P
21	while	while	IN	_	30	DEP
22	the	the	DT	_	25	NMOD
23	maximal	maximal	JJ	_	25	NMOD
24	aggregation	aggregation	NN	_	25	NMOD
25	amplitude	amplitude	NN	_	30	SBJ
26	of	of	IN	_	25	NMOD
27	every	every	DT	_	29	NMOD
28	single	single	JJ	_	29	NMOD
29	curve	curve	NN	_	26	PMOD
30	was	be	VBD	_	15	ADV
31	set	set	VBN	_	30	VC
32	to	to	IN	_	31	ADV
33	100	0	CD	_	34	NMOD
34	%	%	NN	_	32	PMOD
35	.	.	.	_	14	P

1	In	in	IN	_	7	ADV
2	general	general	JJ	_	1	PMOD
3	,	,	,	_	7	P
4	all	all	DT	_	6	NMOD
5	platelet	platelet	NN	_	6	NMOD
6	procedures	procedure	NNS	_	7	SBJ
7	were	be	VBD	_	0	ROOT
8	done	do	VBN	_	7	VC
9	at	at	IN	_	8	ADV
10	22°C	0°c	NN	_	9	PMOD
11	within	within	IN	_	8	TMP
12	four	four	CD	_	13	NMOD
13	hours	hour	NNS	_	11	PMOD
14	after	after	IN	_	13	TMP
15	collecting	collect	VBG	_	14	PMOD
16	the	the	DT	_	18	NMOD
17	blood	blood	NN	_	18	NMOD
18	sample	sample	NN	_	15	OBJ
19	.	.	.	_	7	P

1	Miscellaneous	miscellaneous	JJ	_	2	NMOD
2	methods	method	NNS	_	0	ROOT

1	For	for	IN	_	19	PRP
2	standard	standard	JJ	_	4	NMOD
3	haematopoetic	haematopoetic	JJ	_	4	NMOD
4	measurements	measurement	NNS	_	1	PMOD
5	and	and	CC	_	4	COORD
6	cell	cell	NN	_	7	NMOD
7	counts	count	NNS	_	5	CONJ
8	on	on	IN	_	4	NMOD
9	murine	murine	JJ	_	13	NMOD
10	and	and	CC	_	9	COORD
11	human	human	JJ	_	10	CONJ
12	blood	blood	NN	_	13	NMOD
13	samples	sample	NNS	_	8	PMOD
14	about	about	IN	_	15	QMOD
15	300	0	CD	_	16	NMOD
16	μl	μl	NNS	_	19	SBJ
17	of	of	IN	_	16	NMOD
18	blood	blood	NN	_	17	PMOD
19	were	be	VBD	_	0	ROOT
20	analysed	analyse	VBN	_	19	VC
21	with	with	IN	_	20	ADV
22	an	an	DT	_	27	NMOD
23	ADVIA	advia	NN	_	27	NMOD
24	120	0	CD	_	23	NMOD
25	electronic	electronic	JJ	_	27	NMOD
26	cell	cell	NN	_	27	NMOD
27	counter	counter	NN	_	21	PMOD
28	(	(	-LRB-	_	29	P
29	Bayer	bayer	NN	_	27	PRN
30	)	)	-RRB-	_	29	P
31	.	.	.	_	19	P

1	With	with	IN	_	9	ADV
2	this	this	DT	_	3	NMOD
3	equipment	equipment	NN	_	1	PMOD
4	red	red	JJ	_	6	NMOD
5	blood	blood	NN	_	6	NMOD
6	cells	cell	NNS	_	9	SBJ
7	and	and	CC	_	6	COORD
8	platelets	platelet	NNS	_	7	CONJ
9	are	be	VBP	_	0	ROOT
10	``	``	``	_	9	P
11	transformed	transform	VBN	_	9	VC
12	''	''	''	_	11	P
13	into	into	IN	_	11	ADV
14	spherical	spherical	JJ	_	15	NMOD
15	bodies	body	NNS	_	13	PMOD
16	without	without	IN	_	11	MNR
17	changing	change	VBG	_	16	PMOD
18	their	their	PRP$	_	19	NMOD
19	volume	volume	NN	_	17	OBJ
20	.	.	.	_	9	P

1	Therefore	therefore	RB	_	11	ADV
2	number	number	NN	_	11	SBJ
3	and	and	CC	_	2	COORD
4	volume	volume	NN	_	3	CONJ
5	of	of	IN	_	2	NMOD
6	red	red	JJ	_	8	NMOD
7	blood	blood	NN	_	8	NMOD
8	cells	cell	NNS	_	5	PMOD
9	and	and	CC	_	8	COORD
10	platelets	platelet	NNS	_	9	CONJ
11	are	be	VBP	_	0	ROOT
12	not	not	RB	_	11	ADV
13	calculated	calculate	VBN	_	14	NMOD
14	values	value	NNS	_	11	PRD
15	,	,	,	_	11	P
16	but	but	CC	_	11	COORD
17	directly	directly	RB	_	18	AMOD
18	measured	measure	VBN	_	19	NMOD
19	values	value	NNS	_	16	GAP-PRD
20	.	.	.	_	11	P

1	The	the	DT	_	3	NMOD
2	following	follow	VBG	_	3	NMOD
3	data	datum	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	statistically	statistically	RB	_	4	MNR
6	analysed	analyse	VBN	_	4	VC
7	:	:	:	_	6	P
8	leucocytes	leucocyte	NNS	_	3	NMOD
9	,	,	,	_	8	P
10	red	red	JJ	_	12	NMOD
11	blood	blood	NN	_	12	NMOD
12	cells	cell	NNS	_	8	APPO
13	,	,	,	_	12	P
14	haemoglobin	haemoglobin	NN	_	12	APPO
15	,	,	,	_	14	P
16	haematocrit	haematocrit	NN	_	14	APPO
17	,	,	,	_	16	P
18	mean	mean	JJ	_	20	NMOD
19	cellular	cellular	JJ	_	20	NMOD
20	volume	volume	NN	_	16	APPO
21	,	,	,	_	20	P
22	mean	mean	JJ	_	24	NMOD
23	cellular	cellular	JJ	_	24	NMOD
24	haemoglobin	haemoglobin	NN	_	20	APPO
25	,	,	,	_	24	P
26	mean	mean	JJ	_	28	NMOD
27	cellular	cellular	JJ	_	28	NMOD
28	haemoglobin	haemoglobin	NN	_	29	NMOD
29	concentration	concentration	NN	_	24	APPO
30	,	,	,	_	29	P
31	platelet	platelet	NN	_	32	NMOD
32	number	number	NN	_	29	APPO
33	,	,	,	_	32	P
34	neutrophiles	neutrophile	NNS	_	32	APPO
35	,	,	,	_	34	P
36	lymphocytes	lymphocyte	NNS	_	34	APPO
37	,	,	,	_	36	P
38	monocytes	monocyte	NNS	_	36	APPO
39	,	,	,	_	38	P
40	eosinophiles	eosinophile	NNS	_	38	APPO
41	,	,	,	_	40	P
42	basophiles	basophile	NNS	_	40	APPO
43	.	.	.	_	4	P

1	Peptide	peptide	NN	_	2	NMOD
2	mass	mass	NN	_	3	NMOD
3	fingerprinting	fingerprinting	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	performed	perform	VBN	_	4	VC
6	on	on	IN	_	5	ADV
7	a	a	DT	_	15	NMOD
8	Bruker	bruker	NNP	_	9	NMOD
9	Reflex	reflex	NNP	_	15	NMOD
10	IV	iv	CD	_	9	NMOD
11	MALDI	maldi	NN	_	13	NMOD
12	-	-	HYPH	_	11	P
13	TOF	tof	NN	_	15	NMOD
14	mass	mass	NN	_	15	NMOD
15	spectrometer	spectrometer	NN	_	6	PMOD
16	.	.	.	_	4	P

1	Recombinant	recombinant	JJ	_	3	NMOD
2	annexin	annexin	NN	_	3	NMOD
3	A7	a0	NN	_	4	SBJ
4	was	be	VBD	_	21	DEP
5	purified	purify	VBN	_	4	VC
6	according	accord	VBG	_	5	MNR
7	to	to	IN	_	6	PMOD
8	[	[	-LRB-	_	7	P
9	27	0	CD	_	7	PMOD
10	]	]	-RRB-	_	21	P
11	,	,	,	_	21	P
12	F	f	NN	_	14	NMOD
13	-	-	HYPH	_	12	P
14	actin	actin	NN	_	21	SBJ
15	-	-	HYPH	_	14	P
16	binding	bind	VBG	_	14	NMOD
17	of	of	IN	_	14	NMOD
18	recombinant	recombinant	JJ	_	20	NMOD
19	annexin	annexin	NN	_	20	NMOD
20	A7	a0	NN	_	17	PMOD
21	was	be	VBD	_	0	ROOT
22	done	do	VBN	_	21	VC
23	as	as	IN	_	22	ADV
24	described	describe	VBN	_	23	SUB
25	[	[	-LRB-	_	26	P
26	28	0	CD	_	22	PRN
27	]	]	-RRB-	_	26	P
28	.	.	.	_	21	P

1	SDS	sd	NN	_	3	NMOD
2	-	-	HYPH	_	1	P
3	PAGE	page	NN	_	7	SBJ
4	and	and	CC	_	3	COORD
5	western	western	JJ	_	6	NMOD
6	blotting	blotting	NN	_	4	CONJ
7	were	be	VBD	_	0	ROOT
8	done	do	VBN	_	7	VC
9	as	as	IN	_	8	ADV
10	described	describe	VBN	_	9	SUB
11	[	[	-LRB-	_	14	P
12	29	0	CD	_	14	NMOD
13	,	,	,	_	14	P
14	30	0	CD	_	8	PRN
15	]	]	-RRB-	_	14	P
16	.	.	.	_	7	P

1	Detection	detection	NN	_	4	SBJ
2	in	in	IN	_	1	NMOD
3	immunoblots	immunoblots	NNS	_	2	PMOD
4	was	be	VBD	_	0	ROOT
5	with	with	IN	_	4	PRD
6	enhanced	enhance	VBN	_	7	NMOD
7	chemiluminescence	chemiluminescence	NN	_	5	PMOD
8	[	[	-LRB-	_	9	P
9	17	0	CD	_	4	PRN
10	]	]	-RRB-	_	9	P
11	.	.	.	_	4	P

1	Antibodies	antibody	NNS	_	3	SBJ
2	employed	employ	VBN	_	1	NMOD
3	were	be	VBD	_	0	ROOT
4	mab	mab	NN	_	5	NMOD
5	203	0	CD	_	3	PRD
6	–	–	SYM	_	7	P
7	217	0	CD	_	5	NMOD
8	directed	direct	VBN	_	5	NMOD
9	against	against	IN	_	8	ADV
10	mouse	mouse	NN	_	14	NMOD
11	annexin	annexin	NN	_	12	NMOD
12	A7	a0	NN	_	14	NMOD
13	core	core	NN	_	14	NMOD
14	domain	domain	NN	_	9	PMOD
15	[	[	-LRB-	_	16	P
16	5	0	CD	_	14	PRN
17	]	]	-RRB-	_	16	P
18	and	and	CC	_	14	COORD
19	a	a	DT	_	23	NMOD
20	polyclonal	polyclonal	JJ	_	23	NMOD
21	rabbit	rabbit	NN	_	23	NMOD
22	anti-sorcin	anti-sorcin	JJ	_	23	NMOD
23	antibody	antibody	NN	_	18	CONJ
24	[	[	-LRB-	_	25	P
25	31	0	CD	_	23	PRN
26	]	]	-RRB-	_	25	P
27	.	.	.	_	3	P

1	For	for	IN	_	7	PRP
2	statistical	statistical	JJ	_	3	NMOD
3	analyses	analysis	NNS	_	1	PMOD
4	the	the	DT	_	6	NMOD
5	following	follow	VBG	_	6	NMOD
6	tests	test	NNS	_	7	SBJ
7	were	be	VBD	_	0	ROOT
8	performed	perform	VBN	_	7	VC
9	:	:	:	_	8	P
10	David	david	NNP	_	14	NMOD
11	et	et	FW	_	12	AMOD
12	al.	al.	FW	_	10	NMOD
13	range	range	NN	_	14	NMOD
14	test	test	NN	_	6	NMOD
15	to	to	TO	_	14	NMOD
16	ensure	ensure	VB	_	15	IM
17	samples	sample	NNS	_	18	SBJ
18	are	be	VBP	_	16	OBJ
19	from	from	IN	_	18	PRD
20	a	a	DT	_	22	NMOD
21	normal	normal	JJ	_	22	NMOD
22	distribution	distribution	NN	_	19	PMOD
23	,	,	,	_	14	P
24	F	f	NN	_	26	NMOD
25	-	-	HYPH	_	24	P
26	test	test	NN	_	14	APPO
27	looking	look	VBG	_	26	NMOD
28	for	for	IN	_	27	ADV
29	a	a	DT	_	30	NMOD
30	samples	sample	NNS	_	32	NMOD
31	'	'	POS	_	30	NMOD
32	homoscedascity	homoscedascity	NN	_	28	PMOD
33	,	,	,	_	26	P
34	Student	student	NN	_	38	NMOD
35	's	's	POS	_	34	NMOD
36	T	t	NN	_	38	NMOD
37	-	-	HYPH	_	36	P
38	test	test	NN	_	26	APPO
39	to	to	TO	_	38	NMOD
40	judge	judge	VB	_	39	IM
41	if	if	IN	_	40	OBJ
42	samples	sample	NNS	_	46	SBJ
43	of	of	IN	_	42	NMOD
44	different	different	JJ	_	45	NMOD
45	groups	group	NNS	_	43	PMOD
46	have	have	VBP	_	41	SUB
47	a	a	DT	_	50	NMOD
48	different	different	JJ	_	50	NMOD
49	mean	mean	JJ	_	50	NMOD
50	value	value	NN	_	46	OBJ
51	and	and	CC	_	46	COORD
52	are	be	VBP	_	51	CONJ
53	parts	part	NNS	_	52	PRD
54	from	from	IN	_	52	ADV
55	different	different	JJ	_	57	NMOD
56	normal	normal	JJ	_	57	NMOD
57	distributions	distribution	NNS	_	54	PMOD
58	.	.	.	_	7	P

1	The	the	DT	_	4	NMOD
2	exact	exact	JJ	_	4	NMOD
3	probability	probability	NN	_	4	NMOD
4	values	value	NNS	_	11	SBJ
5	and	and	CC	_	4	COORD
6	the	the	DT	_	7	NMOD
7	significance	significance	NN	_	5	CONJ
8	of	of	IN	_	7	NMOD
9	an	an	DT	_	10	NMOD
10	analysis	analysis	NN	_	8	PMOD
11	are	be	VBP	_	0	ROOT
12	indicated	indicate	VBN	_	11	VC
13	when	when	WRB	_	17	TMP
14	the	the	DT	_	15	NMOD
15	experiments	experiment	NNS	_	16	SBJ
16	are	be	VBP	_	12	ADV
17	described	describe	VBN	_	16	VC
18	.	.	.	_	11	P

1	Authors	author	NNS	_	3	NMOD
2	'	'	POS	_	1	NMOD
3	contributions	contribution	NNS	_	0	ROOT

1	CH	ch	NN	_	4	SBJ
2	and	and	CC	_	1	COORD
3	CSC	csc	NN	_	2	CONJ
4	planned	plan	VBD	_	85	DEP
5	and	and	CC	_	4	COORD
6	carried	carry	VBD	_	5	CONJ
7	out	out	RP	_	6	PRT
8	the	the	DT	_	9	NMOD
9	experiments	experiment	NNS	_	6	OBJ
10	with	with	IN	_	9	NMOD
11	the	the	DT	_	14	NMOD
12	red	red	JJ	_	14	NMOD
13	blood	blood	NN	_	14	NMOD
14	cells	cell	NNS	_	10	PMOD
15	and	and	CC	_	14	COORD
16	platelets	platelet	NNS	_	15	CONJ
17	and	and	CC	_	9	COORD
18	the	the	DT	_	20	NMOD
19	fractionation	fractionation	NN	_	20	NMOD
20	studies	study	NNS	_	17	CONJ
21	and	and	CC	_	4	COORD
22	drafted	draft	VBD	_	21	CONJ
23	the	the	DT	_	24	NMOD
24	manuscript	manuscript	NN	_	22	OBJ
25	,	,	,	_	85	P
26	GL	gl	NN	_	27	SBJ
27	was	be	VBD	_	85	DEP
28	responsible	responsible	JJ	_	27	PRD
29	for	for	IN	_	28	AMOD
30	platelets	platelet	NNS	_	29	PMOD
31	,	,	,	_	85	P
32	RK	rk	NN	_	33	SBJ
33	gave	give	VBD	_	85	DEP
34	support	support	NN	_	33	OBJ
35	on	on	IN	_	33	ADV
36	the	the	DT	_	40	NMOD
37	ADVIA	advia	NN	_	40	NMOD
38	120	0	CD	_	37	NMOD
39	cell	cell	NN	_	40	NMOD
40	counter	counter	NN	_	35	PMOD
41	,	,	,	_	33	P
42	evaluated	evaluate	VBD	_	33	VC
43	and	and	CC	_	42	COORD
44	discussed	discuss	VBD	_	43	CONJ
45	the	the	DT	_	46	NMOD
46	results	result	NNS	_	42	OBJ
47	,	,	,	_	85	P
48	SMP	smp	NN	_	51	SBJ
49	and	and	CC	_	48	COORD
50	BSG	bsg	NN	_	49	CONJ
51	gave	give	VBD	_	85	DEP
52	support	support	NN	_	51	OBJ
53	on	on	IN	_	51	ADV
54	the	the	DT	_	56	NMOD
55	APACT	apact	NN	_	56	NMOD
56	system	system	NN	_	53	PMOD
57	,	,	,	_	56	P
58	platelet	platelet	NN	_	59	NMOD
59	aggregation	aggregation	NN	_	60	NMOD
60	experiments	experiment	NNS	_	56	APPO
61	,	,	,	_	51	P
62	and	and	CC	_	51	COORD
63	evaluated	evaluate	VBD	_	62	CONJ
64	the	the	DT	_	65	NMOD
65	results	result	NNS	_	63	OBJ
66	,	,	,	_	85	P
67	CZ	cz	NN	_	68	SBJ
68	was	be	VBD	_	85	DEP
69	responsible	responsible	JJ	_	68	PRD
70	for	for	IN	_	69	AMOD
71	the	the	DT	_	73	NMOD
72	sorcin	sorcin	NN	_	73	NMOD
73	studies	study	NNS	_	70	PMOD
74	,	,	,	_	85	P
75	MS	m	NN	_	76	SBJ
76	studied	study	VBD	_	85	DEP
77	the	the	DT	_	79	NMOD
78	cytoskeletal	cytoskeletal	JJ	_	79	NMOD
79	activities	activity	NNS	_	76	OBJ
80	of	of	IN	_	79	NMOD
81	the	the	DT	_	82	NMOD
82	protein	protein	NN	_	80	PMOD
83	,	,	,	_	85	P
84	AAN	aan	NN	_	85	SBJ
85	conceived	conceive	VBD	_	0	ROOT
86	of	of	IN	_	85	ADV
87	the	the	DT	_	88	NMOD
88	studies	study	NNS	_	86	PMOD
89	and	and	CC	_	85	COORD
90	participated	participate	VBD	_	89	CONJ
91	in	in	IN	_	90	ADV
92	its	its	PRP$	_	93	NMOD
93	design	design	NN	_	91	PMOD
94	.	.	.	_	85	P

1	All	all	DT	_	2	NMOD
2	authors	author	NNS	_	3	SBJ
3	read	read	VBD	_	0	ROOT
4	and	and	CC	_	3	COORD
5	approved	approve	VBD	_	4	CONJ
6	the	the	DT	_	7	NMOD
7	manuscript	manuscript	NN	_	3	OBJ
8	.	.	.	_	3	P

1	Acknowledgements	acknowledgement	NNS	_	0	ROOT

1	We	we	PRP	_	2	SBJ
2	would	would	MD	_	0	ROOT
3	like	like	VB	_	2	VC
4	to	to	TO	_	3	OPRD
5	thank	thank	VB	_	4	IM
6	M.	m.	NNP	_	7	NMOD
7	Heil	heil	NN	_	5	OBJ
8	,	,	,	_	7	P
9	B.	b.	NNP	_	10	NMOD
10	Hoffmann	hoffmann	NN	_	7	CONJ
11	and	and	CC	_	10	COORD
12	R.	r.	NNP	_	13	NMOD
13	Merkel	merkel	NNP	_	11	CONJ
14	for	for	IN	_	5	ADV
15	the	the	DT	_	17	NMOD
16	biophysical	biophysical	JJ	_	17	NMOD
17	experiments	experiment	NNS	_	14	PMOD
18	,	,	,	_	5	P
19	L.	l.	NNP	_	20	NMOD
20	Eichinger	eichinger	NNP	_	5	GAP
21	for	for	IN	_	20	ADV
22	discussion	discussion	NN	_	21	PMOD
23	,	,	,	_	20	P
24	B.	b.	NNP	_	20	GAP
25	Gassen	gassen	VBN	_	24	NMOD
26	for	for	IN	_	24	ADV
27	expert	expert	JJ	_	29	NMOD
28	technical	technical	JJ	_	29	NMOD
29	assistance	assistance	NN	_	26	PMOD
30	and	and	CC	_	24	COORD
31	R.	r.	NNP	_	32	NMOD
32	Müller	müller	NN	_	30	GAP
33	for	for	IN	_	32	ADV
34	protein	protein	NN	_	35	NMOD
35	purification	purification	NN	_	33	PMOD
36	.	.	.	_	2	P

1	Mass	mass	NNP	_	3	NMOD
2	spectrometric	spectrometric	JJ	_	3	NMOD
3	analysis	analysis	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	performed	perform	VBN	_	4	VC
6	in	in	IN	_	5	LOC
7	the	the	DT	_	10	NMOD
8	central	central	JJ	_	10	NMOD
9	service	service	NN	_	10	NMOD
10	facilities	facility	NNS	_	6	PMOD
11	of	of	IN	_	10	NMOD
12	the	the	DT	_	13	NMOD
13	ZMMK	zmmk	NN	_	11	PMOD
14	.	.	.	_	4	P

1	This	this	DT	_	2	NMOD
2	worked	worked	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	supported	support	VBN	_	3	VC
5	by	by	IN	_	4	LGS
6	a	a	DT	_	7	NMOD
7	grant	grant	NN	_	5	PMOD
8	from	from	IN	_	7	NMOD
9	the	the	DT	_	10	NMOD
10	ZMMK	zmmk	NN	_	12	NMOD
11	(	(	-LRB-	_	12	P
12	Center	center	NNP	_	8	PMOD
13	of	of	IN	_	12	NMOD
14	Molecular	molecular	NNP	_	15	NMOD
15	Medicine	medicine	NNP	_	13	PMOD
16	Cologne	cologne	NNP	_	12	LOC
17	)	)	-RRB-	_	12	P
18	.	.	.	_	3	P

